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CHJl.PTER 1 
JNl ROQUCTION 
Despite optimal anticonvulsant therapy, many e~ileptic patients 
continue to e~p~rience seizures. The reasons seizures occur o~ any given 
day or specific time of day often are not recognized ot~ understood. 
However, missed medication, alcohol abuse, sleep loss, the menstrual 
period, and emotional upsets are among the factors that have been 
suspected as being ·irnportant in modifying seizure threshold (Bennett, 
Nattson, Ziter, Calverley~ Liske, & Pratt, 1964; Gastaut & Tassinar·i, 1966; 
Glass & Mattson, 1973; Gowers, 1885; Mattson, Heninger, Gallagher, & 
Glaser, 1970; Mattson, Lerner, & Dix, 1974; Mattson, Pratt, & Calverley, 
1965; Pratt, Mattson, Weikers, & Williams, 1968; Servit, Dudas, Machek, 
Stercova, Kristof, & Cervenkova, 1962; Symonds, 1959). Infrequently, 
specific se11sory stimuli such as light, sound, or touch may tr-igger 
attacks (Mattson et al., 1974; Servit et al., 1962). 
Despite general agreement that these factors are important, little 
careful statistical data are avai1able to support these clinical 
impressions, and it is not known whether certain precipitating and 
inhibiting factors are important for specific seizure types or 
electroencephalographic patterns, Information about precipitating and 
inhibiting factors of epileptic seizures is based largely on clinical 
impressions or anecdotal case reports (Daube. 1966; Gastaut & Tassinari, 
1966; Gnwers, 1885; Servit et al., 1962; Symonds, 1959). 
1 
2 
For at least 100 years it has been recognized that seizures occur 
with menstruation (Gowers, 1885). Intensive studies of precipitating 
factors of epileptic seizures conducted at the Yale Epilepsy Center have 
indicated that 54% of u group of 100 epileptic women observed an associa-
tion between seizure occurrence and the menstrual cycle, and 85% of these 
women noted an increase in seizures dut·ing the premenstrual and menstrual 
phases of their cycles. In Qddition, 58% of the same group of epileptic 
women observed an increase in their 5eizures when they were emotio~ally 
upset (~1attson et al., 1974; Glaser, Note .l). However, this data, like 
that from previous studies examining the relationship between seizures 
and the menstrual cycle, ·js based only on ret;·ospective anecdotal repor'ts. 
Nonetheless, many investigators have concluded that the increase in 
seizures near the time of the menstrual period has been related to 
emotional factors (Bandler, Kaufman, Dykens, Schleifer, & Shapiro, 1957; 
Gastaut & Tassinari, 1966; Laidlaw, 1956; Logothetis, Harner, Morell, & 
TNTes, 1959). 
Recently, however, reports have indicated that changes in seizure 
frequency near menstruation have been related to hormonal changes. 
Specifically, research has indicated that seizures tend to be more 
frequent and severe just prior to and during menstruation when estrogen 
and progesterone levels are low: and less frequent during the luteal 
phase when progesterone activity is maximal (Backstrom, 1976a, 1976b; 
Backstrom & Carstensen, 1974; Backstrom & Jorpes, 1979; Hall, 1977; 
Laidlaw, 1956; Logothetis, Harner, Morell, & Torres, 1959). The 
probable anticonvulsant action of progesterone and lowered seizure 
threshold due to estroqen which has been demonstrated in animal studies 
~ . 
su9gest a link bc::tween ch;:~nges in hormone levels and epileptic seizures 
(Sanchez & Saldana, 1966). Increased stressful life experiences appear 
to result in increased levels of extra-gonadal estrogen (Speroff, Glass~ 
& Kase, 1973), so that a comb·lned effect of str·essful life experiences 
and fluctuating hormone levels due to phase of the menstrual cycle may 
interactively result in increased seizure frequency. Fluctuations in 
bioavailable antiepileptic drugs may also be a factor in seizure 
incidence {Fernandez & Zaninovich, 1975). 
Werboff (1961) postulated that sex steroids may exert direct 
effects on brain excitability by altering threshold and convulsive 
patterns, thus causing changes in seizure freq~~ncy as levels of sex 
steroids change. Espir (1969) also sug9ested C:t second mecha!iism by 
which sex steroids n~y influence seizure frequ2ncy: estrogen and oroges-
3 
terone may compete for binding sites with a1ticonvulsant drugs, thus 
causing a changed binding of anticonvulsant drugs and consequently changed 
brain excitability. 
Previous studies have not sufficiently controlled for hormonal and 
life stress correlates of seizures during the menstrual cycle. The 
purpose of the present study was to determ·i ne the hormonal and 1 i fe stress 
correlates of increased seizure frequency in epileptic women with relation-
ship to the menstrual cycle. 
The principal hypotheses were: 
H1 : Progesterone inhibits seizures and estrogen increases seizures; 
consequently, epileptic women should have the fewest seizures during the 
mid-luteal phase of their menstrual cycles when progesterone is high 
relative to estrogen; and converst:!ly, seizure frequency should be gr~eatest 
menstrually and premenstrually when progesterone levels are rapidly falling. 
A second seizure oeak might be expected to occur during ovulation, when 
estrogen is high relative to progesterone. 
H2: Stressful life experiences will be associated with increased 
seizure frequency independently of the phase of the menstrual cycle. 
H3: An interaction between low levels of progesterone and high 
levels of stress result in the highest seizure frequency. 
4 
The specific questions addressed by this study were: (a) Does 
progesterone inhibit seizures? (b) Does estrogen exacerbate seizures? 
(c) Does emotional stress result in increased seizure frequency? (d) 
Does an interactive effect occur between fluctuations in steroid hormone 
levels and high levels of life stress that results in increased seizure 
frequency? 
CHAPTER II 
REVIEW OF THE LITERATURE 
Factors Facilitating Epileptic Seizures 
The epileptologist is concerned with the questions ''What determines 
the onset of the seizure?" and "Once a seizure has begun, ~tJhy does it 
stop?" Symonds (1970) discusses a variety of patterns in the onset 
of seizures. Some epileptics experience seizures only at night; others 
only during the day. A lB.rge group experiences myocbnic jerks upon 
~tlaking, and r.ave learned that if they remain in bed fot· a half-hour after 
waking without engaging in any mental or bodily activity, they will not 
experience any seizures. Other groups of patients are particularly apt 
to have seizures after· a short night's sleep; while dropping off to sleep; 
and during sustained ::md concentrated mental activity of any kind. 
Symonds (1970) hypothesizes that in the transition between sleeping 
and waking the brain's arousal mechanisms are in a greater state of 
functional activity than usual, and are thus more easily excited to a 
pathological level. 
Various methods have been used to precipitate seizures for the 
purpose of diagnosis. One such method has been the combination of a 
maximal fluid ·intake with injections of pitr·essin. The physiological 
basis for this remains obscure but may be due to an excessive water 
intake and retention upsetting the electrolyte balance in ths brain~ 
favoring excitation and SEizures, 
5 
Seizures are also commonly precipitated by overbreathing. A 
proposed mechanism involves gamma-amino-butyric acid (GABA) which has 
a powerful inhibitory effect at synaptic junctions and is formed in 
6 
the brain from glutamic acid by the action of a decarboxylase and subse-
quently destroyed by a transaminase. Both enzymes are effective at 
the normal pH, but the decarboxylase becomes less effective and the 
transaminase more so with increasing alkalinity, Under normal conditions 
there is a steady state between the formation and decomposition of GABA 
so that its level in the brain remains constant. It is possible, there-
fore, that the alkalosis resulting from hyperventilation may facilitate 
convulsive activity by removing the C:ampening effect of GABA. 
Photic stimulation is another widely used method to evoke epileptic 
seizures on EEG recording~ and is recognized as a precipitati~g cause 
of petit mal seizures. Precipitation by visuJl stimuli of a mere 
elaborate kind is less common, but includ2s staring at patterns of 
fabric or clothing {Bickford, 1956), staring at small objects (Mitchell, 
Falconer, & Hill, 1954), and looking at lines converging to a point 
and rotating wheels. Seizures may also occur after prolonged reading. 
Auditory stimuli as precipitants of seizures vary from the most 
simple to the very complex, and sometimes the stimulation has to be 
prolonged. Examples in~lude unexpected loud noises, prolonged musical 
sounds, repetitive monotonous sounds, and the noise of machinery 
(Critchley, 1937; Symonds, 1959). 
The precipitation of attacks by tactile stimuli applied to the 
area primarily involved in focal seizures has been recorded, and it 
is generally observed that the stimulus has to be unexpected (Symonds, 
1959). Painful stimulation of the part involved in the seizure is also 
7 
a well-recognized precipitant. Passive stretch of the muscle or tendon 
is knmvn to provoke seizur·es especially of the myoclonic type; sudden 
voluntary movements can also precipitate seizures. Other precip·itants 
of seizures include visceral stimulation, coughing, intestinal contraction, 
distention of the urinary bladder, and sexual orgasm (Symonds, 1959, 1970). 
Investigating the phenomenon of the facilitation of seizures by 
psychological factOl~s is one of the main purposes of the present study. 
Of the long-lasting emotional states, pent-up anger appears to be mere 
effective than any other emotion in facilitating seizures (Symonds, 1970). 
Some patients with temporal lobe seizures state that a particular thought 
will start an attack, but some researchers have theorized that more 
probably the thought is the fit'st symptom of the attack (Symonds, 1970). 
However, among those patients whose seizures begin with particular 
thoughts, many are able to arrest their attacks by a deliberate switching 
of attention; or by some form of activity or stimulation related to the 
mode of onset of the attack and therefor~ presumably to the cortical 
cells in which the discharge arose (Symords, 1970). For example, a 
patient whose attacks began with a forced movement of the eyes to the 
left, might be able to stop his seizures by forcing his eyes back to the 
midline. In cases of this type, the promptness of the corrective action 
taken is a condition of'success in stopping the seizure. A hypothesized 
mechanism is that the stimulus emplc.yed sets up an inhib~t.:n·y process in 
the cortex which determines the cessation of excitatory discharges 
(Efron, 1956, 1957). Therefore, seizures can be suppressed by means of 
a training procedure, resulting in changes in patterned neural activity 
which would othendse be outside voluntary control (Efron, 1956, 1957; 
Kugelber·g & Hagbarth, 1958). 
Another example of the mechanism of a trainin3 procedure in the 
inhibition of seizures is provided by Efron (1956, 1957). Efron's 
8 
patient suffered from seizures arising in the left temporal lobe which 
included a transitory olfactory aura. He found that olfactory stimulation 
by essence of jasmine during the phase in \'~hich his patient was expecting 
her olfactory aura would arrest the attack. Subsequently a conditioned 
reflex was established between the smell of jasmine and the sight of a 
particular bracelet, and then between the smell of jasmine and the 
thought of the bracelet, until eventually the thought of the bracelet alone 
inhibited the seizure. In this case, repeated alteration of the sensory 
pattern eventually resulted in a reduction of epileptic activity, and 
the alteration was such that it might be expected to have an effect upon 
cortex in the immediate vicinity of the discharging focus. In the case 
of Efron's patient who had an olfactory element in her aura, an olfactory 
stimulus was employed. However, no one has ever successfully repeated 
Efron 1 s training procedure. 
Symonds' (1970) interpretation of these phenomena is that what 
happens to an afferent impulse once it has entered the central nervous 
system depends not only upon its own intensity and quality, but upon 
the quality and intensity of all other affert:nt impul ~es entering at 
the same time as well a~ upon what has previously happened. Epileptic 
seizures which appear to occur spontaneously arc determined by a coinci-
dence of many factors, among which afferent impulses are important. 
Symonds (1970) hypothesizes that most afferent impulses arc outside the 
field of perception. Thert:for2~ if certain stimuli are observed to 
precipitate attacks in some cuses (olfactory~ touch, puin, photic 
stin1ulation, and so on) it is reasonable to assume that many ~ore seizures 
are precipitated by affe~~ent imf}ui ses of ~.,rhi ch we may not he currently 
aware. 
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The contribution of emoti_ona l factors _!_o~_i l epti c seizures. 1\ 
major hypothesis of this study is that epileptic seizures are precipitated 
by psychological stress, as reported by the patients themselves, when such 
stress causes a high degree of excitation or change ft·orn everyday, usual 
levels of emotional functioning. Pruyser (1953) proposed that studies of 
psychological precipitants of epileptic seizures should take into account 
the following: 
1. A longitudinal approach to the psychological correlates of 
seizures is appropriate, in which the patient is studied from day to 
day, or from hour to hour, and the focus of the study is on the changes 
that take place in the important psychological variables. The p~tient 
should be his own control subject. 
2. Post-seizure states are just 3S imrartant to consider as pre-
seizure states, and a more or less normal baseline has to be established 
from observations in the inter-seizure period. 
3. The assessment of facts at eny point on the time axis should 
be comparable, based on identical techniques and cast in an identical 
conceptual system. 
4. Inferences from data thus obtained do not imply a causal 
relationship between psychological and somatic ever1ts, but rather at 
best a synchronous relationship. Only when a definitely synchronous 
relationship has been established can one begin to think in terms of 
causality. 
However, not all studies of psychologicQl variables associated 
with epileptic sc~izures have employed Pruyser's {1953) rc:commendations, 
10 
which may be one of the reasons for the equivocal findings of different 
stud·i es, 
Allen (1956) studied two large groups of epileptic patients to 
determine the precipitating causes of their seizures, In the first 
group of 622 cases he determined through history and clinical examination 
that emotional factors influenced the occurrence of epileptic symptoms 
in 20.8 percent of the cases. In a second series of 182 cases he found 
emotional precipitants of seizures in 27.5 percent. Detailed examination 
of these cases revealed the following factors occurring in some of the 
instances: (a) Some patients manifested a steady increase of emotional 
tension for periods which varied in duration from two or three days up 
to three months before the epileptic seizure or a series of seizures 
occurred; and relief from this increase of emotional tension for an 
appreciable time after the seizure or the end of the series of seizures. 
(b) Another pattern was a rapid increase of emotional tension, sometimes 
with the appearance of manifest emotion, for a short time and at most 
for a few hours before the onset of the attack or series of attacks, 
followed by relative relief after the attack or series of attacks had 
ended. (c) In sorr.e cases the patient manifested anxiety in the form of 
hyperventil~tion, which resulted in alkalosis and other biochemical 
changes and then the appearance of an epileptic seizure. (d) Cases were 
seen in middle-aged individuals in which a rise in systolic blood pressure, 
sometimes accompanied by~ rise in diastolic pressure and ?ulse rate, 
appear on a background of anxiety and tension. The patient becomes more 
likely to develop seizures during periods of tension compared to other 
times. 
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Allen (1956) reports that in almost all the cases in which the 
emotional factor was related in some way to the occurrence of the epilep-
tic attack or a series of such attacks, the emotional tension with its 
accompanying symptoms appeared to be of a general character and not of 
a type associated with and due to the occurrence and site of the epilep-
tic discharge. In some patients a background of a lifelong accumulation 
of emotional tension existed, epileptic seizures occurred, anxiety 
relating to the seizures developed, and eventually a vicious circle was 
up with rapid aggravation of the patient's epileptic symptoms. 
These data naturally suggest a central hypothesis of the present 
study, namely, that patients with h·igher life stress scores (as measured 
by the Schedule of Recent Experien~es and the Life Events Diary) have more 
seizures than do patients with lower life stress scores. Patients who 
have more seizures might also be expected to have higher life stress 
scores on a yearly, as well as on a weekly basis. 
In 1937, Critchley obse·rved that in musicogenic epilepsy, fear or 
other negative emotions or physiological accompaniments of emotion 
intervened between the appropriate stimulus and the epileptic discharge. 
Allen•s (1945) observations on reflex epilepsy showed that cases in 
which there was some manifest emotion or symptoms usually associated 
with emotion after the stimulus and before the seizure were characterized 
by a delay between the stimulus and the seizure. Alle;1 (1948) also 
found that the onset of myoc l orii c seizures was often precipitated by an 
emotional crisis or ths development of a stc:te of anxiety tension. 1\:trcks 
accompanied or followed by automatisms (A~len, 1S5l) occurred in all but 
two of 35 patients who showed clear evidence of e@otional stress; in 
some patients autom.'ltisms occurr-ed in ccnjunct·iun with their .;;eizures 
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only during periods of strong emotional tension. 
Fremont-Smith {1934) showed that in 31 of a series of 42 pati~nts 
some emotional situation related to the occurrence of the convulsion, 
and also showed that alleviating the emotional tension lessened the 
frequency of seizures in his cases. Cobb (1936) stated categorically: 
"Emotional stress often precipitates a convulsion in a patient v1ho has 
a tendency to such a seizure. This does not mean that 'epilepsy' is 
'psychogenic', but it does mean that psychological factors act physically 
on the organism and produce symptoms." 
Bridge (1947) reviewed 22 cases of epilepsy in children and examined 
the influence of emotional factors. Bridge found that commonly the first 
seizure followed some emotional episode; recurrence of attacks could 
often be related to placement of the child in foster homes or adoption; 
and many children improved with psychotherapy al~ne and remained free 
from seizures. Richardson (1952) surveyed cases of epileptic seizures 
with predominantly psychic symptoms and described the emotional precipi-
tation of attacks in some cases of reflex epilepsy. ParlJnd (1953) 
illustrated the influence of emotional factors by describing the occurrence 
of seizures following emotional experiences accompanied by inner conflicts 
and guilt; and pointed out that the prel-iminat'Y emotional tension might 
arise from fear, resentment, or guilt. Other \"tt'i ters who d2scri bed 
cases in which epileptic seizures occurred subsequently to stressful 
emotional experiences are Barker (1948)~ Edelston (1949), and Gottschalk 
(1953' 1955). 
Liberson (1954) proposed several mechMii~rn.:; to t'XDlain emotiorlally-
induced seizure activitJ. Err.otiona1 stimul"i may imhce a convulsion 
through the creation of a general excitatory state with an ~xc~ssive 
formation of either acetylcholine or insulin. Acetylcholine is a 
powerful convulsant; and excessive insulin can lead to hypoglycemia, 
which can also precipitate seizures in susceptible individuals. Another 
general mechanism may be through the influence of stress and emotion 
upon cortico-adrenal activity which is known to participate in the 
control of electrolytic balance and water metabolism. A disruption of 
this balance may contribute to the triggering of a seizure. 
Another mechanism as discussed by Liberson (1954) is that brain 
structm'es which med·i ate emotion a 1 experiences, such as the rh·i nencepha-
lon (olfactory brain), may be sensitized because of some local patholo-
gical process. If this occurred, then these areas could be induced into 
an epileptic discharge by stimuli having an emotional significance for 
the individual. The stimulus may be highly individualized and constitute 
a conditioned stimulus of certain types of affective states, which 
produces epileptic seizu-res coming from those areas of the brain \'..Jhich 
participate in the control of emotional processes. 
Caveness (1955) differentiates between emotional problems that 
arise as a reaction to seizures; emotional problems that act as a 
precipitant to seizures; and emotional problems that contribute to the 
pattern of seizures, which in order to be interpreted correctly must 
be made with ful"J appreciation of the e.natornical and pi1_ysiological 
substrata. Caveness (19S5) reports on two cases in which emotional 
factors prccipitJt~d seizures, and in which personality changes later 
occurred as a reaction to the stress of recurrent seizures. 
Friis and Lund (1974) studied 1,250 pacients with convulsive 
disorders over a 13-y0ar period, and identified 37 patients who had 
convulsive attacks pl'ecec!ed by severe stress. The method of i dent ifyi ng 
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these patients and their seizures was by clinical interview and review 
of case records. In this group, stress convulsions were twice as 
frequent in men as in women; no explanation for this phenomenon was 
given. Friss and Lund (1974) found that lack of sleep was the commonest 
stress factor precipitating seizures, followed by emotional strain and 
somatic over-exertion. However, the authors failed to further define 
"emotional strain." One or more of these three stress factors was 
reported prior to all convulsive attacks in this group of patients. The 
authors suggested avoidance of the provoking factors as prophylaxis; 
therapeutic doses of anticonvulsants did not prevent recurrence of 
stress-provoked seizures. Barker and Barker (1950, pp, 90-113) and 
Stevens (1959) have shown that mental stress may cause EEG changes in 
patients suffering from epilepsy. 
Williams (1975) observed that in surveying his own neurolog~cal 
practice over a period of twenty years. only about tvw percent of his 
patients had neurosurgical causes for convulsions or advancing gross 
structural disease. This being the case, Williams (1975) considered 
what might be the precipitants of seizures in any particular instance for 
the vast majority of epileptics, ahd advanced the hypothesis that most 
seizures are the result of an accumulation of physical and emotional 
stress factors: 11 Either a set of predisposing events will anticipate 
immediate serial misfortunes in a predisposed person to culminate in a 
fit; or the v1rath of God in the form of fr.tigue~ fevers, furies, frustra-
tions or fates will together m:1ke a fit 2qual1y inevitc-,b'le,,. From 
Williams' (J975) observations of the patients in his own practice, he 
further asserts that controlled, obs~~sional epileptics who do not 
ventilate their emotions but keep them insic!2 \'l'het·e thei;- feelings build up~ 
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are especially prone to seizures when stressful life experiences intervene. 
A difficulty in assessing ~lilliams' observations occurs, however, beco.use 
he presents no experimental measures of stress, or of the relationship 
of stress to seizures. His statements are limited to clinical observations. 
Glass and Mattson (Note 2) compared temporal iobe epileptics, focal 
non-temporal-lobe epileptics and centrencephalic epiieptics on a variety 
of measures. They found that the Wechsler r~emory Quotients of the 
temporal lobe epileptic (TLE) group were significantly below those of 
the generalized group, while the focal group did not differ significantly 
from the others. Comparisons between pairs of groups showed no significant 
differences on any of the validity and clinical MMPI scales, although the 
TLE group generally showed the most elevated scores, and the generalized 
group the least elevated. 
In the Glass and Mattson study (Note 2) all groups were asked to 
make self-reports on the extent to which they believed nine different 
emotional states caused an increase in seizure frequency. Roughly 
equivalent percentages of subjects in the Temporal Lobe Epilepsy group 
(75%), the Focal Non-Temporal-Lobe Epilepsy group (65%), and the 
Generalized group (75%) reported that some emotional states caused an 
increase in seizure frequency. Although none of the individual category 
differences reached sigriificance, the Temporal Lobe Epilepsy group 
reported a mean of 2.5 of the 9 possible states as resulting in increased 
seizure frequency, as compared to the mean of 1.6 for the Generalized 
group and 1.9 for the Focal group. The results suggest that temporal 
lobe epilepsy, and to a lesser degree other focal epilepsy, are related 
to both heightened Mti:PI psychopathology and sensitiv·ity of se·izUi~es to 
emotional precipitation. In the analysis of the effects of emotional 
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states on seizure frequency, the inter-group differences found here 
indicate that range of sensft~vity across a spectrum of emotional states, 
rather than simply presence versus absence of such effects, may be 
intrinsically related to seizure type. 
Mazurowa and Popielarska {1976) studied the effect of parental 
attitudes on the occurrence of psychological problems in epileptic 
children. In studying the case reports of 272 patients (146 boys and 
126 girls) treated in the psychiatric department and out-patient clinic 
at the Institute of Paediatrics of the Hedical .lkademy in Warsaw for at 
least three years, three main patterns of parental attitudes towards the 
epileptic child were recognized: (a) an overprotective attitude (58%); 
(b) an inconsistent attitude (32%); and (c) a rejecting attitude (8%). 
The authors assert that certain psychological disturbances occurred as 
a function of these parental attitudes, in the form of abnormal develop-
ment of emotions and cognitive functions as well as abnormal social 
adaptation. Mazurowa and Popielarska (1976) stress the widespread 
occurrence of incorrect parental attitudes and the necessity of psycho-
therapeutic influence on the parents. 
Mood disorders present in epileptics may be qualitatively or 
quantitatively different from mood disorders in non-epileptics. 
Taylor (1977) notes that the consensus of current literature is that 
there is an increased risk for schizophrenia in people with temporal lobe 
epilepsy. Cazzullo (1959) discussed thE: a1terations in consciousness 
that occur in epileptics as a direct consequence of their seizures. 
Scott (1977) discusses the interrelatedness of psychiatric 
problems and seizures in epileptic children and adolescents. He 
observes that seizures and psychiatric ryroblems can combine to produce 
both genL1ine epileptic attacks and functional attacks in the same 
patient. Scott (1977) emphasizes that children who are incapacitated 
for wh~tever cause have an increased psychiatric morbidity, and 
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epilepsy is_one of the disorder~ of the brain which leads to psychiatric 
problems. However, these psychiatric problems are not of a particular 
type and there is no evidence of what has been ca 11 ed the epi"l epti c 
personaiity. The cause of psychiatric disturbance is the same in both 
epileptic and non-epileptic children, including such factors as maternal 
psychiatric illness and broken homes. Points of importance in the genesis 
of psychiatric morbidity appear to be early onset of epilepsy, chronicity, 
and brain damage. Seizures with EEG evidence of temporal lobe dysfunction 
are particularly likely to be associated with psychiatric disorder. 
Semenov and Kamenskaya (1973) studied the effects of mental and 
emotional stress on the convulsive susceptibility of 100 epileptics with 
various types of seizures. Emotional stress was induced by stimulating 
recall of mental images of situations associated by the patient with 
positive or negative emotions; an EEG recording was made during the 
stimulation of emotional stress. Semenov and Kamenskaya (1973) noted 
no constant specific factors which may cause seizures; any afferent 
stimuli, mental activity, or emotional stress, depending on the degree 
of the changes in the state of brain function and reactivity and the 
localization of the pathological focus, can enhance convulsive suscepti-
bility and provoke paroxysms. Hov1ever, the authors did find that emotion-
a 1 factors may pt·ovoke and increase the frequency of paroxysmal activity 
in patients with multiple foci, and also in patients with subcortical and 
temporal foci. The mental recall cf negativ2 emot~ons induces responses 
with i nt:reased paroxys!na 1 activity more fr'equen"!:ly th1n the reca n of 
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positive emotions. Thls r~sult suggests that n0t ' Orll:/ i:hc :-; tr-ength of 
emotional stress, but also the quality of emotional reactions is 
important. 
The general relationshio between epileptic seizures and menstruation. 
Gastaut and Tassinari (1966) discuss various triggering mechanisms they 
have found in epilepsy by reviewing their own cases and by reviewing the 
literature. They found that all types of seizures have been reported to 
increase in frequency and intensity as menstruation approaches. These 
authors also found that puberty plays an important role in the genesis 
of seizures, especially in females, often coinciding with the appearance 
of generalized tonic-clonic seizures or, less commonly, of partial 
seizures. On the other hand, puberty often marks the disappearance of 
generalized non-convulsive absence seizures which can sometimes be 
replaced by generalized tonic-clonic seizures. Menopause can lead to 
the reappearance of seizures which had disappeared long ago. Pregnancy 
may reduce or entirely repress seizures, which appear again after 
delivery (Klessens, 1948). Gastaut and Tassinar·i (1966) conclude that 
cyclic seizures depend on factors modifying generalized biologic constants, 
especially a global modification of the threshold of cerebral excitability, 
which are extrinsic to the epileptogenic focus. 
Gastaut and Tassinari (1966) also cite episodes of rest following 
sleep deprivation, or physical or intellectual fatigue as precipitating 
the appearance of epileptic seizures. Emotions may also trigger 
seizures, but Gastaut and Tassinari (1966) note that in none of their 
own cases were they able to collect objective proof of the relationship 
bf•tVJeen the emotion and the seizure,· Their observations of the relation-
ship between emotions ar:d seizures •t~ere based exc1usively on the subjective 
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report of the pctti ents or thei t tem'il i e5. Ti1ey a 1 :;o noted that th~y 
have been able to collect only ten patients whose seizures were regularly 
provoked by ~notions; 
Dickerson (1941) followed 269 female epileptics for one year, and 
found that only 10~~ showed a relationship between menstruation and 
seizure incidence. During this calendar year, Dickerson noted an average 
of only four periods per patient, indicating marked menstrual irregularity. 
Sutter and o•Eshougues (1949) discussed the relationship of 
menstruation to epileptic seizures, and stated that the slighter the 
local, nervous system predisposition to seizures, the more pronounced 
will the general disturbance have to be, such as hormonal changes during 
menstruation, before general disturbances can produce an attack. 
Aird and Gordan (1951) obtained an anticonvulsant effect in eleven 
patients with refractory epilepsy using desoxycorticosterone acetate 
in the form of oral tablets in a double blind study using placebos. 
While desoxycorticosterone acetate was shown to be a good anticonvulsant 
by its increasing of the threshold of electroshock, co·ttisone and cot·tisol 
were found to be convulsant using the same method. In vitro studies by 
Michaelis and Quastel (1941) showed an anesthetic effect of steroids which 
was dependent upon the inhibition of the utilization of glucose and 
oxygen by brain tissue. Brain cells respiring in a glucose substrate 
take up oxygen at a fairly constant rate and the addition of steroids 
produces a prompt inhibHion of the rate of oxygen uptake by these cells. 
The mast potent steroids producing the effect \'Jere desoxycorticosterone 
and progesterone. The site of inhibition was shown to be probably at 
the dehydrogenase level rather than the cytochromes where other 
anesthetic agents exert this effect. 
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If steroids can inhibit the oxygen uptake of the brain, the 
hypothesis seems reasonable that stercids can act as brakes on cerebral 
metabolism (Sanchez L0~go & Gonzalez Saldana, 1966). Sin~0 progesterone 
· is one of the steroids that lowers oxygen uptake and reduces ce~ebral 
metabolism, increased progesterone should tend to raise the convulsive 
threshold and produce an inhibiting or protective effect against seizures. 
Tsung-Yi, Greeribl~tt, and Solomon (1952) report on one case of 
petit mal epilepsy, and found that petit mal EEG discharges were the 
most irregular when their patient was menstruating, even more irregular 
than when she missed her medication. 
Laidlaw {1956) surveyed fifty women who had 33,468 seizures over 
939 patient years, and concluded that 72% of these patients had an 
incl~eased incidence of seizures immediately before, during, and after 
menstruation, with a markedly reduced incidence of seizures during 
ovulation and the mid-luteal phases of the cycle. Unfortunately, 
Laidlaw (1956) did not take b1ood samples from his subj~ct.s to analyze 
their estrogen and progesterone levels, so he could not prove that the 
women had ovulated. The present study indicates that epileptic women 
have a high incidence of anovulatory cycles, so hypotheses about 
changes in seizure frequency due to or correlated with changes in hormone 
levels need to be substantiated by measurement of hormonal levels at 
different stages of the cycle. 
Ansell and Clarke (1956) investigated the role of water retention 
and sodium metabolism in epileptic seizures during the m2nstrua1 cycle. 
Of the 148 female epileptics they studied, 63% reported more seizures 
during menstrual bleeding or dudng the twenty-four hours immediately 
Pl'eceding it; in fact, in some cases the seizures occurrPd more commonly 
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with the periods than before them. This relationship seemed to be 
equally common in both idiopathic and symptomatic groups. The premenstrual 
syndrome \vas no more common in epileptics th3.n in healthy 'tJOmen, and it 
seemed to be as common in those with as in those without a menstrual 
aggravation of seizures. 
In investigating water retention, Ansell and Clarke (1956) found 
no differences in changes in water retention between epilepttcs and 
non-epileptics, and there was no difference between those with and those 
without a menstrual exacerbation of seizures. When body weight and 
seizures were charted, there was no correlation between the greatest 
increase in weight and increased incidence of seizures; nor was there a 
correlation between the degree of premenstrual stress and the edema. 
Ansell and Clarke (1956) conclude that premenstrual edema does not 
play a primary role in the pathogenesis of menstrual epilepsy. The 
authors also found that alteration of sodium metabolism, with consequent 
retention of water before and during the menstrual period, was also not 
a prime factor in the pathogenesis of menstrual epilepsy. If water 
retention is not directly responsible for the premenstrual and menstrual 
exacerbation of epileptic seizures, Ansell and Clarke {1956) suggest that 
the complex hormonal changes that produce water retention may play a 
prominent role. 
Bar:dl er, Kaufman, Dykens, Schleifer, and Shapiro {_1957) reviewed 
the literature relating epileptic seizures to menstruation, and noted 
that in most instances up to the ·time of their report the relatedness is 
a clinical impression rather than a statistical conclusion, ~andler 
et al. (1957) also noted that up to the time of their report, no studies 
\'Jere availab·le which offered data about the normality of the menstrual 
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cycle in epileptic vJOmen with respf~ct to length a.nd ovulation; thus, 
no knov1ledge was available (tS to V'hethcr epileptic worJen es a group 
ovulate or net. Bd~dler et al. (1957) defined each menstr~a1 ~ycle by 
. means of daily vayinal smears and b~sal temperature records into five 
phases: ovulation, progestation, prem2nstruation, menstruation, and 
proliferation. They found that 23 of the 29 subjects studied over a 
period of three years ovu·iatcd every cy:le, ar.d the rer::aining six 
ovulated in at least half the cycles; they conclude that epileptic 
women have normal ovulatory menstrual cycles. The present study will 
demonstrate that the group of women that were followed do not have 
normal ovulatory menstrual cycles. Sandler et al. (1957) also examined 
the relationship between phases of the menstrual cycle and seizures by 
applying the chi square method to a comparison of the percent time 
represented by each phase and the percentage of all seizures occurring 
in that phase fo·r each woman. By using this method, they found no 
significant increase of seizures during any phase. For Sandler's sample, 
seizures occurred at random throughout the menstrual cycle. 
Bandler et al. (1957) also raise the issue of why their sample of 
women have a tendency to relate seizures to the menstrual cycle, when 
statistical analysis shows no relationship. They believe the answer 
lies in the psychological significance of menstruation and the dynamic 
meaning of a particular phase of the cycle to the patient at that 
particular time; for example, a patient with a strong unconscious wish for 
a child may sudden1y have many seizures at the time of ovulation, These 
hypotheses, however~ remain speculative. 
Zaichkina (1963) studied sixty pat-ients suffering fr-om mc::nstrual 
epileptic seizures. In twenty-five cases the connection between the 
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men3trual cycle and epilepsy was apparent only at a definite period, 
namely at puberty, in pregnancy or during the puerperium. During the 
pre-menstrual period 40 of the patients had severe vegetative disorders 
and 30 suffered from nervous tension. Many were found to have endocrine 
. disorders and low blood pressure. Serial evaluation of sex hor·mones 
in the urine at various stages of the menstrual cycle revea1ed two 
types of deviation from normal ex(:retion according t.o which the patients 
could be divided into two groups: one with hyperfolliculinuria (200 to 
250 mg. of estrogens excreted) and the other with hypofolliculinuria (70 
to 130 mg. of estrogens excreted). In the first sroup the excretion of 
pregnanediol was decreased, especially during the premenstrual period, 
while in the second group pregnanediol was excreted in excess. It was 
noted, however, that over a number of cycles the hormonal activity 
varied in one and the same patient. Zaichkina (1963) concludes that the 
deterioration of the patients• condition during the premenstrual and 
menstrual periods is not due to an increase or decrease in one or the 
other hormone, but to a disturbance of their balance. Zaichkina (1963) 
postulates that because of the role of hormonal disturbances in cata-
menial epilepsy, a combination of cortical temporal and diencephalic 
factors operate in these cases. Treatment should therefore consist of 
both anticonvulsants and hormonal preparations. 
Sanchez Longo and Gonzalez Saldana (1966) report on three 
epileptic women who had seizures which occurred during menses or just 
prior to the onset of menses. In one of their patients, administration 
of the oral contraceptive Enovid, which contains both estrogen and 
progesterone, resulted in complete control of an her seizures. 
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' Enovid contains 65 times more progEsterone than estrogen in the mixture. 
Sanchez Longo and Gonzalez Saldana (1966) also report on their 
overall clinical experience with epileptic women and observe that 
ovariectomy reduces epileptic seizures in patients; seizures often begin,· 
or preexisting attacks recur or worsen at the menarche; seizure incidence 
is significantly depressed at the menopause in some instances; and 
estrogens appear to aggravate the epileptic condition. 
Sallusto and Pozzi (1964) reported the cas~ of a female patient 
who suffered convulsive seizures before puberty and later at menopause, 
but not at all during her reproductive years. The authors attributed 
the occurrence of the seizures at these times to the absence of proges-
terone activity, and hypothesized that during the fertility years the 
balance of estrogen-progesterone p·revented the occurTence of seizures. 
Backstrom (1976) made comparisons bet'v"Jeen the number and severity 
of seizures in epileptic women and their estrogen/progesterone ratios 
across different phases of their menstrual cycles. A comparison between 
10 days with high estrogen/progesterone ratios during the follicular 
phase, and low estrogen/progesterone ratios during the luteal phase 
showed that both the number and severity of seizures was significantly 
higher during the follicular phase than during the luteal phase. This 
is in agreement with Laidlaw's (1956) demonstration that seizures are 
mildest during the luteal phase, and Logothetis et al. 's (1959) induction 
of grand mal seizures by treatment of epileptic patients with estrogen. 
Rosciszewska, Dudkiewicz, and BlachJrz (1976) carried out cyto-
hormonal investigations during the menstrual cycle in 16 epileptic \>!omen 
aged 18 to 38, Estrogenand progesterone levels were calculated, a-nd 
the authors found that in all but two cases the hotmonal fluctuations 
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were abnormal. In 13 patients hypoestrogenic cycles were observed 
without adequate progesterone activity in the luteal phase; and in one 
patient 8strogen levels were abnorm<1lly high, The authors hypothesized 
that very long anticonvulsant treatmerit as well as lower efficiency of 
·the hypothalamo--hypophyseal system may c'educe the level of steroid 
hormones produced by the ovati es. 
Backstrom and Jorpes (1979) studied the relationship of serum 
anti-epileptic drug levels to the plasma concentrations of estrogen and 
progesterone. Six ov~latory and three anovulatory cycl€s were studied 
in seven patients with epilepsy, all of whom had been maintained on a 
constant dosage of anticonvulsant medication for at least one month prior 
to the investigation. Blood samples were taken every day. No co~relations 
\'Jere obtai ned between the p 1 asma hormone concentrations and the serum 
levels cf the anti-epileptic drugs. Backstrom and Jorpes (1979) conclude 
that there is no evidence that the relationship between the seizure fre-
quency and plasma hormone concentrations shown in a previous study 
(Backstrom, 1976) was related to a change in serum levels of the anti-
epileptic drugs. 
Summarizing the material presented in this section, the majority 
of authors have observed more seizures to occur just prior to and during 
menstruation in epileptic women. These authors have also observed that 
progesterone tends to inhibit seizures, while estrogen tends to exacerbate 
seizures. However, none of the studies presented above are carefully 
controlled statistical studies in which hormone levels and seizure frequency 
are systematically recorded, Most of the studies done to date relating 
epileptic seizures to the menstrual cycle ~re clinical case reports. 
rather than studies following a large number of women over an extended time. 
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The hormo~al org~i_z_Ejion of_the lll.~!~~_r~J-~tj_~cle~_E-nd "its r§la!ion-
ship to stress ~!!S!_epil~tic seizures. The organization of the human 
mensttual cycle occurs through the interplay of hormones produced in 
the hypothalamus, the p·ituitary, the ovaries, and the placenta. During 
menstruation, the hypothalamus responds to the low levels of estradiol 
with the production of the follicle-stimulating hormone (FSH) secreted 
by the anterioJ~ pituitary. The s··;ng-le egq discharged each month from 
one or the other o·..;ary matures in a follicle. This fc.llicle grmvs in 
size and in number of cells during the early part of the menstrual cycle 
under the jnfluence of FSH. As the follicle gro~tJs, its cells secrt:te 
the estrogenic hormones, chief among them 2str·adiol, that act on both 
the pituitary and the uterus. The feedback to the pituitary reduces the 
output of FSH; the effect on the uterus ·is to stimu·!ate the growth of 
the uterine wall and its glands. 
As the follicle approaches full size, FSH output decreases while 
levels of estradiol increase, finally reaching a critical level at 
which a positive feedback on the hypothalamus results in the midcycle 
luteinizing hormone (LH) surge necessary for ovulation and the formation 
of the corpus luteum. LH completes the maturation of the egg and triggers 
the rupture of the follicle, discharging the egg into the oviduct. It 
also causes the residual follicle cells to be transformed into the 
corpus luteum, vvhich secretes a second ovarian hormone, progesterone, 
that acts on the uterine wall to sensitize the uterus to contact with 
the blastocyst cells if fertilization occurs. If pregnancy does not 
occur, a new set of ovarian follicles begin to grow, and the corpus luteum 
derived from the ovulated follicle begins to decline. The demise of the 
corpus luteum results in a fall in progesterone 1evels 5 which produces 
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degenerative changes in the uterine wall, and menstruation beains. The 
low levels of progesterone and estradiol cause the hypothalamus to begin 
producing FSH again, and a new cycle is initiated (Grobstein, 1979)i · 
This recycling mechanism is regulated in large part by estradiol. 
The negative feedback relationship of estradiol with follicle-stimulating 
hormone (FSH) results in the critical initial rise in that gonadotropin 
during menses, and the positive feedback relationship of estradiol with 
luteinizing hormone (LH) is the ovulatory trigger. Estradiol may there-
fore be viewed as the signal for appropriate hypothalamic-pituitary 
responses in this system. Two possible types of signal failure may 
occur: (a) levels of estradiol may be inadequate to produce the positive 
stimulatory effc-cts necessary to induce the ovulatory surge of LH; and 
(b) estradiol levels may not f~ll low enough to allow sufficient FSH 
responses for folliculal~ stimulation. 
In this second instance, the necessary decline in blood estradiol 
requires cessation of secretion, appropriate clearance and metabolism, 
and the absence of a significant contribution of estradiol to the 
circulation by extragonadal sources. 
Extragonadal contribution to the blood estrogen level has assumed 
recent and significant importance (Speroff, Glass, & Kase, 1973). 
While the adrenal gland does not secrete appreciable amounts of estrogen 
into the circulation, its normal function contributes to the total 
circulating levels of estrogen. This is accomplished by the extragonadal 
peripheral conversion of C-19 androgenic precursors, such as androstene-
dione, to estrogens. In this manner, psychological or physical stress 
may increase the adrenal contribution of estrogenic precursor, and 
subsequent conversion to estrogen may sustain the blood level nf estrogen 
at a time when a decline is necessary for succr.ssful reeycling of the 
menstrua 1 system. Ancvul a tory cyci es wi 1l resuH. 
From the above, the author suggests that greater reported stress 
would be associated with a larger number of anovulatory cycles for 
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the epileptic women in the current study. Also, since high estrogen 
levels are associated with an increased frequency of seizures among 
epileptic women, one could expect a higher incidence of seizures during 
anovulatory cycles than during ovulatory cycles, when the protective 
effect of progesterone is present. Then, if stress produces anovulatory 
cycles which are characterized by high levels of estrogen, and if high 
levels of estrogen produce seizures, then high levels of stress should be 
associated with a high frequency of seizures, even when only the hormonal 
mechanisms are taken into consideration. 
Beta-biocket·s and their proposed relationshi_p_to stre~s ~nd_ 
epileptic seiz_ures. Beta-blockers are substances \'fhich competithc.ly 
and reversibly block beta-adrenergic Y'eceptors in the sympathetic nervous 
system, therefore acting as antagonists of noradrenaline and adrenaline 
(Brunner, 1977). As such~ beta-blockers ha.ve an xi clyti c (anti-anxiety) 
effects, since increased adrenaline and noradrenaline release is· 
specifically associated with anxious emotional states (Carruthers, 1977). 
Beta-blockers have been proven to be useful in combating clinical 
anxiety and phobias (Gosling, 1977; Lader, 1977). The effectiveness of 
small doses of oxprenolol (Trasicor) in reducing anxiety symptoms could 
be accounted for by postulating that this treatment interrupts a self-
perpetuating spiral in which anxiety leads to adrenaline secretion and 
learned peripheral sympathomimet·icsyrnptoms ·increase the anxiety still 
further (Breggen, 1964). Hypotheti ca 1ly, then, the au tho;~ suqg~?s ts 
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that beta-blockers such as oxprenolol (Trasicor) might be used by 
epileptics who are experiencing high degrees of stress, as a way of 
reducing seizures precipitated by stress. A possible side effect, which 
should occur only rarely if at all (Pichot, Olivier-Martin, & Poggi6li, 
1977), is drowsiness. However, Krishnan (1975) administered oxprenol~l 
to nervous students studying for an examination, and concluded that the 
oxprenolol did not interfet·e with the students' critical faculties and 
therefore may be of value in treating people who have to face stressful 
situations calling for unimpaired cerebral function. 
Since increased stress in epil~ptics should lead to increased 
adrenal production, and since increased adrenal production causes extra-
gonadal production of estrogen, which leRds to a higher seizure frequency 
and anovulatory cycles as already discussed, administration of beta-
blockers to epileptiss may result in a positive feedback loop in which 
seizures due to both increased stress and increased estrogen production, 
and to the cause-and-effect relationship between stress and increased 
estrogen production, are controlled. 
Beta-blockers have already been given a trial in the prevention 
of the occasional tachycardia provoked by driving in busy traffic, the 
correction of cardiovascular and metabolic changes caused by public 
speaking, the treatment of catecholamine-induced symptoms in professional 
musicians, and the relieving of examination nerves in students (Siitonen 
& Janne, 1977). Beta-blockers can be used with success in cases of 
anxiety and tension~ especially since they seldom produce unwanted side 
effects and do not give rise to drowsiness. Beta-blockers have been used 
in sports medicine in order to prevent the cardiovascular effects of 
intense emotional stress, such as that associated with car racing or 
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ski .jumping. From most of the studies published .it appears that small 
doses of beta-blockers d6 not impair either mental or physical performance; 
on the contrary, they may even improve H (Si itonen & Janne, 1977). 
Theodes ex.E}aining catam·enial epilepsy. Thiry, Heusgem, and 
Legentil (1954) found one-third of a group of 58 women with catamenial 
epilepsy {seizures aggravated during menstruation) to suffer from 
hyperestrogenuria, further evidence for the disruptive role of estrogen 
in causing increased seizure frequency. Thiry et a1. (1954) also raised 
the question of whether the endocrine disturbances observed are the 
consequence of disturbance or dysfunction of the diencephalic centers 
reacting on the hypothalamohypophyseal system. Their results suggested 
some degree of depression of the hypothalamohypophyseal system from the 
barbiturate treatment which the majority ol" these patients received for 
their seizures. 
Logothetis, Harner, Morell, and Torres (1959) reviewed the main 
theories to explain the increased incidance of seizures shortly before 
or during menstruation in about 50% of epileptic women: (a) Premenstrual 
psychic disturbances and emotional instability have been thought to be 
of primary importance in the precipitation of seizures. Against the 
exclusively psychogenic theory is the fact that, although psychic pre-
menstrual disturbances usually disappear with the onset of menses, 
exacerbation of seizures usually continues during the menstrual flow. 
(b) Water retention has been thought to be partly responsible for the 
symptoms of the premenstrual syndrome. (c) Progesterone is suggested to 
have anticonvulsant properties, si nee se-izures are fe~·Jest when progesteror,e 
levels are greatest. (d) Estrogens appear to aggravate seizure frequency; 
when they are given to epileptic women premenstrua1ly, seizures increase. 
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Logothetis et al. (1959) injected Premarin, an estrogen, into 16 epileptic 
women, and observed clear activation of eleEtroencephalographic abnormal-
ities in eleven of these women within 20 minutes of injection. Thirteen 
patients were given 20 mg. of Premarin, resulting in clinical. seizures 
12 to 24 hours after injection in one patient. Three patients were given 
40 mg. of Premarin; all three had seizures fifteen minutes to a few 
hours after injection. The occurrence of seizures hours after injection 
of Premarin suggests a convulsive effect of estrogenic substances. If 
naturally occurring estrogen does precipitate seizures, one would expect 
seizure frequency to be greatest shortly before ovulation, when estrogen 
levels are highest. If, on the other hand, high levels of estrogen 
increase seizures while at the same time progesterone acts as a seizure 
inhibitor so that rapidly falling levels of progesterone increase seizures, 
two peaks of seizure activity during the menstrua·! cycle might be noted: 
(a) the first, shortly before ovulation when estrogen is at its peak; and 
(b) the second, immediately pre-menstrual"!y ar.rl m2nstrually when pt·oges-
terone levels Rre lcwest. 
Logothetis et al. (1959) note that if seizures are precipitated by 
increased estrogenic activity, admin1stra~ion of hormones having anta-
gonistic properties to estrogen, such as testosterone and progesterone,. 
may help prevent attacks~ Logoth2tis et al. (1959) observed improvement 
in 3 out of 5 patients placed on 10 mg. of progesterone three times a day 
for 4 to 6 days before menstruation, after following these patients for 
six months. Costa and Bonnycastle (1952) had earlier found that 
progesterone prevented the appearance of convulsions following administra-
tion of a convulsant agenL. Spiegel and V!ycis (1945) a.lso found that 
Progesterone has an anticonvulsant effect. 
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Sanchez Longo and Gonzales Saldana (1966) reported the relationship 
between frequency of epileptic seizures and the menstrua 1 cycle in three · 
patients. Control with therapeutic levels of anticonvulsant drugs in 
these patients was poor, but striking improvement occurred after an 
oral contraceptive containing mestranol (an estrogen) and norethynodrel 
(a progesterone) was given. Seizures recurred on withdrawing this 
contraceptive and ceased when the contraceptive was resumed. Sanchez 
Longo and Gonzales Saldana (1966) reviewed the literature on the effects 
of hormones on brain activity, and concluded that, in general, estrogens, 
ACTH, and cortisone lower the threshold for seizures, while testoste1·one, 
progesterone, and desoxycortone acetate raise the seizure threshold. 
Here is a case in which a combination estrogen-progesterone 
contraceptive reduced seizure frequency, which is in contrast to most 
of the literature in which combination drugs either have no effect on 
seizures or increase seizure frequency. 
Stitt and Kinnard (1968) found that estrogen, administered in the 
form of estradio·l benzoate, lowered the electroshock threshold in rats. 
Administration of progesterone had little effect on electroshock threshold. 
Werboff and Corcoran (1961) found that estradiol administration to cas-
trated male rats resulted in an increase of audiogenic seizt:res, while 
in female rats testosterone adr.linistration and ovariectomy rest:lteci in a 
decrease in seizure responses. 
Wieczorek, Bock, and Kluge (1969) studied the effect of the ovula~ 
tion inhibitor Ovosiston on 31 female epileptics. Ovosiston is a combin-
ation contraceptive that conLair1s both rs~rogen- and progestel'Oile, in the 
forms of mestranol and pregnanediol, respectively. In the large 
majority of the cases reported by Hieczorek et al. (1969)~ the epileptic 
women failed to show either a decrease or increase in the frequency of 
their seizures following a drug regimen of both ovosiston and their 
usual therapeutic dosage of anticonvulsant drug. In some individual 
cases an increased susceptibility to seizures occul~red following the 
administration of Ovosiston. This study lends support to the thesis 
that combination estrogen and progesterone preparations have no effect 
or increase susceptibility to seizures in epileptic women, 
Knight and Rhind (1975} investigated the relationship of epilepsy 
and pregnancy in 153 pregnancies of 59 epileptic patients. Six patients 
showed a tendency to have more frequent convulsions in relation to 
menstruation. Rosciszewska and Grudzinska (1975) found the relationship 
between increased seizure frequency and menstruation to be particularly 
marked in those patients who experienced their first convulsions during 
pregnancy. Over one-thil·d of the weight gained in pregnancy is due to 
fluid retention; Dimsdale (1959) showed that rapid and excessive weight 
gains preceded more frequent seizures. The same mechanism may underlie 
seizures that occur predominantly at the time of menstruation, but 
such patients do not necessarily experience more frequent attacks when 
pregnant. A mechanism of increased seizure frequency during pregnancy 
may be as follows: increased secretion of estrogens, glucocorticoids, 
and aldost2rone may be found during pregn~ncy, and all would tend to 
caus2 water and sodium retention which might dehydrate brain cells and 
cause seizures. HO\-Jever, a clear relC\tionsh·ip between hormonal levels 
and clinical events has not yet been fcund (Knight & Rhind, 1975), 
Hall (1977) reports a patient who suffered from an increased fre-
quency of seizu1·es before and during mcnstr·uation (catamenial epilepsy), 
associated with severe dysmenor~hea. Total control of seizures was 
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achieved by continuous administration of a low dose of progesterone, 
namely 0.35 mg. daily of Norethisterone, while she continued on her 
original dose of 90 mg. daily of phenobarbital. Norethisterone is a 
progesterone-only preparation. The patient was comp1etely seizure-free 
for the sevep months she had taken Norethisterone, and in addition had 
only mild dysmenorrhea. 
Menstrual exacerbation of epilepsy occurred in 72% of the patients 
studied by Laidlaw (1956). Laidlaw suggested that the reduction of 
seizures in the luteal phase of the cycle is due to an anticonvulsant 
action of progesterone; the increase of seizure frequency before and 
during menstruation would then be explained by the diminished secretion 
of progesterone at that time. 
Bickerstaff (1975, pp. 87-90) reported complete control of seizures 
using estrogen-progesterone combinations in some epileptics, but also 
noted that certain groups of epileptics are liable to an exacerbation of 
their seizures when using combined onl r.ont.racPptives. Zimmerman et al. 
(1973) reported complete control of seizures using injectable medroxy-
progesterone acetate (Depo-Provera). Hall (1977) is the first report 
of complete seizure control with an oral progesterone-only preparation. 
The literature suggests that a trial of progesterone-only preparations 
may be warranted for control of catamenial epilepsy. 
Backstrom (1977) studied nine periods in se1en female epileptics, 
Six menstrual cycles \•Jere ovulatory and consequently accompanied by a 
rise in plasma. progesterone after ovulation, and three c,ycles ~;ere 
anovulato1·y. Two periods of increased generalized seizure frequency 
\·Jere observed in the ovu1 a tory cycles:- one shortly after the rc:pi d 
decrease of progesterone menstrually; and the second during the preovula-
tory el<:>vatior. o"f estrogen. Po.rt"ial seizures \>Jere .observed to occur 
tnore evenly throughout the cycle, but with a trend towards peaks in 
increased seizure frequency at the same points as the generalized 
seizures. During times tif high progesterone the number of generalized 
seizures v1as very lovt. A comparison between the follicular and lutea.l 
phases showed the greater number of generalized seizures occurring 
during the follicular phase, and fewer days were completely free from 
generalized seizures during the follicular phase. The three anovulatory 
cycles all showed an increased number of seizures during estrogen peaks. 
Backstrom (1977) notes that his findings are compatible with Laidlaw's 
(1956) hypothesis that progesterone inhibits seizures while falling 
levels of progesterone result in increased seizure frequency; and 
Logothetis et al. (1959) who found that estrogen activates seizures. 
Backstrom (1977) also suggests that further studies are needed to exclude 
a possible effect of hormones on changed serum concentration or binding 
of antiepileptic drugs. 
In addition to the adverse effect estrogen seems to have on 
seizure frequency in epileptics> Backstrom (1977) believes that it also 
has an effect on premenstrual tension in non-epileptic women. Backstrom 
and Carstensen (1974) compared women who suffered from a pre-menstrual 
tension syndrome with a control group, and found that during the 2 to 5 
days before the first d~y of m2nstru:tion the pre-menstrual tension 
group had signiflcfnt1y higher plasma estrogpn levels than the con:rols. 
The plasma pfo~esterone levels in the ~r2-~cnstrual tension group were 
significantly lower thar1 in the controls during the whole mid-luteal 
phase. Ths estrogen/progesterone raUos were also significantly h·igher 
on dtt_y·s 3·-6 bc~fore n:c;nscn.ation. This d;ffer2nce in plasrr,a '=strogen levels 
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bet\'1een the pre-menstrua 1 tension group and the contra 1 S)roup 11ms not 
due to changes in the plasma binding activity of estrogen, Backsttom 
and Carstensen (1974} also found a correlation between symptoms of 
anxiety and irritability and the plasma estrogen leve·l on the third day 
before menstruation, suggesting that estrogen may influence emotional 
states in women. 
Ari interesting extension of Backstrom (1977) and Backstro~ and 
Carstensen•s (1974) work would be to compare estrogen and progesterone 
levels b~tween epileptics who have the greatest seizure frequency and 
those who have the least seizure frequency~ Do women with the greatest 
number of seizures have significantly higher plasma estrogen levels 
and lower plasma progesterone levels? 
Stress 
Stress contributes to menstrual dysfunction and seizures. The 
concept of stress, first put forward in definite form by Selye (1946), 
has undergone radical revision in recent years. The original concept, 
developed solely from observations in the experimental animal, foretold 
in general the results of the non-specific reactions to various forms 
of stress, particularly those concerned with endocrine and metabolic 
transformations. The essence of Selye•s hypothesis was that all stimuli 
resulted in either mental or physical stress, the reaction to a stimulus 
being determined by the integrated sum of the stresses induced. 
This basic concept was extended by Levi {1972) and his colleagues, 
They have proposed that the stress induced by psychic stimuli originating 
from en vi rorr;Tlenta 1 causes or society- re 1 a ted events is deter.-ni ned by the 
Propensity of each individua1 to react in the light of ~is experience, 
with 11 genet"ic factors" influencing this psychobiological responseto 
stimuli. The stress engendered by this composite reaction may under 
certain circumstances increase the subject's susceptibility to disease 
arid may even lead to disease itself. This sequence of ev~nt~ may be. 
promoted or neutralized by a number of negative feedback interactions. 
In its usual connotation, 11 Stress 11 is almost universally accepted as 
being an accompaniment of noxious stimuli. One of the crucial points 
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in the chain of reasoning. presented above, however, is that nearly all 
psychic changes, whether pleasant or unpleasant, can be expected to evoke 
a stress reaction. This is an aspect of the stress thesis that has been 
largely ignored in the past. 
The studies of Rahe (1969) lend support to the concept that the 
relationship between stimulus and stress is U-shaped. Rahe found that 
the relationship between life change (sum of pleasant plus distressing 
changes) and morbidity is unipolar, i.e., the higher the sum of stimuli 
the greater the morbidity risk. Howevers no one has subjected the 
evidence linking the many and complexly interrelated factors involved 
in such proposed mechanisms to critical analysis; extreme caution is 
necessary before such arguments are accepted as fact and before unwar-
ranted cause-effect relationships are extrapolated. 
Considerable difficult1es exist in attempting to differentiate 
the primary effects of physical stimuii, or the physical reactions 
induced by stress, from the secondary or tertiary effects eiicited by 
psychological reactions to these st·;muii U'iascn, 1977). Every factor~ 
stands in a cause-effect rPlationship to others; and, since it is rarely 
possible to define and measure all of them, their interact:ons and 
resulting biolc,gical activity can on~y be ~Juessed at. t'.or·eover, if 
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disease is indeed produced by psychic stress, then the disease itself 
can be expected to alter the response of the organism to the same stimulus. 
However, at a clinical therapeutic level the problem is more straight-
forward. Whatever may be the interplay of the primary, secondary, and 
other mechanisms concerned, and whatever may be the complex neuronal 
pathways followed by such stimuli in the central nervous system, the 
efferent effector pathways are clear; they predominantly involve the 
autonomic nervous system and, in particular, its sympathico-adrenal 
component. Selective interventions in the final common pathway of the 
physiolQgical accompaniments of stress are thus possible and provide a 
useful therapeutic tool with which to analyze the link between psychic 
stress and its postulated disease potential (Taylor, 1977). 
Various usages of the word "stress" have given rise to misunder-
standings between the scientist working in animal-experimental research 
ar.d the clinic-ian. Both speak of "stress," but forget that, in the case 
of animals, cognitive f3ctors can be disregarded under certain circum-
stances, with the result that the intensity of a stimulus may well cor-
respond exactly to the intensity of the resultant "stress, 11 v1hereas in 
man it is the cognitive factors associated with the stressful situation 
that have a decisive bearing on the strain involved, i.e., on the 11 Stress.ll 
In clinico-experimental medicine an addition~l point to b~ considered 
is that the effect of stressful situations on tile patients participating 
in a trial varies from one individual to a~other, the degree of variation 
being all th8 more pronounced the mare closely these situations approxi-
mate to real life and thus resemble thosr> occurring in genuine social 
interactions. The amo:.1nt of strain imposed by such situations also 
depend~. on the patient's past histoty and on his ability tc1 resist or 
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cope with strain. 
Psychological stress can provoke symptoms, providing a setting 
for disease and sometimes even death. Engel (1968) collected 100 items 
from newspapers around the world, over a period of six years~ reporting 
the occurrence of sudden death under unusual circumstances. One half 
of these deaths occurl~ed in husbands or wives soon aftel~ the sudden 
death of their spouses. An additional ten died anticipating such a 
bereavement; 32 died suddenly during situations of danger; and 6 died 
on occasions of extraordinary joy. Hhen psychological defenses crumble, 
neurally regulated, biological, emergency reactions take over; and in 
extreme cases these reactions may be catastrophic. 
Cox (1978) reviewed the various approaches in the scientific 
literature to the study of stress and delineates three main approaches: 
(a) The first approach treats stress as a dependent variable for study, 
describing it in terms of a person's response to disturbing or noxious 
environments. (b) The second approach describes stress in terms of the 
stimulus characteristics of those disturbing or noxious environments, 
and thus usually treats it as an independent variable for study. (c) 
The third approach views stress as the reflection of a lack of fit 
between the person and his environment. Stress in this form is studied 
in tenr.s of its antecedent factors and its effects. It is seen as an 
intervening variable between stimulus and response. Much of the physio-
logical response to stress is not di1·ectly detetmined by the actual pre-
sence of the stressor agent but by its psychological impact 011 the person. 
This last approach to stress is the one favored by the present author. 
In 197G, Weitz reviewed and classified the different types cf 
situations which hav~~ been treated as strrssful in cur·r·ent research. 
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He described eighL (a) speeded informa.tiol'l processing, (b) noxious 
environmental stimuli, (c) perceived threat~ {d) disrupted physiological 
function (as a result of disease, drugs, sleep loss, and so on), (e) 
is.olation and confinement, (f) blocking, (g) gt·oup pr·e::;surE:, and (h) 
frustration. In addition, Lazarus (1966, 1974) sees perceived threat 
as the central characteristic of stressful situations and, in particular, 
threat to a person'~ most important·values and goals, while Frankenhaeuser 
(1975a, 1975b) would add lack of control over events to Weitz's list. 
Cox (1978) gives a working definition of stress which the present 
author views as a good framework for conceptualizing the present research 
results: 
Stress, it is argued, can only be sensibly defined as a perceptual 
phenomenon arising from a comparison between the demand on the 
person and his ability to cope. An imbalance in this mechanism, 
when coping is important, gives rise to the experience of stress, 
and to stress response. The latter represent attempts at coping 
with the source of stress. Coping is both psychological (involving 
cognitive and behavioral strategies) and physiological. If norma1 
coping is ineffective, stress is prolonged and abnormal responses 
may occur. The occurrence of these, and prolonged exposure to 
stress _eer ~' may give rise to functional and structural damage. 
The progress of these events is subject to great individual 
variation. {p, 25) 
Viewed in this way the physiological response to stress is itself 
a form of coping mechanism. The physiological response is dominated 
by the major psychoendocrine systems, the sympathetic-adrenomedul1ary 
and pituitary·-adrenocortical systems. Both are influenced by hypothalamic 
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and higher brain activity, Beginning_with Cannon (~927) and repeatedly 
demonstrated by his ~:•Jcc.;ess·Jr5. the sympathet i c--adfeilomedull a ry system 
has been shown to be responsive to environmental stimuli, both physical 
and psychological, and that its function should be discussed in relation 
to the individual person's behavior. 
Qualitatively different stressors, but of the same potency, do not 
elicit exactly the same syndrome, and the same degree of· stress induced 
by the same stt'essor may have different pathological effects in 
different individuals. Selye (1975) has addressed the issue of individual 
variations to stressors by observing, first, that different stressors 
may only differ in their specific effects and not in their non-specific 
stress effects. For example, cold produces shivering and heat produces 
sweating. These are specific effects. They both produce increases in 
adrenocorti ca 1 activity, which is a non-specific stress effect. It has 
to be accepted that in some instances the specific effects may modify 
the non-specific effects. Individual differences in the pathogenic 
effects of the stress response Selye (1975) ascribes to conditioning 
factors, both endogenous (genetic predisposition, age, sex, personality) 
and exogenous (learning, drug and other physical treatments, diet). 
Such conditioning factors can selectively enhance or inhibit different 
aspects of the stress response. 
Cox (1978) discusses the n~chanism of physiological reaction to 
stress. The initial alarm reaction involves increases in sympathetic-
adrenomedullary activity, \<Jhile the stage of resistance is chaTacterized 
by increased adrenocot~tical activity. 
The activity of the adrenal cortex appears to be regulated to a 
large extent by the lr·.;el of adrenocorticotropic hormone U\CTH) in the 
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blood. Adrenocorticotropic hormone is released by the anterior pituitary, 
its output being controlled by the secretion of corticotropin releasing 
factor (CRF) into the pituitary portal blood vessels by the hypothalarws. 
Overall. the anterior pituitary releases two hormones which act in their 
o\lm right, growth hormone and prolactin, and four tropic hormones, 
including ACTH, which act by controlling the behavior of other glands. 
All have been related to the response to stress, and might appea1· to be 
involved in the stage of resistance. However, it is the anterior 
pituitary-adrenocortical system which appears to dominate. 
The adrenal cortex through the action of ACTH produces glucocorti-
coids, which during st1·ess are produced in high concentrations and 
have the effects of blocking the inf"lammatory response, interfering with 
the manufacture of proteins, causing the loss of calcium and phosphate 
from the kidneys, and raising blood sugar levels. The latter action may 
be necessary to fuel the activity of coping during the stage of resistance, 
while the other actions may account for part of the cost of the coping. 
Urinary catecholamines represent estimates of sympathetic-
adrcnomedullary activity, when integrated over extended time periods, 
usually 1-3 hours. Using urinary catecholamines as a measure of the 
stress response, many laboratory experiments and field studies have 
been carried out in the investigation of the occurrence of the effects 
of stress (O'Connor-~1iller·, 1980). Enhanced sympu.thetic-adrenomedullary 
activity has been shown to occur in subjects exposed to a variety of 
stresses (Kagan & Levi, 1975}. From his review of many studies, Levi 
(1972) concludes that there can be little doubt that psychosocial stimuli 
can effect changes in sympathetic-adrenomedullary activity and adt'enaline 
secretion. Most importan~ly for studjes of the response to stress, he 
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also concludes that, a1tbugh tntersubjcct variability is srr<.:a-::, within 
the individual subject catecholamine excretion roughly parallel~ the 
degree of reported emotional arousal. 
Cox (1978) organized a table in which he lists some of the many 
behavioral, physiological and nealth effects which hav2 bee~ variously 
suggested to be linked to the experience of stress: 
1. S~bjective Effects: Anxiety, aggression, apathy, boredom, 
depression, fatigue, frustration, guilt and shame, irritability and 
bad temper, moodiness, low self-esteem, threat and tension~ nervous-
ness, and loneliness. 
2. Behavioural Effects: Accident proneness, drug taking, 
emotional outbursts, excessive eating or loss of appetite, excessive 
drinking and smoking, excitability, impulsive behaviour, impaired 
speech, nervous laughter, restlessness, and trembling. 
3. Cognitive Effects: Inability to make decisions and concen-
trate, frequent forgetfulness, hypersensitivity to criticism, and 
mental blocks. 
4. Physiological Effects: Increased blood and urine catechola-
mines and corticosteroids, increased blood glucose levels, increased 
heart rate and blood pressure, dryness of mouth, S\'.'eating, dilation 
of pupils, difficulty breathing~ hot and cold spells, ''a lump in 
the throat," numbness and tingling in parts of the limbs. 
5. Health Effects: Asthma, amenorrhoea, chest and back pains, 
coronary heart disedse, diarrhoea, faintness and dizzine~s, dyspepsia, 
frequent urination, headaches and migraine, neuroses, nightmares, 
insomnia, psychoses, psychosomatic disorder) diabetes mellitus, 
skin rash, ulcers, loss of sexual ·interest c.nd i'<'eakness. 
6~ Organisational Effects: Absenteeism, poor industrial 
relations, and poor productivity, high accident and labour turn-
over rates, poor organisational climate, antagonism at work and 
job dissatisfaction. (p. 92) 
The chain of events which lead up to pathological reactions to 
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stress can be broken in several ways. First, the P.lements which contri-
bute to the cognitive appraisal of demand and capability and of the 
consequences of coping can be altered. This may be achieved by restruc-
turing the external environment~ by changing the pErson•s 1eve1 of mental, 
physical and social skill, by supporting him in the use of those skills, 
or by altering his perceptual and cognitive processes. Second, if the 
occurrence and experience of stress cannot be avoided then its psycholo-
gical and physiological effects may be modified, as may be the actual and 
perceived consequences of those effects. These prescriptions can be 
elaborated on by considering the specific points in the stressful event 
and its aftermath where an entry can be made to break the critical 
progression to pathology. These entries can be made by the person himself, 
or by another person, a therapist, or a group of people. Meichenbaum 
(1974) has developed a self-instructional approach to stress management, 
among other researchers. 
Another approach to the treatment of stress is the psychopharma-
cological. Kielholz (1975) has argued that antidepressants can be use-
fully classified in terms of their effects on three different types of 
symptoms: inhibited drive, basic feelings of sadness, and anxiety. 
For example, clinical and experimental studies suggest that the effects 
of monoamine oxidase inhibitors (MAOis)) such as iproniazid and pargyline, 
are dominated by incre~sed drive and by mood enhancement, the former 
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being the greater effect. Thus MAO increases with stress, while MAGI's 
ir•hibit the effects of stress by increasing drive and mood enhancement. 
The tricyclic compound, imipramine, has relatively little effect on 
drive, but has a powerful effect on mood. Neither of these two drugs 
produces much relief of anxiety; this ca~ be achieved through the use of 
trimeprimine or chlorprothixene. The prescription of the wrong drug can 
have disastrous effec~s; in depressive ~tates involving anxiety, the 
use of a drug which increases drive may aggravate the anxiety and by 
releasing inhibition may increase the risk of suicide. 
In treating the different types of neurosis, the minor tranquilizers, 
in particular the benzodiazepines, and both tricyclic and monoamine 
oxidase inhibiting antidepressants are used. The benzodiazepines have a 
muscle-relaxant effect. Perhaps their major clinical effect is due to 
their relatively selective action on the limbic system and they are used 
extensively in combating anxiety and tension. Of tile antidepressants, 
the tricyclic compounds appear to have fewer major side effects than the 
MAGI's, and are therefore the drugs of first choice. The MAOI 's are 
more effective in reactive than in endogenous depression. 
The use of drugs in the treatment of neuroses is usually seen as 
a short-term crutch to allow patients to deal more effectively with the 
demands they are experiencing. The anxiety experienced by a person as a 
result of stressful demands may exaggerate the problem by reducing capa-
bility. Hithout benzodiazepine treatment the patient may not cope; ~1/ith 
the drugs he might cope effectively, 
No specific hoi·mona 1 pattern is uniquely characteristic of 
menstrual disorders arising from psycho9enic factor-s. Indeed, the 
1 iteratUt'l2 indicates a variety ·of hormona 1 patterns. a11d presumab·ly a 
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number of different mechanisms by which ~sychogenic factors may cause 
menstrual dysfunction. Ra:~off (1963) summar'izes the clinical observations 
suggesting a relationship between psychogenic factors and disorders of 
menstruation: 
1. Amenorrhea or dysfunctional bleeding occurs in previously 
normally menstr•Jati ng 'v'JOrr.en immediately following an acute psychic 
trauma. The spontaneous return of normal cycles follmoJs alleviation of 
the trauma. 
2. An increased frequency of menstrual disorders occurs in 
psychotic and psychoneurotic women. 
3. A high incidence of amenorrhea is present in the female popula-
tion during periods of prolonged psychic stress, such as during wars. 
4. Amenorrhea occurs with concomitant symptoms of pregnancy in 
situations in which there is a great desire for or fear of pregnancy. 
On the basis of clinical observations and hormonal studies, Rakoff 
(1968) also suggests·several pathways by which psychogenic factors may 
influence menstruation. These include: 
1. Stimuli operating by way of the hypothalamus to influence the 
gonadotropic-releasing factors (Martini, Fraschini, & Motta, 1968). 
2. A direct influence on the ovary by way of the sympathetic 
nervous system or by some other route (Richter~ 1968). 
3. A direct action on the endometrium (Richter, 1968). 
4. The hypothalamic-pituitary-ovarir.m mechanism may be indirectly 
disturbed by extra-gonadal endocrine dysfunction of psychogenic origin 
involving particularly the adrenal cortex and possibly the thyroid 
(Gibbons, 1968; Eayrs, 1968; Levi, 1968). 
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Selye (1947) suggested that stress increases ACTH in the pituitaty 
at the sacrifice of gonadotropi~ secretion. The mechanism may be that 
emotional stress or trauma induces hypersecr·etion of corticotr-Opin-
releasing factor at the sacrifice of secretion of FSH- and LH-releasing 
factor at the hypothalarnic level, resulting in hypersecretion of ACTH 
and hyposecretion of FSH <:;nd LH at the pituitary level, v.:hich could 
result in ano~tul a tory CJC1 es, 
Sevel'a 1 ot~E:r i nves ti ga tors suggest that one common de nom~ nator 
of the stress response is the increased release of adrenocorticotropic 
hormone (ACTH) from the pituitary, initiated by the corticotropin-
releasing factor of the hypothR1amus (Harris, 1948; Pincus & Elmadjian, 
1954; Vernikcs-Danellis, 1964). Adrenaline and noradrenaline secretion 
also have been 1:aken as an index of the same response (Elmadjian, Hope, 
& Lamson, 1958; Euler, 1960; Swan, 1958, pp. 142-162). 
?i!!lpatho-~dre_nomedulla_!':l and related biochemical reactions during 
experimentally induced emot-ional s_!:re_ss. Homeostatic neuroendocrine 
regulation in man is affected by psychic stimuli (Roessler & Greenfield, 
1962; Selye, 1950; Simon, Herbert, & Straus, 1961; Tanner, 1960). Man 
reacts not on1y to the actual existence of danger, but to threats and 
symbols of dange}' experienced in the past. Man wants to be prepared to 
meet a new situation the moment it occurs. This creates a situation in 
which homeostasis is adjusted not only to the needs of the organism in the 
prevailing conditions, but to the anticipated needs as well. Irrespective 
of whether this preparedness 1s adequate or not~ it affects the adaptive-
protective mechanisms of the living organism (Levi, 1967, pp. 78-105). 
The organism's pattern of response involves physiological as well as 
psychic processes (Bajusz, 1967). 
48 
In most of the psychosomatically-oriented medical literature 
various disorders have been related to a number of stressors to which the 
patients state that they were exposed prior to and/or in conjunction 
with the onset of the particular disease (Levi, 1967). The constellations 
of stressors inherent in everyday life are, hm'lever, very complex as a 
rule and it is, therefore, difficult from clinical data alone to 
distinguish between cause and effect in the medical chain of events. 
The assessment of causal connections has been made easier by the 
use of psychophysiological experiments, in which various emotional 
reactions are first induced and then studied together with the accompany-
ing physiological phenomenon (Levi, 1967). The results of Levi's series 
of experiments have proved a valuable complement to clinical observations. 
The use of different kinds of functional and provocation tests 
has long been practiced in physiology and clinical medicine, the patient 
being exposed to such stimuli as physica1 work, ACTH, insulin. cold, 
allergens, and so on. The psychophysiological experiments make use of 
mental stimuli in a corresponding way. These stimuli include induced 
failure and induced disturbance in a task, stimuli that elicit anxiety 
and physical discomfort, working aginst time, isolation and sensor~ 
deprivation, and fatigue arising from prolonged work. A number of inves-
tigations in this field have been pel~formed by Levi at the Laboratory 
for Clinical Stress Research in Stockholm. The experiments conducted 
include investigations of sympa,tho-adrer.omedullary re~ponses during 
pleasant and unpleasant emotional states; central nervous function and 
sympt~tho-adrenomedull ary l'esponse; emotional stress; plasma lipids and 
catecholamine excretion; specific stressor effects of sympatho-adreno-
medullal~y function; and iong··term stress. 
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In all of these experiments, simultaneous recordings were made of 
a number of psychological as well as physiological and biochemical 
variables. The design usually involved a stress period, flanked by two 
control periods of equal duration or, alternatively, consecutive periods 
characterized by diffen:!nt degrees of intensity or quality of stimulus. 
The experiments suggested the following conclusions: 
l. Psychic stimuli ar·e capable of evcking an increased catechoia·-
mine excretion. 
2. The bebJ(:en-subject va1·iability in catecholamine secrE:tion is 
very considerable, but intra-individually the catecholamine excretion 
very approximate-ly parallels the degree of reported emotional arousal. 
3. The catecholamine excretion rates cf each individ~al during 
corresponding periods of different experiments are positively correlated. 
4. Experimental stimuli evoking responses of calmness and 
equanimity lower the catecholamine excretion significantly below control 
levels. 
5. Pleasant stimuli evoking amusement are nearly as potent as the 
unpleasant ones in provoking an increased catecholamine excretion rate. 
6. Stressors of short duration and moderate intensity are potent 
in increasing free fatty acids and triglycerides of arterial plasma. 
This response is significantly blocked by treatment with large doses 
of nicotinic acid. 
7. Stressors of longer duration (three days or more) are potent itl 
inducing a number of bodily reC~ctions inclL:ding changes in E:r_ythrocyte 
sedimentation rate (ESR), protein-bound iodine and serum iron, as well 
as electrocardiograms (EKG) during work. 
8. Some support has been found for the hypothesis that the 
experimentally-induced reactions reflect functional changes in the 
organism which, if they persist for a long time, may be of pathogenic 
significance in disposed individuals. 
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Thus, Levi's (1967} results suggest that emot~onal changes produce 
physiological changes in levels of catecholamines, fatty acids, tri-
glycerides, erythrocyte sedimentaticn t·ate, electrocardiograms, pr·otein-
bound iodine and serum iron. The psychically produced emotions appear 
to be causes, and the physiological changes are the effects. 
Levi (1968) conducted another series of experiments in which he 
demonstrated that (a) stimuli lowering the degree of emotional arousal 
belo\'1 a control level decreased urinary catecholamine output; and (b) 
pleasant emotional stimuli were as effective as unpleasant emotional 
stimuli in evoking an increased sympatho-adrenomedullary response. Thus, 
mental stressors can elicit an increased release of adrenal hormones. 
Gibbons (1968) found that a modest but significant increase in 
adrenocortical activity was a common accompaniment of all sorts of 
emotional disturbances, whether this was in response to the normal 
vicissitudes of life or to artificial situations in the experimental 
laboratory. Similar increases in adrenocortical activity were found in 
patients whose emotional disturbance was part of a psychiatric disorder. 
Gibbons (1968) also showed a modest increase in adr-enocortical activity 
\-Jhen a group of norma 1 subjects encountered various nove 1 experiences. 
The results of these studies suggest that the intensity and dutation 
of psychological stress may be accounted for on the physiological level 
by disturbances in (a) honnonal r·egulatory mechanisms, (b) vascular 
horn2ostasis, (c) permeability of histohemc.tic barriers of the internal 
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organs, (d) blood-brain barrier~, (e) tropic processes in the cells, (f) 
efferent and afferent neural transmissions, or (g) interrelati~nships 
between neocortex and subcortex centers. 
_physiology of the t·1enstrual Cycle 
The ovary. The ovary is anatomically divided into three separate 
compartments: (a} the follicles where germ cell maturation and estrogen 
synthesis occur during the first half of the ovarian cycle; {b) the 
corpus luteum, which is derived from the ruptured ovarian follicle and 
is responsible for progesterone and estrogen secretion during the 
latter half of the cycle; and (c) the interstitium which surrounds the 
follicles and corpus luteum and is responsible for androgen synthesis. 
Ovarian function is coordinated in a cyc1ic manner by the central nervous 
system, through the sect·etion of pituitary FSH and LH. During a.n ovarian 
cycle a group of follicles are developed, a. single ovum is ovulated, and 
a corpus luteum develops and is maintained for a fixed period of time. 
As corpus luteum function decreases a new set of follicles begins to 
develop and a new ovarian cycle begins. D•JY'ing the onrian cycle the 
endometrium proliferates under the influence of ovarian estrogen and 
progestins. With regression of the corpus luteum, the endometrium is 
sloughed and a menstrual period occurs. The period of time between the 
beginning of one menstrual period and the begir.ning of the next is 
termed the menstrual cycle (Bardin, 1973, pp, 7·95 to 7-111), 
Although in the strict sense the ovarian cycle and the menstrual 
cycle refer to cyclic changes in the ovary and endometrium, respectively, 
these terms are often used synonymously with "reproduct~ve cyc·le" which 
implies the cyclic morphologic and hormonal changes which occur in the 
cent!· a 1 nervous system, a.nteri or pituitary, ova r·y, and uterus. 
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1; Follicle-stimulating_ hormone _lFSt!_L. ·The function of FSH is to 
stimulate growth of the ovarian follicle. FSH promotes mitosis of the 
granulosa cells and conversion of the surrounding stroma into a layer 
of theca cells. Administration of pure FSH stimulates follicular growth 
but ovulation does not occur (McCracken, Uno, Goding, Ichkawa, & Baird, 
1969). Furthermore, ovarian follicles do not reach mature size and 
secrete significant quantities of estrogen until LH is administered 
with FSH {Gemzell & Roos, 1966, pp. 492-517). 
2. Luteinizing hormone (LH). In contrast to FSH, LH has a much 
more varied action. It is synergistic with FSH in bringing about 
follicular maturation and estrogen secretion. The midcycle peak of LH 
is believed to trigger ovulation in 16 to 24 hours. Furthermore, recent 
studies of hypophysectomized women have demonstrated that LH facilitates 
maintenance of the corpus luteum. 
3. Estrogens. The most important e:~stY'Ogen secreted by the ovary is 
estradiol. The important biologic activities of estrogen include: (a) 
stimulation of growth of both the myometrium end endometrium; (b) 
maintenance of a thick vaginal mucosa and indil~ectly the acidic vaginal 
pH; (c) stimulation of cervical glands to secrete copious quantities of 
viscous mucous; (d) stimulation of br~ast growth and developm2nt; (e) 
deposition of subcutaneous fat which results in a characteristic feminine 
habitus; (f) sensitization of the ovaries to gonadotropins; and (g) 
retardation of 1 inear body grov,rth in association with facilitation of 
epiphyseal closure . 
. 4. PrQ_~_stir.s. Progest-in was the name originally given to the 
crude extract of the corpus luteum ~hich could prepare and maintain a 
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secr·etory endometrium during the latter half of the reproductive cycle. 
and during pregnancy. l~e biologic actions of progesterone and other 
gestagens include: (a) antagonism of the gro11th promoting effect of 
estrogen on the endometrium and conversion of this rapidly proliferating 
organ into a secretory structure capable of maintaining an irr.planted 
blastocyst; {b) conversion of the cervical mucous from a very viscous to 
a nonviscous fluid; (c) stimulation of gland growth and development; and 
{d) inhibition of uterine motility. 
During the reproductive cycle and in the first trimester of preg-
nancy, progesterone is secreted almost exclusively by the corpus 1uteum. 
During the latter two-thirds of pregnancy the placenta assumes this 
function. The adrenal also secretes a small quantity of progesterone. 
Hormona 1 changes C:ur~ the r·er-.rcdt..:ctiVe r:ycl e. For descriptive 
purposes the reproductive cycle can bG divided into a fo11icular phase, 
which can be subdivided into a first and second half; an ovulatory phase; 
and a luteal phase (Ross, Cargille, Lipsetti, Rayford, Marshall, Strott, 
& Rodbard, 1970; Vandewiele, Bogumil, Oyrenfurth, Ferin, Jewelewicz, 
Warren, Rizkallah, & Mikhail, 1970). 
1. Follicular phase, first half. This period begins in the late 
luteal phase of the preceding cycle with a rise in the plasma levels of 
FSH and a concomitant initiation of follicula'' growth. LH levels also 
rise during this phase but the increase starts several days later than 
the increase in FSH. It is important to note that during the first half 
of the follicular phase there is no change in the blood levels of 
estrogens or progestins. 
phase begins approxirn?tteiy 7 to 8 days be ~ore the preovul a.tor·y LH sur·ge 
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and is characterized by an increase in plasma estrogen levels (estradiol 
and estrone). Estradiol increases slowly at first and then rapidly 
reaches a maximum on the day before the LH peak. The initial rise in 
estrone is not as great, but estrogen levels reach a peak concomitant 
with the peak of LH. While plasma estrogen levels are increasing, plasma 
FSH decreases and plasma LH slowly and steadily increases. Several days 
before ovulation there is a rise of 17-hydroxyprogesterone which reaches 
a maximum on the day of the LH surge. It is significant that plasma 
progesterone levels do not increase during this period. 
3. Ovulatory pha?~· During this period there is a rapid rise in 
plasma LH levels which leads to the final maturation of the Graafian 
follicle and follicular rupture some 16 t:::> 24 hours after the LH peak. 
Soon after the beginning of.the LH surge and prior to ovulation, plasma 
estradiol levels drop precipitously and plasma progesterone increases 
slightly. 
Both estrogen and 17-hydroxyprogesterone secretion decrease rapidly 
in the ovulatory period but both increase again in the luteal phase as 
the corpus luteum with both its theca interna cells and luteinized 
follicular cells becomes vascularized. 
4. Luteal p~ase. As noted above, luteinization is initiated by 
LH. Recent studies also have indicated that ova exert an inhibitory 
influence on follicle luteinization, LH is required for normal corpus 
luteum survival and function. Furthermore, LH administered in high 
doses can luteinize follicular cells even without ovulation and can 
produce a luteinized follicle with a trapped ovum (Ludwig & Horowitz, 
1969). These observations i ndi ca.te that either LH or ovum r·emova 1 
can luteinize the ovarian follicle; however, during a normal reproductive 
cycle both mechanisms are probab1y operative. 
The sine qua non of the luteal phase is the marked increase in 
progesterone secretion which reaches a maximum about 8 days after the 
midcycle LH peak. 
5. Control of FSH and LH secretion. Both FSH and LH are subject 
to negative feedback control as evidenced by the rise in both of these 
hormones following castr·ation and from the decrease in their levels 
following estrogen administration. Examination of the hormonal events 
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of the reproductive cycle indicates that control mechanisms in addition 
to negative feedback inhibition are operative. This is particularly 
true in the second half of the follicular phase when FSt! decreases -and 
LH increases concomitant with a rapid rise of blood estrogens. This 
paradox may be explained if one assumes that there are hypothalamic centel~s 
for posit·ive and negative feedback control of gonadotropins in man as 
there are in the rodent (McCann & Porter, 1969). In addition to the 
negative feedback upon gonadotropin secretion, estrogens also exert a 
positive feedback on LH secretion but not upon FSH. The factors which 
determine whether LH win increase or decrease in response to estrogen 
administration ate net completely undErstood at the present tiTile. Suffice 
it to say that from the available data it would appear that both d 
positive and negative feedback control of LH are operative at different 
periods during the reproductive cycle, 
In light of the~e observations the difference betwee~ the behavior 
of FSH and LH during the late follicular and luteal phases may be 
explained. In the second half of the follicular period as estrogens 
rise, FSH decreases due to the negative f~edback effect. By contrast, 
the positive feedback control of estrogen is operative upon LH secretion 
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during this pedod as the level of tt:lis hormone increases. Both FSH and 
LH decline during the luteal phase under the negative feedback inhibition 
of estrogen and possibly progesterone, 
A midcycle LH surge represents still another facet of the complex 
mechanisms which are operative in the control of gcnadotropin secretion 
in women. The available studies support the hypothesis that the rise in 
estrogens during the later follicular phase triggers the preovulatory 
LH surge. Evidence in favor of this theory has been provided by several 
of the above-named investigators who demonstrated that estrogen admin-
istration can produce repeated bursts of LH, and in some instances, 
ovulation. 
Sawyer {1975, pp. 401-408) summarizes some of the brain-pituitary·-
ovarian relationships discussed above. Luteinizing hormone-releasing 
hormone is produced by neurons in the arcuate nucleus of the hypophysiotro-
pic area and secreted into the proximal capillary plexus of the pituitary 
portal system in the median eminence. Ovarian steroids feed back directly 
to the pituitary and to severa 1 sites in the brain ¥there they influence 
both pituitary-ovarian function and sexual behavior. Electrophysiological 
evidence has been presented for 11 ultrashort" feedback action of luteinizing 
hormone-releasing hormone on arcuate neurons as well as the 11 Short 11 
feedback loop of tH. Evidence has been presented that adrenergic 
mechanisms influence luteinizing hormonE-releasing hormone release with 
norepinephrine facilitatory and dopaJTiine inhibitory to the process. Rapid 
strides are now being made in these areas of research with the use of 
immuno l ogi ca 1 methods such as radi oimr:1unoassay and immunohistochemistry. 
Chan and O'Malley (1976) state thqt the regulation of pr·oteiri 
synthesis in the target tissue is the p~inci~al action of steroid hormones. 
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The_ steroid molecule must be transported to the target tissue via the 
bloodstream and tissue fluids. It then penetrates the cell by sirnp1e or 
facilitated diffusion. On entry of the hormone into the cell, it is 
bound to a specific hormone recepto}'. This hormone-receptor complex is 
then transferred to the nucleus, in an "activated" form, where it is 
bound to the target-ceil genome. Then the tar'get cell responds by 
increased RNA synthesis followed by increased protein synthesis. This 
sequence of events is probably the primary mechanism by \·Jhich the sex 
steroids regulate target-tissue metabolism (Chan & 0'~1alley, 1976). 
The specific sex steroid progesterone is an ~strogen antagonist. 
The simultaneous administration of these two hormones results in inhibi-
tion or modification of estrogen-induced growth and differentiation of 
target organs. Progesterone does not compete for the estrogen-receptor 
binding site, and it does not interfere with the cytoplasmic estrogen-
receptor complex to translocate the nucleus (Anderson, Clark, & Peck, 
1972). One possible effect of progesterone would be the interference 
with the replenishment of cytop1asmic estrogen receptors. That such 
an effect can indeed occur was de~onstrated ~y Hsueh, Peck, and Clark 
(1975). The reduction cf cytoplasmic estrogen receptor rsndev-ed the 
uterus much les5 ~esponsive to additiona1 estrogen. 
The ~choendocri no 1 ogy of the Mens t ruo.l_S,_yc 1 e 
VJhile there is little evidence fa:· serious cyclical deficits in 
motor or intellectual performance during t11e ro1enstrual cyc·i.:? (Pie~·son 
& Lockhart, 1963; Somner, 1972; Wickham, 1958), many women clearly suffer 
from some premenstrual symptoms which may range from mild tin'dness and 
depression to extreme irr·itability and fatigue (Dalton, 1964; Lan1b, 1953~ 
fvloos, 1968; Redgrove, 1971 ). Among the physiological explanation:; for 
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these symptoms have been Wineman (1971) who postulated increased sympa-
thetic nervous system activity; MacKinnon (1954) who found higher post-
ovulatory hear-t ratr; Hith less sweat giand product-ion; and Lyons (1969) 
who reported a higher respiration rate during the luteal phase of the 
menstrual cycle. \~iener and Eimadjian (1962) found a significant 
increase in the urinary excretion of norepinephrine during the premen-
strua l period as compared with the preovulatory period, vJhi ch was accom-
panied by irritability and depression. However, Patkai, Johannsen, and 
Post (1974) failed to find significant cyclical differences in the 
excretion of either norepinephrine or epinephrine. 
Lamprecht, Matta, Little, and Zahn (1974) assessed changes in 
peripheral sympathetic nervous system activity during the menstt·ual 
cycle as reflected in the activity of plasma dopamine-beta-hydroxylase 
(DBH) and compared these changes with peripheral indicators of autonomic 
functioning, such as skin conductance and heart rate. Lamprecht et al. 
(1974) found that the activity of this enzyme does not paral'lel levels of 
estrogen, progesterone, skin conductance, or heart rate; but that the 
mood "Surgency," as measured by the NmAJlis Adjective Check List (Nowlis, 
1965, pp. 353-398), showed comparable changes over the cycle. Both 
DBH activity and Surgency increased during the follicular phase, peaked 
soon after ovulation, and decreased to a minimum during the premenstrual 
phase. 
Ito (1964)~ Suwa, Yamashita, Ito, Yoshimura, and Moroji (1966), and 
Yoshimura (1964) studied the interrelation between emotional changes and 
gonadal hormone secretion~ and found some a.bnormal patterns in the 
urinary output of estrogens,- pr-egnanediol and gonadotropins during 
periods of emotional distress. Yamashita (1964) also reported severa.l 
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cases with abnormal endocrine findings, particularly .the decrease of 
pregnanediol levels. It is now generally accepted that the steroidal 
hormones produced by the gonads act upon the brain to control the 
secretion of pituitary gonadotrophic hormones and to promote sexual 
behavior (Donovan, 1968; r~artini, Fraschini, & Motta, 1968; Swyer, 1968). 
Smith and Sauder (1969) surveyed 300 nurses and found an association 
between the occurrenc~ tif cravings for food and sw~ets on the one hand, 
and premenstrual feelings of tension or depression on the other. They 
also found an association between cravings for food and premenstrual 
fluid retention. The authors hypothesized that the basis for the food 
cravings might be hypoglycemia, and suggested that this possibility be 
investigated. 
Patkai, Johannsen, and Post (1974} found no significant differences 
in adrenaline and noradrenaline excretion betvJeen the menstrual, ovula-
tory, post ovulatory, and premenstrual phases of the cycle in six free-
cycling women. Restlessness and disturbed night sleep were greater 
and more significant during the premenstrual phase of the cycle than 
during other phases. 
Rose (1978) notes that an unfortunate tradition in research on 
sexual behavior during the menstrual cycle has been the almost complete 
isolation of psychological and endocrinological studies, with the~work 
of Benedek and Rubenstein published in 1939 and 1942 being an outstanding 
exception. Psychologists have focused on changes in moods and sexual 
behavior \'!ithout using appropriate endocrinological markers, and conversely 
many paper·s document daily endocrine changes during the cycle but without 
psychological assessment. Because variabi"i ity of the menstrual cycle 
is well established, level~ of estrogen and progesterone are difficult to 
infer from estimated cycle day alone. Psychological t·eseurch vdthout 
endocrine data consistently makes these assumptions. 
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An important aspect of the present study is that both psychological 
data and endocrinological data are collected on all subjects, making 
possible the endocrinological validation of the stage of the menstrual 
cycle at which data are obtained. 
Rose (1978) also points 6ut that the absence of appropriate endo-
crinological data has made it difficult to validate or invalidate some 
commonly held beiiefs~ among them the belief that women are substantially 
and uniformly incapacitated by premenstrual distress because of changing 
hormone levels. When one examines the literature, the paucity of rele-
vant psychoendocrine data is clearly evident (Parlee, 1973). 
Adams, Gold, and Burt (1978) found a thirty percent increase in 
the average rate of female initiated and mutually initiated sexual 
behavior during the periovulatory phase of the menstrual cycle. Rose 
(1978) believes that Adams et al. (1978) might have found even more 
substantial differences between female initiated sexual behavior at the 
periovulatory phase of the cycle versus other phases of the cycle, if 
they had been able to measure the peak of estradiol or the initiation of 
the rise in progesterone and thus to define more clearly the time of 
ovulation. Rose (1978) found that estimating the time of ovulation from 
counting backwards 14 days from the beginning of the next menstrual 
bleeding is correct only 70 to 75 percent of the time, 
Examination of Adams et al. (1978) data -suggests another peak of 
sexual behavior in the early follicular ~tage of the menstrual cycle, 
\-Jhen estrogen 1evels are low. This rindi!l9 raises the issue of mediating 
mechanisms. RosE (1'_Yf2, pp. 251-293) pr~settt.s data suggest·in£ thi'lt 
adrenal andro9ens r:121y be mute impor'Lan'; in -:nfluen::ing t.uma:1 female 
sexuality than estrogens, 
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Prog~~ ter'o_ne metabQ_}_ism _l!:!__!~~nst_r_ua :!__s_ycl e. Est in,ates of the 
prevalence of psychic disturbances in the premenstrual phase of the 
menstrual cycle vary considerably, from about 5~0 UkCance, Luff, & 
Widdowson, 1937) to 95% (Pennington, 1957), with a mean perhaps around 
50%, if all the many studies are considered (Ladisich, 1977}. These 
large differences might be due to differences in methodology or to 
different sociocultural attitudes in the investigated population. 
There is an interesting cornrnon feature of the premenstrual and 
postpartum disorders: they occur at a time of withdrawal of progesterone 
from the system. While this withdrawal is most abrupt at the time of 
partuition, a similar though less dramatic change occurs at the end of 
each menstrual cycle. Data on fluctuation of progesterone levels during 
the normal menstrual cycle are considei~ably less reliable than those of 
pregnancy; smaller amounts of hormones are involved. Nevertheless, 
investigations by Short and Levett (1962) and by Woolever (1963) utilizing 
recently devised assay procedures, indicate the occurrence of a pre-
menstrual fall in circulatory progesterone levels, as wouid be predicted 
on the assumption that most of this steroid occurs in the corpus luteum. 
Pre-ovulatory plasma progesterone levels are very low-- about 1 pg. 
percent. Progesterone concentration is higher in the second half of the 
cycle about 2-3~g. percent, There is often an abrupt rise beginning 
about mid-cycle, and a racid fall starting several days before the onset 
of menstruation. The latter point is strengthened by measurement of 
progesterone in human ovarian vein blood (Mikhail, Zander, & Allen, 1963). 
More recent rasults are consistent with this pattern of cyclic variation 
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(Van Der ~1olen & Groen, 196S). By thE? first day of mer.stru!ltion, 
there is often no detectable progesterone. In their comprehensive review 
of the existing data, Dorfman and Unger (1965) give the following figures 
for progesterone secretion: in the follicular phase, 4-5 mg. per day; in 
the luteal phase, 30 mg. per day. Thus, there is approximately a 7-fold 
increase in secretion of progester·one, as compared to a 2-3 fold increase 
in blocd levels~ One line of inquiJ~ in this area involves the concomi-
tant measurement of progesterone and behavioral variables through the 
menstrua 1 cycle, centering attention particularly on the fin a 1 ~'leek of 
the cycle, and utilizing comparisons of women who do and do not have 
severe premenstrual distress (Hamburg, Moos, & Yalom, 1968). These 
investigators have not found differential progesterone levels between 
women who do and do not have severe premenstrual distress. 
Ladisich (1977) investigated whether there were differences in 
physiological reactions to experimental stress at a time in the menstrual 
cycle when progesterone pr·oduction is high compared with a time when it 
is low. Half the subjects received 10 mg. a day of Provera and the other 
half did not. The experimental stress was administered as follows: 
the subject sat in a darkened room and was instructed to memorize a 
list of words she heard from a tape, and during the six minutes she was 
given to do this she received four mildly to moderately painful electric 
shocks administered to one hand, Afterwards, she was asked to recall the 
words she had heard. Pulse·and respiratory rates were recorded before, 
during, and after the strEss perioci. The hypothesis that larger dif-
ferences in progestei~Orle levels might go alonq with higher fluctuaticns 
in mood was tested by correlating the differences in a mood scale, the 
Scale of Well-B~ing, witt1 progestercne concentrations, but no correlations 
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could be found. There was a significantly higher reaction to stress one 
day before menstruation than eight days before menstruation for the drug 
group only. Thus, the subjects who received Provera appeared to be 
more sensitive to emotional stress than the subjects on placebo. This 
result is contradictory to the reported beneficial effect of rnedroxypro-
gesterone on premenstrual tension (Soule, 1960), but there were large 
individual differences between subjects, which colors the interpretation. 
No correlations were found between mood ratings, stress reaction, and 
progesterone levels. 
Creutzfeldt, Arnold, Becker, Langenstein, Tirsch, Wilhelm, and 
Wuttke (1976) found that an acceleration of the EEG alpha rhythm during 
the luteal phase of the menstrual cycle was paralleled by an acceleration 
and improvement of performance in psychometric tests such as reaction 
time, simple arithmetic, and spatial orientation. Creutzfeldt et al. 
(1976) hypothesized that the common denominator of these changes during 
the luteal phase was probably concentration and speed of performance. 
The significant correlation between the psychometric changes and the 
changes of alpha rhythm suggest a common cause. 
Creutzfeldt et al. (1976) also found that of all the hormonal changes 
observed during the menstrual cycle, the increase of progesterone during 
the luteal phase appears to be most :losely related to the alpha 
acceleration and the psychological performance acceler·atio:-~. The temporal 
correlation shows, however, a delay of the functional acceleration by 
1-2 days as compared with the hormonal data. Furthermore, comparison of 
individual values of progesterone increase and alpha acceleration did 
not reveal a direct cor·relation, 1hereforE~ if the speeding up of cer·eb1·al 
functions is caused by the p."o~estErone inc·eas:.::, a~1 ir.te~·mediary link 
should be assumed. 
The speeding up of mean alpha frequency and psychometric. 
performance, espec-ially durin(] t;1e seco1d half of the 1ut=;:~1 phase, 
might be the physiological basis of the premenstrual psychological 
syndrome. The physiological changes may produce different objective and 
subjective psychological effects in different persons, however, since 
basic brain mechanisms, identical in principle, may find variable expres-
sion in different personalities. 
Monoamine oxidase and mechanisms of action of behavioral changes 
in the menstrual cycle~ A mechanism which can hypothetically explain 
behavioral changes during the menstrual cycle is monoamine alteration by 
increased levels of monoamine oxidase. 
Schildkraut's (1965) 11 Catecho1a:nine hypothesis" holds that mental 
depression reflects a deficiency of catecholamines at adrenergic receptor 
sites in the brain. Monoamine oxidase, found intracellularly in the 
mitochondria, is one enzyme believed to regulate catecholamine action in 
the brain, and drugs which inhibit high MAO activity are found to 
transiently relieve psychological depression and have been also used 
to treat ovarian-hormone-linked menstrual depressions (Dalton, 1964; 
Slitton & Gershon, 1966). 
The success of such treatment with MAO inhibitors led several 
researchers to investigate the levels of W\0 over the normal menstrual 
cycle and in oral contraceptive users. Endometrial ~11\0 v;as found to 
fluctuate throughout the human menstrual cycle in accordance with 
hormona.l changes in estrogen and progesterone {Cohen, Be1ensky, & 
Chaym) 1965; Southgate, Grant, Pollard, Pryse-·Davies) 5 Sandler, 1968). 
Southgate et al. (1968) found that in normc.:l cycling wornen, t1.!\0 activity 
is highest premenstrually. In oral contraceptive users, endometrial 
MAO activity was increasing frrn~ day 12 of the cycle for wowan taking 
pills high in progesterone. For strongly estrogen pill users~ MAG 
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levels r·emained low thr':lughout the cycle. Grt!nt and Pryse-Davies (1968), 
Klaiber, Braverman, Vogel, Kobayashi, and f1otiarity (1972), and Youdim, 
Holzbauer, and Woods (1974) found that progesterone acts to increase MAO 
levels and cor.ve11 sely that estrogen has an inhibitory effect vn MAO 
activity. 
Because estrogen appears to inhibit MAO activity, and since MAO 
inhibHors appear to relieve psychological depression, estrogen therapy 
has been utilized and reported to alleviate menopausal depression and 
involutional depression. Klaiber et al. (1972) has observed that free-
cycling dep11 essed v-Jomen have higher plasma r~AO levels than nor.depressed 
women, as measured by the Hamilton Rating Scale of Depression and 
clinical psychologists• evaluations of depression. 
Plasma and platelet MAO activities in humans and in the rhesus 
monkey have been shov-m to vary during the menstrual cycle (Belmaker, 
t~lurphy, Hyatt, & Loriaux, 1974; Redmond, Murphy, Baulu, Ziegler, & Lake, 
1975). Belrnaker et al. (1974) found a preovulatory increase in platelet 
1•1AO that peaks during the ovulatory interval and then decreases sharply 
and reaches a nadir 5 to 11 days later. This roughly parallels the 
menstrual changes in progesterone levels. However, no statistically sig-
nificant relationship was observed between platelet MAO activity and 
a global scale of menstrual mood variation. 
Carruthers (1977) found that monoamine oxidase inhibitors increase 
brain noradrenaline and can alleviate depression. 
Emoti9nal Aspects of r"knstrual Dysfunction 
The menstrual and premenstr~al p~ases 0f ~woman's cycle are a 
time of increased stress and susceptibility to injury. Suicides and 
accidents are at a peak during the luteal phase of the cycle, as are 
the number of attempted suicides, admissions to psychiatric hospitals 
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for depression, and acute outbreaks of schizophrenia (Dalton, 1959; 
t~acKinnon & r·1acKinnon, 1956; Mall, 1958, p. 96). During the menstrual 
and pre-menstrual phases the tendency to commit violent crimes is greater 
(Dalton, 1961) and symptoms of emotional stress such as anxiety are at 
their maximum 2 to 4 days before the onset of menstruation (Moos, Kopell) 
Melges, Yalom, Lundh, Clayton, & Hamburg, 1969; O'Connor-Miller, 1980). 
It is clinically well known that fluctuations of mood frequently 
occur in corr·elation with the menstrual cycle. Typ·ically, the premenstruum 
can be a phase of increased irritability and depression. The phenomena 
has attracted considerable clinical attention. Thus, Dalton (1959) studied 
the emergency admissions of 276 female psychiatric patients to a L')ndon 
hospital and found that the overall rate of admissions d~ring the 4-day 
premenstruum and during the 4-day period of menstruation was nearly twice 
as high as at the other times in the cycle. More than half (53%) of all 
attempted suicides in her sample took place during the premenstruum or 
menstruation. Coppen and Ke-ssell (1963) note that the premenstrua 1 
syndrome occurs in about one-fourth of all women. 
Moos (1968) undertook a large scale questionnaire study to detennine 
the incidence and severity of di. fferent syr.!ptoms in the menstrual, prerner~­
strual and intermenstrual phases of the menstrual cycle in a saJnple 
of young man'ied women. Each i'Joman \'las asked to descr-ibe hel~ r.xpedencE: 
of 47 symptoms during four different time periods: (a) dur·ing IH::r most 
recent menstrual flow; (b) during the o~e week before her most recent 
menstrual flow; (c) during the remainder of her most recent menstrual 
cycle; and (d) during her worst menstrual cycle. 
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Results showed that only about 20% of the women in the sample 
complained of moderate, strong, or severe symptoms of irritability, mood 
swings, depression, and tension in the menstrual and premenstrual phases 
of their most recent menstrual cycle. This is clinically significant 
\'Jhen compared to the sample's intermenstrual sccres, but by no means an 
indication of hormonal determinism. Less than 10~£ of the sample reported 
behavioral changes such as lowered performance, naps in bed, or decreased 
efficiency, menstrually and premenstrually. 
The questionnaire devised by Moos (1968) was also used to examine 
the characteristics of the menstrual cycle in women taking steroid con-
traceptives. Four hundred and twenty women currently taking oral contra-
ceptives were compared with a matched group of 298 women currently not 
taking steroid contraceptives but utilizing other means of contraception. 
Results showed that women not on oral contraceptives complained of 
greater severity of symptoms in both the menstrual phase and the pre-
menstrual phase of their cycles, as compared to women taking oral contra-
ceptives. These symptoms were mainly in the areas of pain (cramps, gener-
al aches and pains), concentration (lov;ered judgment, distractibility), 
negative affect (restlessness, tension, depression, and irritability), 
and behavior change (lowered school or work performance, decreased effi-
ciency). For example, 36% of t~e non-oral contraceptive group complained 
of moderate~ severes or disabling irritability in the premenstrual phase 
whereas only 24% of the oral contraceptive group showed similar complaints. 
The fact that t~ere were no control symotoms which significantly 
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differentiated the groups, and that there were no significant differences 
between the two groups in symptoms during the intermensttua1 phase. and 
only three significant differences in worst menstrual cycle symptom 
reports, indicates that the women not on oral contracep~ives are not 
merely prone to excessive) generalized complaints. 
Kane, Daly, Ewing, and Keeler (_19G7) reported adverse psycho.logica~ 
effects from progestational agents used for contraception. However, the 
present author suggests that progesterone compounds such as oral Provera 
might have positive psychologica1 effects, so that ~omen ta~ing them 
might complain of fewer menstrual and premenstrual symptoms, including 
decreased seizure frequency. 
Glass, Heninger, Lansky, and Talan (1971) assessed the differential 
effect of the menstrual cycle on psychiatric emergencies by completing 
a quantified clinical evaluation intermittently over a one year period 
on a representative female sample of emergency room psychiatric patients. 
The actively menstruating patients not on orai contraceptives entered 
the emergency room twice as frequently as expected during the premenstrual 
week and as frequently as expected during the menstrual week. Suicide 
attempts occurred at three times the expected frequency during the pre-
menstrual week and the premenstrual patients were rated higher on 
hostil-ity and suicidal ideation and had a more severe past medical histo1·y 
than the patients seen during the intermenstrual phase of the cycle. 
Glass et al. (1971) suggest that their data indicate that the menstrual 
cycle does have a differential effect on the psychiatric admissions of 
women, specifically, non-psychotic n1enstruating women with more severe 
past medical and gynecological histories who have more sexu~l and marital 
problems appear to be more susceptible to a premenstrual psychiatric 
emergency characterized by hostility, suicidal ideation) and actual 
suicide attempts. 
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Kramer (1977) reports on psychotic episodes lasting four to seven 
days that occurred in an adolescent epileptic girl only at the time of 
her period. Unfortunately, in this case the patient was not consistently 
compliant on her anticonvulsant regimen of Dilantin; and when therapeutic 
blood levels of Dilantin were mainta.ined, the psychotic episodes were 
eliminated. Nonetheless, this is another 2xampl2 of new the or,set of the 
menstrual period implicates liormonal or metabolic changes occurring 
around the time of the menses in the expression of underlying psychopatho-
logical processes. 
Kramer (1977) also suggests that various hormonal therapies might 
be efficacious in controlling the pnstulated underlying endocrinological 
disturbance. Livingston (1966, pp. 99-119) achieved seizure control in 
menstrual epilepsy by means of conventional oral contraceptives~ and 
Zimmerman, Holden, Reiter, and Dekaban (.1973) reported successful treat-
ment of menstrual epilepsy in an 8-year-old precocious girl with medroxy-
progesterone acetate (Provera). 
Check (1978) asserts that psychological factors are the most 
common cause of menstrual dysfunction. He cites instances in which 
couples \vho have been trying unsuccessfully to conceive for years, do so 
after they have adopted a child and quit worrying about pregnancy. In 
most of these cases, the mental pressures of failing to conceive induced 
such anxiety that ovulation ceased; v:hen an xi et.y ended, spontaneou~ 
ovulation and pregnancy followed. 
Mild anxieties may lead tc changes in the menstrual cycle, infer-
tility, or· habitual nbot·tion by causing an ir.adequ~~te developm2nt of t:1e 
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corpus luteum. This is due to i~sufficient secretion of progesterone. 
The main function of orogest.erom• is to caLse secretory changes in the 
endometrium in preparation for implantation of the ferti!ized egg. Hith 
inadequate progesterone, the endometrial lining is insufficient to 
support implantation, and abortion or infertility occurs. 
The same emotional factors causing an inadequate corpus luteum 
may result in anovulation, irregu~ar periods d~c to brea~through bleeding 
{ o 1 i gomenorrhea), or no peri oct at all (amenorrhea). Some of the common 
environmental factors leading to these problems that Check (1978) has 
documented include loss of a loved one, moving to a new environment, 
fear of pregnancy, marital strife, and change of jobs. 
The mechanism of how emotional problems can lead to irregular 
eye 1 es, dysfunction a 1 uterine b 1 eed i ng, or amenorrhea can be ex am-i ned 
at the hypothalamic level. The basic control of the menstrual cycle 
is dependent on a ver·y exact and del-icate relationship bet\veen the 
hypothalamus, pituitary, and ovary (Check, 1978). The dominant relation-
ship during the preovulatory phase of the menstrual cycle (the fo11 iculat· 
phase) is a positive feedback to the cyclic center of the anterior hypo-
thaiamus, resulting in pulsatile release of gonadotropin-re1easing 
hormone, and thus causing pulsatile release of luteinizing hormone (LH) 
and to a lesser degree follicle--stimulating hormone (FSH). H'ds e·ventually 
results in the mid-cycle surge of LH required for ovulation, 
Mfld dysfunction in the hypothalamic-pituitary-ovarian axis may 
involve production of either slightly less estrogen than needed to c~use 
the positive stimulation necessaY'Y for the mid-cycle LH surge or slightly 
too much estrogen, which exerts a negative feedback for FSH, thus 
preventing proper follicular maturation. 
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The hyp0thala~us is not the highest center of control, however; 
the cerebrijl cortex and limbic system both influence hypothalamic control 
by means of biogenic amines, and it is through this mechanism that 
emotions alter ovulat0r_y function. The main CNS biogenic amines are 
dopamine, norepinephrine, and serotonin. They influence all hypothalamic-
releasing hormones. ,Ci,t present, there is evidence that dopamine sup-
presses LH (Lachelin, LeBlanc, & Yen, 1977; LeBlanc, Lachelin, Abu-Fadil, 
& Yen, 1976). 
Another hormone involved in control of the menstrual cycle is 
prolactin. Elevation of serum prolactin causes reciprocal lowering of 
the gonadotropins, especially FSH, resulting in amenorrhea and sometimes 
galactorrhea (Bohnet, Dahlen, Wuttke, & Schneider, 1975). Malarkey, 
Jacobs, and Daughaday (1971) found that dopamine is the prolactin-inhibit-
ing factor that normally keeps the prolactin-producing cells in a 
suppressed state. Psychological stress can result in an increase in 
prolactin, which in itself can alter the menstrual cycle by the inhibi-
tory effect that it has on LH (~liyabo, Hi sad a, Asato, Mi zushima, & Ueno, 
1976). 
Stress may alter· ovulatory function through its effect on still 
another pituitary hormone, ACTH (Check, 1978). ACTH stiniulates secretions 
of glucocorticoids from the zona fasciculata and androgens from the zona 
reticularis of the adrenal gland, There seems to be two areas of the 
hypothalamus producing the corticotropi~-releasing factor (CRF), which 
is responsible for ACTH secretion. The lower area is considered the 
center responsible for the daily nor:nal diurnal type of secretion of 
cortisol; the higher hypothalamic center causes gr·eater increases of ACTH 
under stress conditions, resulting in greater cortisol secrctio~ necessary 
during fight or flight. An increase in either cortisol or androgens 
can inhibit the gonadot·r·opins. This adre:1al stress syndrome can result 
in anovulatory cycles, among other problems. 
Psychologicfl disturbances can thu~ cause certain somatic manifes-
tations that are difficult to discern from organically caused disease. 
However, in most instances the psycholog~c31 disturbance interfers only 
\'iith ovulation, and the ovary cnntinues to produce estrogen, allovling the 
endometrial lining to b~ild up. 8epression can occasionally cause 
dysfunctional uterine bleeding that is extremely resistant to hormonal 
therapy. Thus, the psyche appears also to have a direct effect in some 
instances on the endometrial lining. This endometrial factor can also 
be responsible fol~ amenorrhea, vJhich can be very resistant to homonal 
therapy even with high doses of estrogen and progesterone (Goldzieher 
& Goldzieher, 1952). For some reason, this condition occurs frequently 
following automobile accidents. Its etiology has not yet been explained. 
Psychological factors also may influence the ovary directly. Check 
(1978) reports several cases of women who developed amenorrhea, hot 
flashes, elevated gonadotropins, and other symptoms of menopause shortly 
after their husbands died. When these women began dating, their symptoms 
frequently abated, with return of menstrual function and normal levels 
of LH and FSH. 
These findings suggest the hypothesis that high emotional distress 
should manifest itself in anovulatory cycles and cycles \vith inadequate 
luteal production (ILP), in the specific group of epileptic women seen 
in this current study. Even more strongly, one may postulate that high 
levels of emot·ional distress cause anovulatory and ILP cycles. Hi9h 
ratings on th2 SRE Weekly Schedule of Recent Experiences should be 
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highly correlated with anovulator·y and ILP cycles. Since anovulatory 
cycles are by definition deficient in the production of progester·one, 
anovulatory cycles should also be highly correlated v1ith incren.sed 
seizure frequency, if one accepts that seizures are inhibited by high 
levels of progesterone. By this mechanism, increased seizure frequency 
should be highly correlated with emotional distress. 
Schematically, the author proposes that the following relationships 
hold: 
l. Emotional distr·ess leads to anovulatory cycles, via the hypo-
thalamic-pituitary-ovarian pathways outlined above. 
2. Anovulatory cycles are deficient in progesterone. 
3. Seizures increase when progesterone is low. 
4. Anovulatory cycles should therefore be associated with increased 
seizure frequency, particularly in the last two weeks (normal luteal 
phase) of the cycle as compared to a normal ovul<:,tcry cycle. 
5. Therefore, by this mechanism increased seizure freque~cy should 
be highly correlated with emotional distress. 
~1ood changes during the menstrua1 ~ycl_£. Ivey and Bard\IJick (1968) 
tested 26 female college students for differences in anxiety level during 
the menstrual cycle. The subjects were asked to talk for five winutes on 
any memorable life experience, dt..ring their OVL:latcl-y p11ase and :;.lso 
during their premenstrual phase, for two menstrual cycles. Ovulation 
was determined from basal body temperature records and by history fmm 
the length of previous menstrual cycles. The verbal samples were scored 
according to Gottschalk's (1966) Verbal Anxiety Scale and were examined 
fer thematic variations. The Verbal Anxiety Scale showed that anxiety 
premenstrually was significantly higher than at ovulation for all subjects. 
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Consistent themes of hostility, depression, and noncoping apr:r~ared · 
premenstrually, ns opposed to themes of self-satisfaction, adequacy, and 
coping at ovulation. Ivey and Bardwick (1968) conclude that their find-
ings support significant affective fluctuations during the menstrual 
cycle which correlate with presumed endocrine changes. 
Schell, Roca, t~lcMahan, Bearup, and Pederson (1974) found only very 
mild effects of cycle day on mood and symptom variables in a group of 
nine free-cycling women, with subjects experiencing slightly more negative 
affect or lack of activation and water retention during the premenstrual 
and menstrual period. Reaction time increased but performance on the 
Miller Analogies test improved slightly premenstrually. Heart rate and 
skin conductance were unaffected. These findings suggest that changes in 
mood and ANS system activity are not an inevitabie consequence of the 
normal menstrual cycle in young, healthy, free--cycling worr.en. 
Golub (1976) studied the magnitude of premenstrual and intermenstrual 
mood changes in 50 parous adult women, using the State-Trait Anxiety 
Inventory and the Depression Adjective Check List. Golub notes that none 
. . 
of the studies done previously to his 1976 study assessed the magnitude 
of mood changes with respect to the menstrual cycle in a way that would 
permit comparison with normative c:ata; or evaluated premenstrual anxiety 
as a transitory or state phenomenon, as opposed to a mi':lrdfestation of 
trait anxiety, whir::h ~s a relatively stable per-sonality characteristic. 
Goluh (1976) found that prernenstrua1 stute anxiety and depression 
mean scores were significantly higher than those obtained midcycle, but 
were much lower than those cf a normat·ivc group of patients with 
psychiatric disorders. The st~t~ anxiety ~cores of Golub's sample were 
close to nor-rnat.ive va·lues for fn::shrr:en college vmmen taking a.n examination. 
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Trait anxiety scores were 1m•/ t~.nd were not significar:tiy cor-related Viith 
preme11strual depression and anxiety sco}·es. 
The Moos Menstrua1 Distn.'_?5_Chles_ti~i1~1Air!:.· C1in1ca1ly, it is well 
known that the premenstrual phase of the menstrual cycle is a time of 
increased irritability and depression. However, few studies have taken 
systematic account of the role of biochemical factors in the premenstrual 
syndrome. Hamburg, i~oos, and Yalom (1968) r·eport on the t~oos ~1enstrua1 
Distress Questionnaire and observe that the differentiated menstrual 
cycle symptom profile analysis suggested by the e·ight scales of Pain, 
Concentration, Behavioral Change, Dizziness, Water Retention, Negative 
Affect, Positive Arousal, and Control Symptoms would allow for investiga-
tion of differential treatment effects of drugs or hormones on different 
types of menstrual symptoms and invest-igation of the biochem·ical cor-
relates of each type. Hamburg, Moos and Yalom (1968) found that anxiety 
is high during the menstrual flow, decreases sharply, and then slowly 
increases up to the 90-93rd percentile of the cycle. A sharp and puzzling 
decrease occurs in the 94th to 97th percentile of the cycle, and then 
anxiety goes up again just before the menstrual flow begins. Sexual 
arousal is lowest during the menstrual flow, gradually increases up to 
mid-cycle, and then decreases and levels off for the remainder of the 
cycle. The pattern of anxiety described above suggests that progesterone 
may inhibit or at least be related to anxiety; while sexual arousal may 
be influenced by the amount of estrogen present. 
The r~1oos t·1enstrual Distress Questionna·ire Vias designed to assess 
changes in several symptom clusters across the various stages of v!Or1en's 
menstrual cyc1+:;s. Form A and Form T of the Questionnaire appears in 
ft.ppendix l1. Fcmn T of the Questionnaire vtas designed ·~o be suitab.le for· 
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repeated assessments of symptoms from the same subjects. Subjects note 
their experience of each of 47 symptoms on a 6-point scale, ranging from 
no experience of the symptom to an acute experience of the symptom. 
Since the questionnaire is repeatable, women can differentiate between 
their experience of different symptoms in terms of the phases during the 
cycle in which they occur. The intercorrelations among the eight scales 
are all positive (Moos, 1977), indicating that women who score high on 
one scale also tend to score high on the others. The control scale is 
positively related to each of the other scales, indicating that women 
who tend to complain of relatively frequently occurring menstrual cycle 
symptoms also tend to complain about non-menstrually related symptoms. 
High inter-cycle symptom correlations suggest women tend to complain of 
generally consistent symptomatology from one menstrual cycle to another. 
The Moos Menstrual Distress Questionnaire, Form T, is sensitive to 
menstrual cycle phase effects: women do complain of more symptoms in 
the menstrual and premenstrual than in the intermenstrual phase of their 
most recent cycle. Voda (1976} used Form T to study 20 ovulating women 
every other day for one menstrual cycle. She factor analyzed the 
Menstrual Distress Questionnaire (MDQ} and generated four symptom 
categories (positive affect, negative affect, concentration, and physical 
complaints). Negative affect, concentration, and physical complaints 
showed significant phase effects. Other researchers who found significant 
phase effects for various scales on Form T have been O'Connor-Miller (1980), 
Silbergeld, Brast, and Noble (1971), Stultz (1971), and Wilcoxon, Schrader 
and Sherif (1976). Since normal subjects do show phase effects on the 
different scales of the MDQ, an important question to ask regarding 
epileptic women is whether they also show these phase effects and if 
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they do, whether heightened menstrual distress occurs in conjunction 
with increased seizure frequency, However, reported relationships 
between cycle phase and mood may be independent of underlying physiologi-
cal changes and more a consequence of women's expectations. Ruble, 
Brooks, and Clarke (1976) found that women who believed they were pre-
menstrual reported a significantly higher degree of menstrual distress 
than ~mmen \'Jho believed they were intermenstrual, regardless of whether 
the women were actually premenstrual or intermenstrual. Possibly epi-
leptic women may expect more seizures premenstrually and menstrually if 
they believe they are in these phases, and the ~ension caused by this 
expectation may actu~lly produce more seiz~res. However, Markun: (1976) 
found that expectations about phase of the menstrual cycle that c '.'loman 
thought she was in, did not affect responses to the MDQ. Markum argues 
that this casts doubt on the hypothesis that the r1DQ measures stereotypi c 
beliefs about menstruation. 
Wilcoxon, Schrader, and Sherif (1976) found no substantial evidence 
of MDQ deterioration over the course of longitudinal studies. 
Several of the MDQ scales are related to complaints of physical 
symptoms and of negative affect. Paige (1973) found that women who 
complained of physical discomfort and psychological stress during men-
struation tended to report such symptoms in other situations as well. 
A related question that can be raised with regard to the epileptic popu-
lation is, do women who complain the most of physical discomfort and 
psychological stress during menstruation also tend to report mere 
seizures and have more seizures. Silb~rgeld, Brast, and Noble (1971) 
found high ccneiutions betwe2n ~1DQ anxiety and tiood Adjective Checklist 
(MACL) anxiety, and between MOQ irritability and MACL aggression. 
The MDQ appears to be an adequate instrument to mea~ure psyc!1ological 
stress in the form of anxiety~ at least as anxiety is defined by these 
cohstructs. In terms of the present study, the MDQ has construct 
validity as a measure of anxiety and psychological stress. Symptom 
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scores on the MDQ are positively related to scores on other questionnaires 
measuring physical symptomss general health, and negative affect. 
Several studies investigated the relationships between menstrual 
cycle symptomatology as measured by the r~DQ, and attitudes regarding 
menstruation, sex, and femininity. Ruble, Brooks, and Clarke (1976) 
concluded that a woman's attitudes about menstruation may be related to 
her expectations regarding her menstrual cycle symptoms, and that these 
expectations may, in turn, influence the actual symptoms she experiences. 
However, an alternative explanation is that these attitudes are directly 
related to a woman's actual symptoms: since women who experience more 
symptoms probably expect more symptoms in subsequent menstrual cycles. 
Di Nardo (1974) suggested that women with fewer MDQ symptom 
complaints have more positive attitudes about their bodies, whereas 
those with more symptom complaints are less likely to accept certain 
aspects of their sexual role (Berry & McGuire, 1972). According to 
other studies, howevei~, other important variables are operative. For 
example, Gough (1975) found that women with higher MDQ total distress 
scores tended to have higher scores on f2mininity, but lower scores on 
well-being, tolerance, good impression, achievement via conformity, 
intellectual efficiency, and self~control, Paige (1973) also found 
that those who bel1cved that a woman's place :1as in the home, and who 
had no personal career ambitions, were the most likely to have severe 
menstrual symptoms. Paige conc11~lled that, contrary to popu1at stereotypes, 
the traditiona"!ly fe:n-inine \'JOmC!n, rather than ambitious career types, 
are most likely to complain the most about menstrual and premenstrual 
distress. 
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The foregoing results indicate that any relationship between men-
strual distress and various aspects of femininity may be moderated by 
such factors as religious orientation, somatic concern, social competence, 
and self-esteem. Investigations which have attempted to relate MDQ scale 
scores to various general personality characteristics and psychiatric 
diagnostic categories have met with little success, since there are 
important moderating variables (Gough, 1975; Gruba, 1973). 
Gruba and Rohrbaugh (1975) found that the MMPI subscales of 
Hypochondriasis (Hs), Psychasthenia (Pt), Hystel'ia (Hy), and Schizophrenia 
(Sc) were significantly related to the MDQ scale~ of Behavior Change and 
Autonomic Reactions in the menstrual phase; and Pain, Negative Affect, 
and Autonomic Reactions in the premenstrual phase. They interpret their 
results as supportive of the hypothesis that premenstrual tension, ir-
ritability, and depression are related to neuroticism. It should be 
pointed out that correlation does not speak to the nature or direction 
of causality, but does suggest areas in which causal relationships rnay 
be investigated. Personality variables may influence mood, pain per-
ception, and hormonal changes; but physiological processes may also 
influence pet·sonality variables; or both direct·ions of causality may 
operate simultaneously. However, Moos points out that these findings 
may simply indicate that women who complain of menstrual and premenstrual 
symptoms also tend to corr.plain of other· physical symptoms and of general 
negative affect. 
Most studies indicate that women's cognitive and perceptual-motor 
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performance is not affected by menstrual cycle phase (Dalton, 1969; 
Favreau, 1974; Golub, 1976(a); Golub, 1976(b); Niesz, 1976; Olasov, 1972). 
HoHever, Sommer {1973) found that ~;omen who complain of more symptoms 
in the menstrual phase of their cycles tend to perform more poorly on 
perceptual-motor tasks. Baisden and Gibson (1975) found some relation-
ships between performance on complex perceptual-psychomotor tasks and 
the Menstrual Dist;~ess Questionnaire subscaies. They point out that 
the symptoms measured by the MDQ are common reactions to stress for both 
men and women, and speculate that people who have a general tendency to 
complain and a low tolera~ce to stress and disco~fort may experience 
performance decrements as a reaction to any type of environmental or 
physical stress. In regard to the present investigation, then, one 
might hypothesize that vmmen epileptics who have a lower tolerance to 
stress, as per·haps manifested in increased seizure frequency, may exper-
ience performance decr'ernents. Ar. alternative possibility is that \'/hen 
women epileptics have seizures, a reaction to their seizures may be 
performance decrements. Extrapolating from the literature, one might 
speculate that women who have an increased seizure frequency menstrually 
and premenstrually, will also complain of a greater severity of other 
menstrual and premenstrual symptoms. Women epileptics might be expected 
to show more menstrual and premenstrual complaints as measured by the 
~loos rlDQ scales, compared to the intermenstrual phase of their cycles; 
just as non-epileptic women have been shown in the literature to have 
more complaints ~enstrually and premenstrually, as compared to intermen-
strually. Epileptic \oJOmen whose seizures cluster menstrually and pre-
menstrually might also be expected to have more menstrual and premenstrual 
distress than epileptic women whose seizures do not cluster menstrually 
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and premenstrually. 
Moos (1977), in his review of the literature on the Moos Menstrual 
Distress Questionnaire. has concluded that subtypes of women exist who 
are differentiated ·in terms of the particular areas in which they 
complain of symptoms. Moos then raises the issue of whether women who 
are having only one set of symptoms are experiencing the same syndrome 
as the women who have another set of symptoms; for example, are the 
women who have only pain symptoms experiencing the same syndrome as the 
women who have only autonomic reaction symptoms? Moos (1977) relates 
that some women appear to have dysmenorrhea but little or no premenstrual 
tension, whereas others have premenstrual tension but little or no men-
strual pain, and still others complain of both dysmenorrhea and premen-
strual tension. Certain clusters of symptoms may be more highly related 
to cyclical physiological fluctuations than others (Cullberg, 1972) and 
the present author hypothesizes that this m&y be true fer epileptic women 
as well as non-epileptic women. Po~sibly only a small subgroup of 
epileptic women exist 1n which premenstrual complaints are c1ear1y 
hormone dependent. 
Stressful life events questionnaires. Growing numbers of investi-
gators are using lists cf stressful life events, in an attempt to 
delineate the relationship between these events and physical and psycho-
logical disorders. The hope is that through careful detailing of events 
antecedent to physical and psychiatric distress, predictions can be made 
about the type and amount of stress that might precipitate illness in 
individuals experiencing such stress. An important function of behavioral 
assessment can be to establish the relationship between changes in psycho-
logical events and chanqes in a phys·iolog·lcJ.l response, as 1nany 
psychiatric and medical disorders involve physiological changes to 
specific environmental stimuli. In the present study, an important 
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issue that has been addressed is the nature of the precipitants of 
increased seizure frequency in epileptic women. The author postulates 
that an important correlate, if not cause of seizure episodes, is an 
increase in the experiencing of stressful life events prior to seizure 
onset. A well-designed life events questionnaire administered to ~n 
epileptic population could be of great value in delineating the relation-
ships between stressful life events and seizure frequency. It is from 
this perspective and interest that the present review and critique of 
life stress literature is presented, with suggestions for improving the 
sampling and recording of stressful life events for individual subjects. 
An experimental self-monitor-ing diary is also included, and is meant to 
be an improved way of recording and analyzing daily stressful life events 
that might precipitate seizures in epileptic women. 
Research on life events originated with Adolph Meyer's work in 
psychobiology. His invention of the 11 life chart 11 (Lief, 1948) organized 
medical data as a dynamic biography, and provided a method for demon-
strating his schema of the relationship of biological, psychological, 
and sociological phenomena to the processes of health and disease in man. 
Beginning in 1949, the Social Re~djustment Rating Scale, developed by 
Holmes and Rahe (Holmes & Masuda, 1973) and arising out of the theorizing 
of Adolph Meyer, has been used systematically with more than 5,000 
subjects to study the quality and quantity of life events that were 
empirically observed to cluster at the time of disease onset. The Social 
Readjustment Rating Scale remains the most widely used of all rating 
scales. The 1 He events on the scale WP.rc clet~ived from both ordinary 
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and extra0rdin0ry su:ial and interpersonal transactions, ana pertain to 
major areas of dynamic significance, including family constellation, 
marriage, occupation, economics, residence, group and peer relationships, 
education, religion, recreation, and health. A ~riteria for inclusion on 
the scale were those life events that usually evoked, or were associated 
witt1, some adaptive or coping behavior on the part of the involved indivi-
dual. Each ite~ was constructed to contain life events whose advent 
either is indicative of, or requires a significant change in, the ongoing 
life pattern of an individual. The emphasis was on change from the 
existing steady state and not on psychological meaning, emotion, or 
social desirabil-ity. 
Scaling of the Social Readjustment Rating Questionnaire {SRRQ) was 
described by Holmes and Rahe (1967). In order to provide an estimate of 
the magnitude of life events, a sample of convenience of 394 subjects 
was asked to rate a set·ies of life events according to their relative 
degrees of necessary readjustment. The event of Marriage was given an 
arbitrary value of 500. The subjects were instructed: 
As you complete each of the remaining events think to yourself, 
11 Is this event indicative of mol~e or less readjustment than 
. marriage?" "\~ould the readjustment take longer· or shorter to 
accomplish?!! If yr:•u decide that the readjustment is more intense 
and protracted, then choose a proporti_Qnate1_t__l9_!:_g~_r_ number and 
place H in the blank directly opposite the evtnt in the column 
marked "Value." If you decide that the event r·epresents less 
and shorter readjustment than marriage, then indicate how much 
blank. (Holmes E~ t~ctsuda, 1973, p. 166) 
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Thus, the magnitude of each life event was derived by calculating 
the mean score of each event for the entire sample. Guilford {1965) 
documented high correlation coefficients demonstrating that consensus 
was high concerning the relative order and magnitude of the means of 
items between the discrete groups contained in the sample. Replication 
and validation of the scaling method was made on two American samples 
(Pasley, 1969; Ruch & Holmes, 1971). Appendix A shows the items in the 
Holmes and Rahe Social Readjustment Rating Questionnaire, and their 
relative weights. 
The Holmes and Rahe (1967) Social Readjustment Rating Questionnaire 
has generated a great deal of research, including methods for assigning 
magnitudes to each of the life events (Holmes & Rahe, 1967; Masuda & 
Holmes, 1967); the prediction of near future health changes from subjects' 
preceding life changes (Rahe, Mahan, & Arthur, 1970); and changes in 
health as a consequence of long-term life changes (Casey, Masuda, & 
Holmes, 1967). Long-term stress up to ten years prior to the onset of 
illness, and frequency of disease occurrence have been studied in groups 
exposed to the same conditions, one of which comes down with the disease 
and the other of which does not (Rahe, Meyer, Smith, Kjaer, & Holmes, 
1964). Validation of the Social Readjustment Rating Scale across 
different populations has been done in a variety of cross-cultural studies 
(Harmon, Masuda, & Holmes, 1970). Pesznecker and McNeil (1975), using a 
linear correlation and multiple regression design, studied the relation-
ship among health habits, social assets, psychological well-being, life 
change, and alterations in health status. Garrity, Somes, and Marx 
(1977) found that social conformity, liberal intellectualism and emotional 
sensitivity are independently and significantly predictive of health 
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change; these relationships hold even when recent life experience is 
introduced as a significant predictor of health change. Ruch (1977), 
performing a multi-dimensional analysis of the concept of life change, 
found that life change has three dimensions: the degree of change evoked, 
the desirability of the change, and the life area in which the event 
occurs. Ruch's analysis also indicated that while the life change data 
are multidimensional, the quantitative dimension {degree of l~fe change) 
is more pr-imary than the qualitative dimension (desirability of life 
change and area of life change). Holmes and Masuda (1973) have written 
a review of the Social Readjustment Rating Scale (SRRS), and have 
concluded that across a wide variety of studies, the magnitude of life 
change was observed to be highly significantly related to time of disease 
onset. The greater the magnitude of life change, the greater the probabil-
ity that the life change would be associated with disease onset, and the 
greater the probability that the population at risk would experience the 
disease. A strong positive correlation also exists between magnittlde of 
life change and seriousness of the chronic illness experienced. The 
major health changes observed covered a wide range of psychiatric, medical, 
and surgical diseases. 
One obvious problem with the Holmes and Rahe (1967) method of 
scaling their Social Readjustment R&ting Sc~le is Lhat the magnitudes 
assigned to each of the life change items represent magrli tudes for a 
group, not fo1' an i!lcividual. A common sense obse1·vation mi9nt be tllJt 
a particular ev~nt could be very stressFul for a given individual, b~t 
not for another individual, For example, some people who have lived in 
the s2.me house, which they owned fl)r 25 ye':l rs, n'i g;1t •"i ncl tha l: the 
adjustment to a residenti~l rnnve is enormous, w~ile student5 who move 
from college dorm room:: to off-campus apartments every summer and back 
again may feel that ve;~y little life adjustment is required to move. 
I\ form currently in use by psychiatrists in the United States Navy, 
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called the Recent Life Changes Questionnaire (Rahe & Arthur, 1978), recog-
nizes this point and asks respondents to both indicate what life changes 
they have experienced during different time periods and to assign their 
own ratings, from 1 to 100, for each of the life changes they experienced. 
Knowledge of the precipitants of physical and psychiatric illness in a 
given individual is far more useful to a pl1ysician in the treatment of 
that individual, than general knowledge of precipitants of physical ill-
ness in a group. 
The Navy Recent Life Changes Questionnaire (Rahe & Arthur, 1978) 
illustrates another problem with the popularly used Holmes and Rahe (1967) 
Social Readjustment Rating Questionnaire: the SRRQ samples too limited a 
population of stressful life events. Holmes and Rahe (1967), in devising 
the SRRQ, argued on a priori grounds that their particular list was a 
good one: they appealed to 11 Common sense 11 by making the assumption that 
most people would agree that the events chosen were stressful. However, 
what can be considered as stressful might be much better arrived at by 
asking subjects to indicate these events solely on the basis of their 
own introspective experience, without recourse to any prearranged lists, 
as well as by indicating the magnitude of the life change experiences 
for themselves individually, The Navy Recent Life Changes Questionnaire 
contains more items than the standard SRRQ) including events that are 
specific and meaningfu·l to military populations, such as demotions and 
transfers. 
87 
Holmes and Rahe (1967) also sample events that occur too ·infrequent-
ly to make meaningful correlations between daily changes of life events 
and daily changes in specific types of physical illness, for example 
seizure frequency in an epileptic population. In fact, such rarely 
occurring events as death cr divcrce, or even a major change in the num-
ber of arguments with a spouse, can be far separated in time frcm such 
relatively frequently occurring physical disabilities as seiz~re fre-
quency. Seizure frequency caul d have far mor·e mundane immediate ante-
cedents, for example a particularly bad single argument with a spouse; 
although seizure frequency may conceivably be correlated with, say, 
death of a family member six months previously. A far more useful stra-
tegy would be to look at life changes that occur on a monthly, weekly, or 
even daily basis as they are related to changes in physical illness and 
psychiatric disorder, rather than life changes that occur in the distant 
past. 
Holmes and Rahe (1967) do not sample the day to day, stressful 
life events that people might experience, such as arguments with spouse, 
problems with children, in-laws coming to visit, failures of household 
equipment, and overly-hectic days at the office. Very conceivably, 
these daily and relatively minor occurrences, or a certain magnitude of 
them, may be most responsible for physical ailments such as headaches, 
stomach aches, accidents of various kinds, and seizure frequency. Know-
ledge of the particular stressful occurrences that precipitate illness 
in a given individual is extremely important for treatment and management 
of that individual. 
Holmes and Rahe (1967) have not published the only life change 
questionnaire; nor is their questionnaire the only one with major 
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theoretica1 and methodological problems. Other investigators who have 
published their own lists of stressful life events include Antonovsky 
and Kats (1967), Brown and Birley (1968), Dohrenwend (1973a), and Murphy, 
Robins, Kuhn, and Christensen (1962). Although the events lists compiled 
by different investigators alv1ays overlap to some extent, the lists are 
by no means identical. They vary in number of items: from 27 on the list 
used by Murphy, Robins, Kuhn, aild Chd stensen (1962) to 62 on the 1 i st 
used by t~yers and his co-workers (1972). They also vary in content: for 
example, court martial is specific to lists used to investigate military 
personnel (Rahe et al., 1967); experience in Nazi concentration camps is 
included in research done in Israel (Antonovsky & Kats, 1967). The dictates 
of common sense definitions vary with the subjects being studied, the set-
ting in which the research takes place, and the type of i1lness or dis-
order being investigated. 
Other differences between the var~ous lists of life change events 
reflect theoretical divergencies among thP investigators. For ~xample, 
differences exist between investigators over how important it is to 
distinguish between objective events and subjective events (Thurlow, 1971), 
gain events and loss events (Dohrenwend, 1973a), and between events the 
individual is responsible for bringing abo~t and eveilts ov:r which he 
has no control (Brown, Sklair, Harris, & Btrley, 1973; Dohrenwend, 1973b). 
A difficulty in all of the life change questionnaires is the failure 
to separate the relationship of psychopathology to physical illness from 
the relationship of other life events to physical illnes~, as well as the 
converse: the relationship of physical illness to psychopathology. In 
such research, physical illness is one type of event among many, as is 
psychopathology one type of event among many; the ~ontribution of physical 
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illness to psychopathology is obscured in reductions of the life events 
reported to total Life Change Unit scores (Masuda & Holmes, 1967; Rahe 
& Arthur, 1968), total events, or summary qualitative distinct~ons 
such as "gain" versus "loss" (DohrenvJend, 1973a) or "desirableil vet~sus 
"undesirable" (f~yers et al., 1972). Like.,.rise, the contribution of 
psychopatho 1 ogy to phys i ca 1 i 11 ness is obscured. Indi vi dua 1 s may bring 
about many of their own life changes and physical iTlne~ses because of 
emotional instability which leads them to behave in bizarre ways, provoking 
individuals close to them and disrupting the·ir environment (Fontana~ 1976). 
We have already mentioned that the defense of the event lists used 
by d·i fferent investigators has been based on appea 1 s to common sense and 
reference to retrospective reports of the types of event or crisis 
included by patients under treatment for various disorders or il"lnesses. 
Only Dohrenwend (1974) reports on nominations of items for a life events 
list which are made independently of the researcher-constructed lists 
themselves, by samples of subjects drawn from the general population. 
Dohrenwend (1974) had leaders, a community sample, psychiatric outpatients, 
psychiatric hospital patients, and convicts nominate the last major event 
in their lives that, for better or worse, interrupted or changed their 
usual activities. Dohrenwend (1974) also had his sample complete a 
standard checklist. He found that very fev-J of the events reported in 
response to the checklist were previously nominated by the respondents 
themselves as the last major events in their lives o.ccurring in the 
preceding year. Most of the events on the standard checklist were not 
"major11 by even a substant·j a l minority cf the respondents who exper·i enced 
them. 
A standard checklist, then, is appc~l'2nt1y ;1ot a very gJod \Ai3.Y to 
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reference to the Dohrenwend (1974) study, the types of events that 
respondents nominate as major appears to be very much dependent on the 
personality structure and degree of success of the respondents. Commun-
ity leaders tend to report as major evP.nts~ objective gain events that 
they were likely to have some responsibility for bringing about. By 
contrast, patients and prisoners tend to report either subje~tive or 
objective loss events f:Jr which they \'Jere likely to be at least partly 
responsible. Commur.ity sample respondents who resemble leaders in 
reporting last major events involving gain also resemble them in showing 
low rates of psychiatric disorder. Unfortunately, Dchrenwend (1974) 
does not specify in any great detail the specific life events which his 
sample reported, that are different from the more usual checklist events. 
Dohrenwend (1974) concludes from his ana1ys·is of the responses of 
his sample that examining stressful life events in terms of vvhether 
they represent gain or loss, the number involved, or the amount of 
change associated with them is not likely to tell us much about their 
role in the etio"logy of psychopathology. Some types of gain or loss 
events are too hopelessly confounded with superior functioning on the 
one hand and impairing psychopathology on the other to be helpful in 
investigating the causation of either. Rather, what appears to be 
crucial to the differences in psychopathology among those reporting 
different types of objective loss event is whether the events involve 
physical illness or injury to the respondent and whether or not their 
occurrence is outside the subject's control. 
What are some of the implications of Dohrenwend's (1974) findings 
for future research? If an investigatoris interest is in the role of 
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stressful life events in the etiology of phys1cal illness, then Dohren-
wend's results imply that there are several different event populations: 
for example, objective and subjective events, gain and loss events, and 
events for which the individual may or may not be responsible. In 
addition, it is necessary to keep analytically distinct at least thr·ee 
different populations of events if the investigation is focused on 
problems of etiology: {a) a population of events that are confounded with 
the psychiatric condition of the subject; (b) a population of events 
consisting of physical illness and injury to the subject; and (c) a 
population of events \vhose occurrences a1·e independent of either the 
subject's physical heaith or his psychiatcic condition. Thr: Elore the 
sample of items in a particular measure of stressful life events 
represents a mixture from these three event populations, the more difficult 
it will be to assess the implications of a relationship betv:een such a 
measure and either various types of psychopathology or various types of 
physical illness. The key problem becomes how to sample these events in 
such a way that their interrelations with each other and their possible 
contribution to psychopatnology can be evaluated. 
A possible research design to solve thts problem might consist of 
the following: (a) a probability sample of subjects unselected for 
psychopathology :n;d preierably drawn fror. the general population; (b) 
baseline measures of their psychiatric condition~ including measures of 
various types of psychopathology and related role functioning; (c) 
retrospective measures that sample and date the most significant events 
from each of the three event populations over· the major developmental 
stages of the subject's life history; and (d) a short>-ter.n follow-up, at 
which time postmeascn·es of the psychiatric condit·ion of the respondents 
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would be secured, as well as intervening measures of the most important 
events that occurred during the year from each of the three populations, 
with each event carefully dated \vi th respect to every other in terms of 
time occurrence. In this design, the key variables whose etiologi~al 
significance would be evaluated are events from the populations of 
physical il'Jness and injury, and events outside the subject's control, 
that occur between the pre-measures and post-measures of psychiatric 
condition. The events from event population 1 that occurred between the 
pre-measures and post-measures would be used as control variables to test 
for possible early onset or exacer·bation of psychopathology if they 
preceded the events from event populations 2 and 3 or as part of the 
post-measures of psychiatric condition if they followed the events from 
event populations 2 and 3. A similar strategy could be used to study the 
etiological significance of life events in physical illness rather than 
psychopathology. 
Several reviews on the status of the life stress questionnaires 
and problems inherent in them have been written (Hull, 1976; f'1ason, 1975a; 
Mason, 1975b; Mechanic, 1975; Mechanic, 1976; Rahe, 1978; Singer, 1977). 
Ma~y of the problems of the current life stress questionnaires and some 
ideas for improving them have been considered in this paper. Some further 
prospects for research on stressful life events will rtow be considered. 
The process of measuring the stressfulness of life events involves 
making a decision on how the domain of possibly stressful life events 
is to be defined; hov1 a sample of events is to be drmm from that 
domain; e..nd how the actua·l sti'essfulness of events is to be reliably 
measured. The investigator needs additionally to ask himself what are 
the factors that mediate the impact of stressful life events on the 
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individual. Thi:. specifically trans!atP.:; ~G asking: {a) Hhat are th~ 
physiologica·l processes that mediate th8 individual's response to 
stressful life events? (b) What are the psychological processes that 
mediate the individual's responsF to stressful life events? (c) What 
are the social processes that mediate the impact on the individual of 
stressful life events? The problem for the investigator is to ask the 
right questions about life events and their effects under circumstances 
in which the answers will provide clear demonstrations of whether and to 
what extent they are causally implicated in the disorders in which he 
is interested. Reviewing the literature on and criticisms of life 
events questionnaires suggests a number of considerations for future 
research: 
1. Prospective designs need to be used more frequently in the 
development of life events questionnaires. Pr·ocedures need to be developed 
to assess whether stressful life events are perceived as being within or 
outside the control of the individual and whether the events were 
anticipated or unanticipated. 
2. Another issue for future research is specification of relevant 
populations of life events and systematic sampling of the events from 
each population. Events contemporaneous in the lives of the individuals 
being studied and events in their past both need to be sampled. Such 
samp1 i ng would permit us to seek answers to questions sucb as: (a) ~~hat 
are the roles of primacy, frequency, and recency for different types of 
events in the life of the individual? (b) What are the relationships 
among events from different event populations? {c) Are there combinations 
and sequences of events that fit a stress-strain model of strass and 
illness? (d) Do some types of events at different developmental stages 
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of the individual have inoculation effects for some types of disorders? 
3. Research designs need to be expanded to includ~ a larger 
number of possible outcome variables, involving both physical illnesses 
and psychopathology. 
The Schedule of Daily Expe_ri~n~(SDE) adapted to weekly visits 
of an epileptic_Eopulation. Holmes and Rahe (1967) originally developed 
the Social Readjustment Rating Questionnaire (SRRQ) as a scaling iristrument 
for the life changes empirically determined to precede major health 
changes. The Schedule of Recent Experiences (SRE), a self-administered 
paper and pencil survey (Hawkins, Davies, & Holmes, 1957; Rahe et al., 
1964), lists these life changes by year of occurrence. By assigning to 
the 1 ife changes the empi rica lly d2termi ned magnitudes of the SRRQ, it was 
found that the highe·f a. person's life change scan: for a given ye::1r, the 
greater his chances of experiencing a major healtfi change within the near 
future (Edwards, 1971; Holmes, 1970; Rahe, 1968; R~he & Lind, 1971; Rahe 
& Paasikivi, 1971; Theorell & Rahe, 1971; Tollefson, 1972; Wold, 1968). 
From the Schedule of Recent Experiences, Holmes and Holmes (1970) 
derived a Schedule of Daiiy Experiences (SD~). In the Schedule of Daily 
Experiences, the 42 life change items in the Schedule of Recent Experience 
and the Social Readjustment Rating Questionnaire were recorded 011 a daily 
basis. Using the SDE, Holmes & Holmes (1970) adduced data about the 
association of life change and minor health change, Minor health changes 
were defined as the signs a,nd symptoms of evel~yday 1 i fe, such as cuts, 
bruises, headaches, stomachaches) backaches, and colds) that do not cause 
time lost from work or require a visit to the doctor. The findings indi-
cated that subjects were much more likely to experience the signs and 
symptoms of everyday life on days of greater-than-average life chan9es. 
Life change~; tended to cluster significantly around health changes. 95 
The opposite also was confirmed: subjects were much less likely to 
experience signs and symptoms on days of less-than-average life change; 
and low amounts of life change tended to cluster significantly around 
symptom- free days. 
The Schedule of Daily Experiences can easily be modified to fit 
the needs of weekly monitoring the relationships between life changes 
and seizure frequency in epileptic women. The author hypothesizes that 
epileptic women are much more likely to experience seizures during weeks 
of greater-than-average life changes, independently of hormona 1 fl uc-
tuations during different stages of the menstrual cycle. Although the 
Schedule of Daily Experiences includes many items that occur only rarely 
in the average .person's life and cannot be expected to fluctuate very 
much from week to week, and a lthougr; the SDE does not sample the day to 
day, stressful life events that people might experience (such as minor 
arguments w·ith spoilS?., problems with children) and that might reasonably 
be expected to correlate with minor physical ailments, yet it is the life 
stress questionnaire that has been most widely used and shown most 
reliably to be highly significantly related to occurrence, time, and 
magnitude of disease onset. Additionally, Helmes and Holmes (1970) have 
shown that the SDE can be used as it stands to show the relationship 
between life change and minor health changes. 
The directions for the Schedule of Daily Experiences. as adminis-
tered by Holmes and Holmes (1970) are as follows: 
Each of the following items has a space beside it for each 
day of the coming week. If, during the course of the week~ any 
of. the items applies to you, check the appropriate box. If one 
should apply more than once in a single day, indicate by the 
appropriate number in that box. Begin the chart on the day 
you receive it, and indicate the day by circling it and writing 
in the date. Do not mark in any space which does not apply. 
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In the spaces below, record briefly the day to day health 
changes which you may experience. These might inciude minor acci-
dents, injuries, cuts, bruises, eyestrain, backache, headache, 
toothach~, earache, stomach ache, muscle strain, coughing, sneezing, 
running nose, bloody nose, allergic reactions, nausea, vomiting, 
diarrhea, shortness of breath, skin rash, acne, athlete's foot, 
hay fever, sunburn, and the like. If you can, try to give some 
brief reason for a symptom, such as "Sore eye due to irritation 
of contact lenS 11 or "Sore muscles due to swimming yesterday. 11 
Also try to give some indication of your general state of 
thought, feeling, and behavior, for example, nervousness, tension~ 
elation, moodiness, irritability, anxiety, anger, fatigue, etc. 
In general, include the signs, symptoms, and inconveniences of 
everyday life which usually pass unnoticed. Try to be as complete 
as possible. (p. 121) 
These directions were modified as follows to make them appropriate 
to the epileptic sample that was followed on a weekly basis in the 
present study: 
For each life event listed below please do the following: 
Think back on the event and decide if it happened to you 
within the past week, including today. 
If, during the ccurse of the last w~Ek, any of the items 
applies to you, place a check n1ark in the appropriatE space to 
the right. If one of the items should.apply more than once 
during the vJeek, indicate the number of !J.~'!1es_ the event occurred 
to you within the past week. 
If the event in question did not happen to you during the 
past v1eek, check CJnder "Does not apply.'' 
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Instead of recording bri~fly the day to day health c~anges which 
the subject might experience, in the Schedule of Weekly Experiences used 
for the presen"t study the subject was a.sked to record the number and 
type of seizures \'ihi ch she may have had during the previous week. 
Appendix A shows the Schedule of Recent Experiences (SRE), as 
devised by Holmes. Appendix A also shows the author's adaptation of 
the Schedule of Recent Experiences for use on a weekly basis. 
The PDr•1S Profile of Mood States. The P0~1S Profile of r~ood States 
was developed to assess transient, fluctuating affective states, both 
positive and negative (McNair, Lorr, & Droppleman, 1971). The POMS 
has beer. factor analyzed to identify six separate mood at~ affective 
states: Tension-Anxiety, Depression-Dejection, Ang2r-Hostility, Vigor-
Activity, Fatigue-Inertia, and Confusion-Bewildennent. In their scoring 
manual, McNair et al. {1971) note that the POMS has been proven to be a 
sensitive measure of the effects of various experimental manipulations 
upon normal subjects, psychiatric outpatients, and various nonpsychiatric 
populations. 
The original POMS was developed to assess a subject 1 s mood within 
the week prior to the rating, including the day the rating i$ done. 
However, to meet the demands of a particular study, other time sets have 
been used with the POMS, including the one which has been used in the 
present study, POMS Today (Pillard, Atkinson, & Fisher, 1967). However, 
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most of the data reported in the manual are based on a one-week rat·ing 
period; Pillard et al. (1967) have cautioned that it should not be con-
sidered applicable for longer or shorter rating periods. Norms are 
available for comparisons with psychiatric outpatients and with college 
students. 
Six independent factor analytic studies have been conducted in 
the development and validation of the POMS (Lorr & McNair, 1964; Lorr, 
McNair, & Weinstein, 1964; Lorr, McNair, Weinstein, Michaux, & Raskin, 
1961; McNair, Lorr, & Droppleman, 1971). These studies indicate the 
same six mood factors can be identified, measured reliably, and replicated 
in VA male psychiatric outpatients, in male college students, and in 
male and female outpatients at a private teaching institution. Further: 
the factors appear to be relatively invariant whether the rating period 
is the immediate present or spans a one-week period. 
In the studies reported by McNair et al. (1971), t tests indicate 
sex differences at a high level of significance on most POMS factors; 
however, the authors of the POMS do present standardized T scores for 
each sex for their psychiatric cutpati ent norms. Separ·ate nol~ms for 
each sex are not given fo,· the college student nonns. ~1cNair et C!l. 
(1971) therefore recommend that unless the res~archer wants to remove 
treatment-by-sex interactions from consideratio~, POMS raw scores should 
be used in the analysis of research data, 
For the purposes of the present study, the PO~S was given to the 
entire sample of subjects on a week"ly bas·is, with instructions to take 
the test keeping in mind how the subject had felt throughout the previous 
week. In this way, weekly changes in mood could be related to changing 
1 ife events, b i ood hormone 1 eve 1 s, more enduring and stab 1 e persc.,na 'li ty 
traits) and of course seizure frequency. The POMS answer sheet and 
scoring norms appear in Appendix A. 
The~i el berger State-Trait Anxiety Inventor1_. One of the goa 1 s 
of the present study was to establish the magnitude of the anxiety and 
depression associated with the various phases of the menstrual cycle 
in epileptic women, and to compare these mood changes with available 
normative data. Another goal was to determine the interrelationship 
between premenstrual mood changes and trait anxiety. If changes in 
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mood during the premenstrual phase are a function of personal adjustment, 
one would expect the greatest mood disturbance among women high in trait 
anxiety. Conversely, if premenstrual depression and anxiety are hormonally 
determined, no significant correlation would be expected between depression 
and state anxiety on the one hand, and trait anxiety on the other. 
The Spielber·ger State-Trait Anxiety Inventory (STAI), developed 
by Spielberger, Gorsuch, and Lushene (1968) is designed to measure state 
anx·iety as well as trait anxiety and has good reliability and validity 
data. State anxiety refers to a transitot·y emotional state characterized 
by conscious feelings of tension and subjective awareness of heightened 
autonomic nervous system activity. ConvPrsely, trait anxiety refers to 
anxiety proneness, which is a relative1y stable, baseline personality 
characteristic. The STAI consists of two separate 20-item self-report 
rating scales for measuring state anc trait anxiety. The A-State scale 
is g·iven first, followed by the A-Trait. Instructions on the State scale 
require that the examinee report how she feels at the time of administra-
tion, whereas the Trait scale instructio~s ask that she indicate how she 
generally feels. Spielberger et al. (1968) have demonstrated in several 
studies that t'l.-State scores i ncrea.se in response to s ituat i ona 1 stress 
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and decrease under relaxed condition5, and that A-Trait scores reflect 
relatively stable indiv~duai differences that a~·e unresponsive to 
situational stress. 
Golub {1976) found that in a group of nomal women studied 
menstrua lly and i ntermenstrua 1ly, their premenstl~ua 1 mood changes wer·e 
not a function of personal adjustment. The A-Trait scores of this group 
\'Jere low compared with normative data obtained from Spielberger's sample 
of college women, yet they showed a high incidence of premenstrual 
depression and anxiety. In addition, no significant correlation was 
found between trait anxiety and premenstrual state anxiety or depression. 
This means that within the sample studied those subjects who were high 
in tra·it anxiety were not necessarily those who were high in premenstrual 
depression and state anxiety. Consequently, trait anxiety should be a 
relatively stable measurement, regardless of the stage of the menstrual 
cycle in which the present gr·oup of subjects respond to this item. 
However, state anxiety might be expected to fluctuate according to rises 
and falls in progesterone levels (O'Connor-Miller, 1980). 
Life Events Diary. Another method of assessing the relationship 
between environmental events and physiological processes is self-monitoring, 
which requires the subject to detect and record environmental events by 
keeping track of them herself on a daily basis, for instance in a small 
spiral notebook which has been arranged for the recording of necessary 
information. An advantage of self-monitoring for stressful life events 
is that the subject has the opportunity to indicate what life events 
are particularly emotion-provoking for her, rathet' than trying to respond 
in terms of the orearranged categories of an instrument like the Schedule 
of Daily Experiences which may have many categories of 'life events which 
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she herself does not experience as particularly stressful, or which pre-
se1ected life changes may occu;· so infrequently thc.t the predictive 
value of the Schedule for seizure frequency is minimal. Self-monitoring 
can thus be used to generate hypotheses about important controlling 
environmental events. From an analysis of self-monitored logs of daily 
stressful life changes, events that are reliably related to a disorder 
can be identified, operationally defined, and then again self-monitored 
to produce a fine-grained analysis of the relationship between specific 
events and the disorder. 
The method used in this study for self-monitoring life events that 
may be associated with the occurrence of seizures in epileptic women 
is the Life Events Di2.LY. presented in Appendix A. The author hoped 
that tabulation of this data would help generate good hypotheses about 
important controlling environmental events in the onset of seizures in 
epileptic women. 
The present study. The present study will assess hoth cyclical 
hormonal changes and various environmental stresses and frustrations, 
specifically the interaction between physiological and environmental 
stress in producing seizures in epileptic women. 
The hypotheses are: (a) H1: High levels of progesterone inhibit 
seizures; (b) H2: High levels of stress, as mea~ured by the Spielberger 
State~ Trait Anxiety 1 nventory, the POM$ Profile of r~uod st,~tes ~ the 
Moos Menstrual Distress Questionnaire, the Holmes and Rahe Sch~dule of 
Recent ExpEriences, and the daily Life Event D·lary resuH in incrEased 
seizure frequency; end (c) H3: An interaction between H1 and H2 results 
in the highest seizun:~ ?requency. The epil.:ptic subject::: were expected 
to have the greatest number of seizures during the menstrual and the 
premenst:ual stages of their menstrual cycles when estrogen and 
progesterone levels wer·e lm·test, if life stress was held constant. 
The subjects were also expected to have a large number of seizures 
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if life stress was great, indepenrlently of p~ase of the menstrual cycle. 
The highest seizure frequency wo~ld be expected to occur during maximal 
psychological stress, plus lowest estrogen and progesterone levels 
(which occurs during the menstrual and premenstrual stages of the cycle). 
C:HAPTER I II 
r~·iETHOD 
Subjects 
Subject selection criteria. The experimental group was composed 
of 15 female epileptic subjects. Criteria for including potential 
subjects in the experimental group were: 
1. All women must be between the ages of 18 and 45. 
2. All subjects should currently have a regular menstrual cycle 
(i.e., not amenorrheic, menopausal. or using oral contraceptives). 
3. All subjects should be experiencing at least ~ moderate number 
of seizures p2r mom:h by h·istory (at least three or four seizures a 
month) with no upper limit of number of seizures per month. 
4. All subjects should be aware of the occurrence of their seizures, 
and be capable of counting them and recording the count. Relatives whom 
the subjects \<Jere living with w(:(e enlisted in countir.g and verifying 
the number of each subject's seizures. All subjects except two were 
living \'lith a relative v1ho could verify the seizure count. 
5. All subjects should have a measured I.Q. of at least 80. 
6. Subjects should have a reasonable likelihood of complying with 
the experimental procedures, as based on previous clinical history and 
the opinion of their neurologists, 
7. Subjects must have a history of compliance on their anticonvulsant 
medication, as indicated by previous clinical history. Compliance was 
monitored by measuring anticonvulsant blood levels on each visit for the 
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study. In addition to the authot·, a.ll subjects were screened by 
Richard H. Mattson) M.D., Chief of the Neurology Service at the 
West Haven V.A. Hospital, for compliance with these criteria. 
Criteria for excluding potential subjects from the experimental 
group were: 
1. Women who were pregnant or wished to become pregnant during 
the time period covered by the study were excluded. 
2. Subjects should have a non-psychotic MMPI profile (Dahlstrom 
& Welsh, 1960; Meehl & Dahlstrom, 1960). 
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Characteristics of subjects. The subjects comprising the experi-
mental group were drawn from female epileptic patients followed at the 
Epilepsy Center of the West Haven V.A. Hospital, the Seizure Clinic of 
Yale-New Haven Hospital, and private patients referred from department 
neurologists. An extensive history data fonn concerning precipitat·ing 
and in hi biting factm·s in epilepsy, seizure type~ and seizure frequency 
prior to entering this study, was compieted by every subject and reviewed 
by the present author. This history data form, entitled Epilepsy Backg~~.QQ 
and History, appears in Appendix B. This information was supplemented 
and validated by detailed review of all medical records, including reports 
of observed seizures. 
Seizure type or types were coded accot·ding to the Inten1ational 
Classification System (Gastaut, 1970). In addition to extensive interviews 
with the patient, the classification was based on a description of a 
witnessed attack by a family member or oth2r observel·. In every case, 
this was checked independently ~lith reports inade by n~.~rs8s, ph~'~icians, 
or other medical personnel, In some patients, v~deotape recording of the 
seizures added further validation. These videotape recordings can be 
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obtained at the West Haven Veterans Administrcttion Hospital Seizure 
Clinic. Seizure frequency prior to entrance into the study was recorded 
in clinic and hospital written reports. 
The purpose of the study was explained to each patient. Specific 
data relating to seizures was answered by the patient and family 
utilizing the Epilepsy Background and History questionnaire previously 
mentioned (Appendix B). This form was reviewed during detailed interviews 
with the research investigator. The form was returned by the patient and 
family after initial completion, at which time it was reviewed and 
amplified by extensive documentation and anecdotal support of positive 
responses. 
Other forms made detailed inquiry into the timing of seizures 
within a twenty-four hour period and other observed cyclical patterns. 
These forms were the Epil~sy and the t•1enstrual Cycle Pa~ient Information 
fonn; the Early r~orning Temperature Recot'd and Daily Seizure Record,_ 
Menstru~J_iyck_St~:~dy; the Seizure Record; the £pj_leps¥_~~_J:_he M~ns~r-~al 
Cvcle Clinic Visit form; and the Checklist for ~1enstrual Cycle Sti:!d.>~ 
form (all in Appendix B). The subjects and/or family members were 
instructed to keep records of seizure occurrence by numbers, hour, and 
date. These written records were reviewed at each clinic visit, not 
only to record seizure frequency, but to note time of occurrence and 
percent of s~izures occurring at any given time, Subjects were instructed 
to make a record of seizures occurring during the morning, the afternoon, 
and at night. These did not represent comparable segments of time but 
could be expressed as a percent of the twenty-four hour day. 
The effect of selected emotianal factcrs in precipitating seizures 
was a majm· issue addressed by this study. As a sepc'rate category, a 
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record was made of the emotional state of the subject antecedent and 
consequent to seizures. This record was kept by means of a Life Events 
Diary, in which the subject recm·ded daily life expe·riences on a scale 
ranging from 1 = Extremely Pleasurable throu~h ~ = Extremely Upsetting 
(Appendix A). The frequency of seizu~2 occurrence during emotional 
stress was later compared with the number of seizures occurring under 
non-stressful circumstances. 
Potential risks and consent forms. At each testing session~ 
approximately 27 cc of blood was drawn from each subject. The venipunctures 
and EEG recording required as part of a larger study presented no risk, 
but did involve minor discomfort. The nature of the potential discomfort 
was explained to the epileptic subjects in Consent For Pdrticipation In 
A Research Project, Part 1 (Appendix C). 
Matedal inducements. Visits to the Epilepsy Laboratory/Clin·ic 
and blood tests for antiepileptic drug levels were free of charge for 
the duration of the study. Thus, routine clinic visits which the subjects 
normally would have to pay for during this time period were not charged. 
Apparatus 
Basal body temperature recorqj~ and seizure record. The time of 
ovulation for the epileptic subjects in this study was calculated 
primarily from two sources of information: knowledge of the women's 
usual menstrual cycle length and basal body temperature. Knowledge of 
a woman's usual menstrual cycle length was useful in pinpointing the 
time of ovulation because ovulation usually occurs fourteen days, plus 
or minus two days, prior to the onset cf menses regardless of the length 
of the cycle (Shapiro, 1977, p. 116). Thus, a woman with a thirty-seven 
day cycle, measured from the first day befor~ the next period, usually 
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ovulates between Days 21 and 25. It is a misconception that ovulation 
occurs on the fourteenth day of the cycle, unless the vJOman has the 
twenty·-ei ght day eye 1 e described in textbooks, which on 1 y BX of a 11 women 
of childbearing age do. Therefore, with the group of women used fer 
this study, ovulation was assumed to occur 14 days prior to the onset of 
the next menstrual cycle, and this specific point was defined in 
relation to each woman's reports and the examiner's observations of usual 
menstrual cycle lengths. The only time when ovulation was not assumed 
to occur fourteen days prior to the onset of the next menstrual period 
was when information from basal body temperature records indicated 
that ovulation occurred at an earlier point in time. 
Following ovulation, progesterone is produced by the cor·pus 
luteum and is responsible for an elevation of a woman's temperature for 
approximately fourteen days until the onset of menstruation. The basal 
body temperature (the temperature taken immediately upon ris~ng 
in the morning before getting out of bed), will rise between .4° and 
.8° F. during those fourteen days. By charting an accurate daily record 
of temperature using Tempa-Dot oral thermometers 'Organon, Inc.), the 
Homen in the study had an aid in determining the time of ovu·;at~on. 
Daily temperatures ~tJere recorded on the Ear:.l,t_l}orn_ing Temperatu~e Record 
an~ __ Dai]L~eizur·e Record (Appendix B). ''pamphlet was also given to 
the women to explain in more detail the tech~ique of recording the basal 
body temperature (Planned Parenthood Federation of America, Inc., 1977), 
The temperatur2 rise usually takes place within twenty-four hours 
after ovulation, although there may be variations in the temperature record. 
Occasionally the temperature may rise gradually each day by less than 
.4°, and at other times it may have a step-like appearance, with a .20 rise 
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every two or three days. This may lead to i1-:a~ct,;;·acies in pinpointing 
the time of ovulation if only th~ basal body tenoerat,re method 1s used. 
Statistically, only 8 percent of women of childbearing age have perfectly 
regular cycles each month (Shapiro, 1977, p. 121). The burden of charting 
temperatures in the early morning when the subject is only half awake 
may lead to inaccuracies both in faking the temperature and in recording 
it. A source of confusion may be a temperature elevation in the presence 
of an unrecognized infection or of tension, or following a sleepless night. 
Smoking a cigarette prior to taking the basal temperature may falsely 
elevate it, while drinking large amounts of alcohol may falsely lower it. 
Since the women in this study shovJed many var·iations in the 
temperature record, the main technique relied upon in pinpointing the 
time of ovulation was counting backward 14 days from the next menstrual 
bleeding, based on the women's usual menstrual cycle length. Two of the 
women in the study reported experiencing a short, sharp pain at ovulation, 
known as r~ittelschmerz (Shapiro, 19l7, p. 128); they wer·e encoul~aged to 
report this pain and the information was used to schedule their ovulatory 
testing sessions. 
For the epileptic subjects, seizures were recorded on the Earlt 
MorniM_Temperature Record and Daily Seizure Record (Appendix B). For' 
subjects who had more than one type of seizure, space was provided for 
indicating the different types. Also, subjects were instructed to 
describe in detail any atypical seizures on a chart provided, called the 
Seizure Recor~ (Appendix B). By recording seizures on the same chart 
as the basal body temperature, a direct visual compal'ison could be rnade 
between seizure frequency and stage of the menstrual cycle. Historical 
information on each c~pileptic subject with r·ega1~d to menstn1al cycle 
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and seizures was cbta i ned and recorded or. the Epi_l~m_:_~nd t}1e t·1ens t~~~_1_ 
Cycle Patient Infor!nation Form (Appendix S) ~ and on the ~oi l~E~_Backg.ro~nd 
an~ist~ form (Ap~endix B). 
A Checklist for· Menstrual~le Stuqy_ (Appendix B) vJas used to make 
sure that all necessary information v1as collected on each clinic visit 
by every subject. An ~il_§Esy and the_Menstrual~~~linic Visit form 
(Appendix B) was used to review current anticonvulsant drug dosage and 
levels, seizure frequency, stage of the menstrual cycle, and use of 
adjunct medication with each subject at each clinic visit. 
Mood measures. On the initial visit, each subject filled out the 
Moos Menstrual Distress Question_naire~ Form A {Appendix A); the !Jo1mes_ 
and Rahe Schedule of Recent Experiences_ (.A.ppendix A); the ~ielb~!"qer 
_?tate-Trait Anxiety Inventory, Form X-2 (Appendix A); and the PDr·1S Profile 
of Mood States (Appendix A). 
On all clinic visits, including the initial visit, each subject 
filled out the following questionnaires: the Moos Menstrual Distress 
Questionnaire, Form T (Appendix A); the Holmes and Rahe Schedule of Recent 
Experiences, modified to reflect life changes occurring on a weekly basis 
(Appendix A); the Spiel berger State-Trait Anxiety Inve!'_~_t?I.122JAL_For~-l 
(Appendix A); and the P0~1S Pro_fi 1 e _C?_f_}1ood --~t~_tes (Appendix A). 
The questionnaires given on each clinic visit were for the purpose 
of measuring ongoing stressful life events and changes in mood since the 
previous clinic visit. 
The questionnaires given on the initial visit only were for the 
purpose of comparing each subject's expectations and impressions of 
changes occurring dUJ~i ng different phases of the menstr-ua 1 cycle, \vith 
the actual changes that took place during different phases of the cycle 
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as reported in the (":uE:st:icnnaires ·f"illed out at each clinic visit. The 
initial questionnaires were also given to establish baseline measures 
of trait anxiety and stressful life experiences for each subject. 
piar.v._. Each epileptic subject recurded on a daily basis all 
stressfui life e·1ents in a .!-if~~ Eve_l}_~s Diary, Instructions given \'lith 
each Diary are sho·wn in i\ppendi x A. All subjects recorded, from their 
perspective, life events which they considered to cause a significant 
amount of upset or which gave the~ a significant amount of pleasure. 
Life events were rated acco:'ding to the fo'llo,.,ring scale: 
1 = Extremely Pleasurable 
2 ~ Moderately Pleasurable 
3 = Mildly Pleasurable 
4 = Mildly Upsetting 
5 = Moderately Upsetting 
6 = Extremely Upsetting 
This scale appeared on each page of an otherwise blank diary, 
which subjects kept fer the period of time they were follmved in the 
study. 
The purpose of this diary was to determine whether epileptic 
subjects have more seizures in conjunction with or following significant 
amounts of life st;·ess, either positive or negative, as viewed from 
their personal perspective. 
Biochemical analvsis, ___________ __..)<_,... __ _ 
l. f,ntj-e~~-i.}-~Qti_c._\t~_·_uo l~:_~els. At each testing session, approximately 
27 cc of blood was drawn from each subject. Serum concentrations of 
anti-epilep·Uc drugs taken by the SL1bjects w~::re obta·ined for each testing 
session. One 9 cc tube was drawn for this purpose. The reason for 
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obtaining the anti-epileptic blood levels was tc guarantee that subjects 
were taking their medication) so that seizures occurring because of sub-
therapeutic levels of anti-~onvulsant drugs could be ruled out. Serum 
concentrations were obtained on the following anticonvulsant drugs: 
di phenyl hydantoin ( Dil anti n) , phenoba rbita 1 , pri mi done U1yso 1 i ne) , 
carbamazepine (Tegretol), ethosuximide (Zarontin), mephobarbital 
(Mebaral), and valproic acid (Depakene). Commonly accepted therapeutic 
ranges of the serum concentration of these drugs ar·e as follows: 
diphenylhydantoin, 10 - 22 }Jg/ml; phenobarbital, 18 - 45 }.lg/ml; 
primidone, 5- 12»g/m1; carbamazepine, 5- 12 ~g/ml; ethosuximide, 
40- lOO~g/ml; mephobarbital, 18- 45JJg/ml; ar.d valproic acid, 
40- 85~g/ml (American Society of Hospital Pharmacists, 1975). 
Gas liquid chromatography (GLC) was the standard analytical method 
used in the laboratories of the West Haven V.A. Hospital for measuring 
the total serum concentration of anti-·epileptic drugs in this study. 
A modified methoa of Kupferberg (1970) was used for GLC analysis. 
2. Steroids. Estrogen and progesterone assays a1lowed positive 
delineation of each subject's menstrual cycle into menstrual, ovulatory, 
high progesterone, and premenstrual phases. Two 9 cc samples of blood 
were drawn fo1· this purpose during each testing session. A progesterone 
level of at least 8.0 rng/ml was used as the indicotor of an adequate 
luteal phase and the occurrence of ovulation. Burton Caldwell, M.D., 
an obstetrician/gynecologist at the Yale University School of J'vledicine, 
was the consultant who judg.~d whetrl'H' an adequate Dr indcieqt ate 1 uteal 
phase took pl?.ce in eacr; c~·cle. The subjects' menstrua·i cyc~e:; 1-Jere 
separated fo~" furthe:' study acccr·ding to wh<:tiler ovulation had o;' h::1d not 
taken place. 
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The Endocrinology Laboratory at Yale-New Haven Hospital performed 
the tests to determine serum concentration of the steroid hormones 
estrogen (measured in pg/ml) and progesterone (measured in ng/ml). 
Determination of estradiol levels was accomplished by the method of 
Jiang and Ryan (1969) and Kley, Bartmann, and Kruskemper (1977}. 
Progesterone determination took into account the serum protein binding 
affinity of progestins (Blanford, Wittman, Stroupe, & Westphal, 1978; 
Duax, Cody, Griffin, Rohred, & Weeks, 1978; Heyns, 1977; Westphal, 
Stroupe, Cheng, & Harding, 1978). Recent advances in radioimmunoassay 
(RIA) technology have resulted in sensitive, accurate, and reproducible 
procedures for the assay of steroid hormones in biologic fluids. The 
basic principle of RIA is the competition between radiolabeled and 
unlabeled antigen for a fixed number of antibody binding sites. If 
increasing amounts of unlabeled (standards on samples) and fixed amounts 
of labeled antigen are allowed to react with a constant and limiting 
amount of antibody, a decreasing quantity of labeled antigen is bound to 
the antibody. After separation of bound from free antigen, the radio-
activity in one or both of these fractions is determined and the data is 
used to construct a dose-response curve (Note 1). 
In the procedure used at the Yale-New Haven Endocrinology labora-
tory, the New England Nuclear procedure, specificity is achieved by 
chromatographic purification prior to RIA. The plasma extracts are 
chromatographed on columns of Sephadex LH-20 to minimize potential inter-
ference of other naturally occurring steroids. Since the antiserum is 
not monospecific, the step is considered essential for the accurate 
determination of each steroid hormone. 
Charcoal is utilized to separate the bound antibody from free 
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antigen. The charcoal differentially adsorbs the free material, and the 
supernatant containing the antib0dy-antigen complex is counted. The 
concentration of the particular st(~r·)id norrlione assay~c; is obtained by 
correcting the amount read on the dose-response curve with appropriate 
dilution and recovery factors. 
The determination of estrogelis in plas~a was specific for estradiol 
using standards prepared by New England Nuc·lear. The tracer was 
tritium labeled Estrad·iol - 178 - !-J3. Progester·one ~Jes dE.termined in 
plasma using tritium labeled Progestel~one {-1, 2-H3 (N) _j (Note 1). 
El ectroenceoha 1 o_graph_.'L. The present study was part of a larger 
grant, and consequently electroencephalograms (EEGs) were performed on 
each subject during each testing session, in addition to the monitoring 
that was done for the purposes of the present study. The electroencephalo-
grams were performed using a Beckman R611 8-Channel Polygraph with a 
Beckman 702 Lead Selector Panel and a Beckman Type 944A Lead Terminal Box. 
The EEGs were simultaneousiy recorded on the Beckman polygraph yielding 
a paper printout, and on Scotch Brand #888 1/4 X 2300 PR Instrumentaticn 
Tape (audiotape) by means of a Hewlett-Packard 3968A Instrumentation 
Recorder. Recordings consisted of 20 minutes of eyes opened and ten 
minutes of eyes closed, using a parasaggital montage with a temporal bite, 
and measured according to the International Ten-Twenty System of electrode 
placement (Harner and Sannit, 1974). Thirteen needle electrodes were 
used for this pl acerr.ent (_Grass Instrument Company E2B 48 11 Length Subdennal 
Electrodes). 
Electroencephalograms were recorded for each testing session, so 
that idea"lly t1t1elve EEGs v;ere obta-ined from each subject: during the 
menstrual, ovulatory, high progesterone, and premer.strual phases of her 
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cycle over three consecutive menstrual cycles. 
Each subject was monitored for three to four months. The goal 
was three months of complete data for each subject in which the menstrual, 
ovulatory, high prcgester·one, and premenstrual phases of the cycle were 
correctly identified and sampled. 
Initial laboratory visit.· The timing of the initial iaboratory 
visit was to coincide with the menstrual phase of the subject's cycle. 
Each subject was told that wheh she got her period, she was to call the 
examiner to make an appointment to come in sometime during the next two 
days. 
Procedures for the first laboratory visit were as follows: 
1. Subjects were instructed to record all seizures, including their 
number and severity, for the duration of th2 study. 
2. Subjects wPre instructed to indicate the onset of menses on 
their seizure calendar. 
3. Subjects were instructed to record their daily basal body 
temperature. 
4. Subjects \vere informed they vwuld visit the laboratory four 
times a month for three months (the dates would be adjusted to individual 
cycle variations). The dates would be as follows: 
(a) Day 1 - 2, onset of menses, follicular phase, 
(b) /-\pprox·imately d~.y 14, mid cycle, ovulatorv 
., phase. 
(c) Approximately day 21' late cycle, luteal phase. 
(d) P.pproximate ly day 25, premenstrual phase, 
5. Subjects were told that during each visit to the laboratory, 
three smaT! tubes of bloo<j (approximately 27 cc) would be dravm, 
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inciuding during the ir'.it-lal v:~·it. Th\~ purpose of t:1c hlcnd tests ~1as 
to analyze anticonvulsant blood levels, estrogen levels, and progesterone 
levels. 
6. Subjects were instructed in keeping a daily ~jJe Events Diary. 
7. Certain psychological tests to measure stressful 1 ife events and 
changes in mood retrospectively were administered only during the first 
testing session. These tests were: 
(a) f~oos Menstrual Distress Questionnaire~ For·m A. 
(b) The Holmes and Rahe Schedule of Recent Experiences. 
(c) The Spielberger State-Trait Anxiety Inventory, Form X-2. 
(d) The POMS Profile of Mood States. 
8. Psychological tests to measure ongoing stressful life events and 
changes in mood were given both during the first laboratory visit and 
during each subsequent 1 aboratory vis it. These tests :,-1ere: 
(a) Moos Menstrual Distress Questionnaire:, Form T. 
(b) Holmes and Rahe Schedule of Recent Experiences, moaified 
to reflect life changes occurring on a weekly basis. 
(c) Spiel berger State-Trait ,l\nxi ety Inventory, STAI Form X-1. 
(d) POMS Profile of Mood States. 
Succeeding laboratory visits. The phases of the menstrual cycle 
during which each subject was studied are as follows: menstrual, 
ovulatory, high progesterone, and premenstrual. These phases we1·e 
defined in the following way: 
1. Menstruation-- defined as the days of menstrual bleeding. 
2. Ovulatory-- defined as the periovulatory period, i.e., the 
point in time fourteen days prior to the onset of the next menstrual period 
is found, and the periovulatory p2riod extends fl~orn tv1o days b.~fo-re t!ris 
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point to two days after this point. 
3. High Progesterone -- defined as the point in time ten days 
prior to the onset of the next menstrual period up until the point in 
time four days prior to the onset of the next menstrual period. 
4. Pre-Menstrual -- defined as four days prior to the onset of the 
next menstrual period, until the onset of the next menstrual period. 
At least three full menstrual cycles were recorded for each 
subject. For each menstrual cycle, a subject carne for a lacoratory 
visit during the menstrual, ovulatory, high progesterone, and rre-·rnenstrual 
phase of her cycle. Thus, each subject had a total of at least twelve 
iaboratory visits. Analysis of estrogen and progesterone levels du1~ing 
the course of each subject's laboratory visits indicated that some 
subjects experienced one or more arovuiatory -:ycles. Those ~;t;bjccts 
who were identified as experiencing anovulatory cycles were invited to 
remain in the study for additional menstrual cycles. The goal v:as to 
record at least three full ovulatory cycles for each subject. 
Procedures for each laboratory visit succeeding the initial visit 
\'/ere as fo 11 ows: 
1, The Early ~1orning Tempe1·ature Record and Daily Seizure Record, 
Menstrual Cycle Study was reviewed with each subject. In order tc 
chart each subject's menstrual cycle for the purpose of determining the 
time of ovulation and for recognizing the premenstrual phases of each 
subject's cycle, each woman kept a Basal Body Temperature Record. 
Temperatures were to be taken immediz.te1y upon c.rising each morning, 
using Tempa-Dot single-use sterile thermometers (Organon, Inc.), and 
recorded on the Earlv Morning Temperature Record and Daily Seizure Record. 
___ x_._ _________ • --~--w-·---,.......------~•-·•-·~-------·---·-
This record and the instructions for using it are in Appendix B. 
The subjects were impressed with the importance of taking their 
,,-. ~·'I 
temperatures every morning immediately upon a~;;akeni ng, before ads i ng. 
They were told not to take aspirin or diuretics, such as Midol or Diuril, 
because of the possibility of changing and rendering inaccurate the 
Basal Body Temperature record. If a subject did take any additional 
medications, or had any infections or illnesses, these were recorded on 
the Epilepsy and the Menstrual _Cycie Clinic Vi~it form (Aopendix B). 
2. The Seizure Record ~vas reviewed with th2 subject. 
3. The examiner recorded the number of seizures since the last 
clinic visit en the Epilepsy ani_t~~ ~lenstrual Cycle Clinic Visit form. 
The date, tirne of day, and type of eaci1 seizure was also recorded on 
this form. Additiona1ly, the total daily dose of articonvulsant medication 
and the number of hours since the last dose were recorded. The date that 
the last rnenstr·ual period started was recorded. The number of days since 
the first day of the last menstrual period was calculated to detennir.e 
the phase of the cycle that the subject was experiencing at the time of 
a given clinic visit. Any medication besides the subject's regular 
anticonvulsant medication that she took since the last clinic visit was 
recorded, if relevant. 
4. The subject was given a specific date for the next clinic visit, 
if this was appropriate. 
5. Approximately 27 cc of blood were drawn for the analysis of 
anticonvulsant blood levels, estrogen levels, and progesterone levels. 
6. The Life Events DiaY):_ was revie\lled. 
7. The following psychological tests were administered: 
(a) Moos Men~trual Distress Questionnaire, Form T. 
118 
(b) Holmes and Rahe Schedule of Recent Experiences, modified 
to reflect life changes occurring on a weekly basis. 
(c) Spiel berger State-Trait Anxiety Inventory, STAI Form X-1. 
(d) POMS Profile of Mood States. 
8. The examiner reviewed the Checklist for ~1enstr·ual Cycle Study 
to make sure that all procedures had been completed. 
Addjtio~al monitoring. This study was part of a larger research 
grant. For the purposes of the larger research grant, during each clinic 
~isit subjects also experienced the following procedures: 
1. Electroencephalogram recordings, 20 minutes eyes open and 
10 minutes eyes closed. Thirteen needle electrodes were used to record 
a parasaggital montage with a temporal bite. 
2. Neuropsychological tests were administered: 
(a) Grip Strength 
(b) Finger Tapping 
(c) Lafayette Pegboard 
(d) Color Naming (Rennick) 
(e) Trunkal Ataxia 
(f) Digit Span 
( ' o· '{ <: b 1 g, 1g-: .: _,ym o 
(h) Trails B 
(i) Visual Search (Rennick) 
CHAPTER IV 
RESULTS AND DISCUSSION 
The three main hypotheses investigated by this study are: (a) 
high levels of progesterone inhibit seizures, and consequently seizures 
will occur most frequently during premenses and menstruation when levels 
of progesterone are low, and least frequently during ovulation and high 
progesterone phases of the menstrual cycle; (b) high levels of stress, 
as measured by the STAI, POMS, Moos MDQ, Holmes and Rahe Schedule of 
Recent Experiences, and Daily Life Events Diaries will be associated 
with high seizure frequency; and (c) a combination of low levels of 
progesterone and high stress is associated with the highest seizure 
frequency. In order to address these hypotheses adequately, several 
steps of analysis need to be performed. 
Since the stages of an ovulatory menstrual cycle are marked by 
distinct differences in the estrogen/progesterone ratio, the first step 
in the analysis is to examine these ratios. Ovulation was considered 
to have occurred in a given cycle if the progesterone level at the 
luteal peak reached at least 5 ng/ml, if the estrogen level at the 
luteal peak reached at least 100 pg/ml, and if the estrogen/progesterone 
ratio at the luteal peak was at least 4:1 (Caldwell, 1979; Speroff, 
Glass, & Kase, 1973). Using those criteria, 30% of all cycles studied 
were anovulatory. Sixty percent of the subjects had at least one anovu-
latory cycle. Given that the absolute hormonal levels and estrogen/ 
progesterone ratios are vastly different in ovulatory and anovulatory 
cycles, and also given that an important physiological event -- ovulation 
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-- occ~;rs in ovulatory cycles but not in anovulatory cycles, the bJO 
types of cycles will be examined separately in all the subsequent 
analysP.s reported here. 
!:.f1P.othesis: Level of Progesterone Is ~elate2_!_g__Seizur_~ Freguensz. 
To test the hypothesis that level of progesterone is associated 
with seizure frequency, seizure frequency at each of four stages of the 
menstrual cycle was examined for ovulatory cycles. The follicular phase 
of the cycle was defined as beginning at menstruation and continuing 
until two days before ovulation. Ovulation was defined as occurring 
fourteen days prior to the onset of the next menstrual cyc1e; the 
periovulatory period extended from two days before ovulation until two 
days after ovulation. The next seven days constituted the high proges-
terone phase of the cycle; and the la~t four days prior to the onset of 
the next menstruation constii:utcd the prernens trua 1 p:1ase of t:1e cyc1 e. 
During the follicular phase estrngen and progeste}'One levels are both 
low and near ovu1ation they both begin to rise slmvly. Dur~r.g the peri-
ovulatory phase estrogen levels peak and prog~sterone levels are l01v, so 
that the estrogen/progesterone ratio is highest. At the high progester-
one phase progesterone levels peak and estrogen levels are lt a midpoint, 
so that the progesterone/estrogen ratio is highest. Premenstrually both 
estrogen and progesterone are rapidly falling to low levels. Thus, the 
subjects were expected to have the fewest seizures during the high 
progesterone phase of their menstrual cycles when progesterone levels 
are highest, and seizure frequency was expected to be greatest menstrual-
ly and premenstrually when progesterone levels are low or rapidly falling. 
To test this relationship, a one-way repeated measure factor 
analysis of variance i·tas performed~ in which the dependent measure \'WS 
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tota 1 seizure frequency, and the repeated mea:.;ure facto!' was stage of the 
menstrual cycle. The four levels of the factor were the follicular') 
peY'iovulatory, high progesterone, and premenstrual stages. The unit of 
analysis v1as one complete menstrual cycle for one subject. Results of 
this analysis appear in Table 1. The analysis of variance indicated a 
significant stage of the menstrual cycle effect, .E. (3, 39) =' 7.0517, 
E. L. 001. When the Tukey mu1ti pl e-range test was pe1·formed on the 
K(K - 1)/2 paired contrasts representing the four stages of the menstrual 
cyc"le, a significant difference was found bet~tJeen seizures at menstrua-
tion (f = 10.0714) and seizures at ovulation (! = 1.9286), ~ (39) = 7.3617, 
£ L.Ol. Significant differences were also found between seizures at 
menstruation (X= 10.0714) and seizures at high progesterone(~= 2.0), 
~ (39) = 7.3617, £ L .01; and between seizures at menstruation 
(! = 10.0714) and seizures premenstrually (Y = 1.4286), ~ (39) = 7.3617, 
£L.OJ.. 
Therefore, the subjects had the highest number of seizures at 
menstruation. The number of seizures at menstruation was significantly 
greater than the numter of se·izul·es at ovuiation, at high progesterone, 
and at premenses. The results of this group of ar1alyses indicate that 
a simple relationship does not exist betv1een progesterone levels and 
seizure frequency. A graphic illustration of the relationship between 
seizure frequency and hormone levels appears in Figure 1. 
Seizure frequency during anovulatory cycles, when progesterone 
levels are consistently low and estrogen levels fluctuate~ was &lso 
analyzed (Figure 2). A one-way repeated measure factor analysis of 
va.ri a nee ~t1as petformed, in ~tihi ch the depeliden t mea:;ure iti<:.S seizure fre-
quencys and the repeated measw·e factor was ~;ta9e of the: ~~~enstTual cyc1e 
Table 1 
Means and Analysis of Variance for Seizure Frequency Across Four 
Stages of the Menstrual Cycle, Ovulatory Cycles Only (~ = 14) 
Mensttuation 
Mean 10.0714 
SD 12.7065 
Source of Variation 
Between Subjects (Error) 
Within Subjects 
Stage of the Menstrual Cycle 
Stage of Cycle 
Ovulation High Progesterone 
1.9286 
4.1411 
2.0000 
4.4202 
Sum of Squares 
1317.3571 
2057.5000 
df 
13 
42 
Stage of the Menstrual Cycle X Unit 
723.5714 
1333.9286 
3 
39 
Total 3374.8577 55 
***E. L • 001. 
Premenses 
1.4286 
2.4088 
Mean Square 
101.3352 
48.9881 
241.1905 
34.2033 
61.3610 
Grand ~1ean 
3.8571 
F-Test 
7.0517*** 
..... 
~'.) 
N 
Figure 1 
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for anovulatory cycles only. Of course, ovulation does not occur during 
anovulatory cyc1es by def·inition, so the four levels of the factor \•Jere 
equivalent time pedods only to the follicular, periovulatory, high 
progesterone, and premenstrual stages of an ovulatory cycle. The unit of 
analysis was one complete anovulatory menstrual cycle for each subject. 
Results of this analysis appear in Table 2. The analysis of variance 
indicated a significant stage of the menstrual cycle effect, 
f. {3, 18) = 3.4597, .E_L.05. When the Tukey multiple-range test was 
performed on the K(K - 1)/2 paired contrasts representing the four stages 
of the menstrual cycle, a significant diffen::''ce was found between 
seizures at menstruation {X = 14.8571) and seizures premenstrually 
(! = 2.0), ~ (18) = 4.0, £ L .05. 
By comparing Figure 1 with Figure 2, one can see that: (a) almost 
b1ice as many seizures occur during anovulatory cycles,!== 25.5714 per 
cycle, as occul~ during ovulatory cycles, X= 15.4286 per cycle; (b) 
seizure frequency peaks during menstruation for both ovulatory and an-
ovulatory cycles; and (c) the seizure frequency curves are very similar 
for ovul ato1·y and anovulatory cyc1es, with the exception that the curve 
for anovulatory cycles is much higher. Although Table 3 shows that the 
mean of 15.4286 seizures for a11 ovulatory cycles was not significantly 
different fr·om the mean of 25.5714 seizures for a 11 anovulatory cycles, 
inspection of Table 3 also shows that for both ovulatory and anovulatory 
cycles, seizure frequency is highest at menstruation. 
Even though ~ simple relationship bet4een level of progesterone 
and seizure f<'equ2ncy was not fourtd in thi~. data, \'.'hen progesterone is 
nearly eliminated seizure frequency doubled since a major difference 
between ovulatory and anovulatory cycles is the virtual absence of 
progesterone in anovulatory cycles. Of course, changes in mood states 
may also account for differences in seizure frequency at different 
stages of the cycle for this sample of subjects, either independently 
of hormonal variables or interactively with hormonal variables. The 
contribution of mood states to changes in seizure frequency will be 
examined later in this Chapter. 
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All subjects were seen for three to six successive menstrual 
cycles, with measurements being taken at the four stages of the cycle 
each month. A two-repeated measure factor ANOVA, with the first repeated 
measure factor being month of observation and the second repeated measure 
factor being stage of the cycle showed no main effect for month of 
observation on the dependent variable total seizure frequency, 
£ (2, 16) = 1.568, £ = 0.239. For the first month of observation, mean 
total seizure frequency was 12.445 seizures for the entire month; for 
the second month of observation, ! = 4.889; and for the third month, 
I= 12.334. Thus the subjects as a group did not have significantly 
more seizures during one month of observation than during another month 
of observation. 
Differences in seizure frequency at the menstrual and the high 
progesterone phases of the cycle were not significantly correlated with 
changes in progesterone level at the menstrual and high progesterone 
phases of the cycle (~ = 0.239, ~ = 38). 
Hypothesis: High Levels of Stress Are Associated 
With High Seizure Freque~ 
The second hypothesis, high levels of stress, as measured by the 
STAI -1, PONS, Moos r~DQ, Schedule of Recent Experiences, and Daily Life 
Event Diaries are associated with high seizure frequency, was examined 
Table 2 
Means and Analysis of Variance for Seizure Frequency Across Four 
Stages of the Menstrual Cycle~ Anovulatory Cycles Oniy (~ = 7) 
Follicular 
~iean 14.8571 
so 21.5749 
Stage of Cycle 
Peri ovulatory 
3.4286 
5.5334 
High Progesterone 
5.2857 
8.3609 
Source of Variation Sum of Squares df 
Between Subjects (Error) 2290,4286 6 
Within Subjects 1932.2500 21 
Stage of the Menstrual Cycle 706,6786 3 
Stage of the Menstrual Cycle X Unit 1225.5714 18 
Total 4222.6786 27 
* / a~ E .... _ . o. 
Premenses 
2.0000 
4.4721 
Mean Square 
381.7381 
92.0119 
235.5595 
68,0873 
156.3955 
Gra.nd r•iean 
6.39?.9 
12.5058 
F-Test 
3.4597* 
....... 
N 
-.....1 
Table 3 
Seizure Frequency of Ovulatory and Anovulatory Cycles {~ = 21) 
Types of Cycles Stage of Cycle 
Follicular Peri ovulatory High Progesterone 
Ovulatory ~1ean 
(D_ = 14) 
so 
Anovulatory ~1ean 
(n_ = 7) 
so 
Column Mean 
Marginals 
SD 
Source of Variation 
Between Subjects (Error) 
10.0714 
12.7065 
14.8571 
21.5749 
11.6667 
15.8093 
1.9286 
4.1411 
3.4286 
5.5334 
2.4286 
4.5670 
Type of Cycle (Ovulatory vs. Anovulatory) 
Subjects Within Groups 
Within Subjects 
Stage of the t~enstrual Cycle 
Type of Cycle X Stage of Cycle 
Stage of Cycle X Subjects Within Groups 
***.e. L. . 001. 
2.0000 
4.4202 
5.2857 
8.3609 
3.0952 
6.0159 
Sum of Squares 
3727.8095 
120.0238 
3607.7857 
3989.7500 
1380.9881 
49.2618 
2559.5001 
df 
20 
1 
.1. 
19 
63 
3 
.., 
.,) 
57 
Premenses 
1.4286 
2.4088 
2.0000 
4.4721 
1.6190 
3.1381 
Mean Square 
120.0238 
189.8835 
460.3294 
16.4206 
44.9035 
Row Marginals 
3.8571 
7.8333 
6.3929 
12.5058 
4.7024 
9.6428 
F-Test 
0.6321 
28.0337*** 
0.3657 
..... 
r" o:> 
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next. Since the concept of examining each of these independent variables 
at the four defined stages of the menstrual cycle properly applies mainly 
to ovt(iatory cycles, results for ovulator·y and anovulatory cycles \·till 
again be discussed se!Jat·ately. 
Ovulatory Cycle~ 
Since each subject was studied for at least three successive months, 
a question that needed to be addt~ssed was whether a practice effect 
occurred; that is, whether the subjects showed a tendency to endorse mor·e 
or fewer negative mood items with each succeeding month they were studied. 
A two-way analysis of variance was performed for each of the mood scales, 
with month and stage of the menstrual cycle being the repeated measure 
factors. That is, the repeated measure factors "month" and "stage of the 
menstrual cycle" were analyzed for each of the dependent variables 
STAI-1, each of the POMS scales, each of the Moos MDQ scales, and the 
Schedule of Recent Experiences. The unit of analysis was each measure-
ment of the dependent variables for one subject during one ovulatory 
cycle. 
Results of the bJo-repeated measure factor analysis of varia nee 
showed no significance for month, stage of the menstrual cycle, or month 
by cycle interaction for the dependent measures the Spielbet~ger State 
Anxiety Inventory, POMS Tension, P0t·1S Depression, Pm1S Anger, POf•1S Vigor, 
POMS Fatigue, POMS Confusion, POMS Total T-Scores, Moos Pain, Moos 
Concentration, Moos Behavior Change, Moos Autonomic Reactions, Moo~ Water 
Retention, Moos Negative Affect, Moos Arousal, Moos Control, and the 
Holmes and Rahe Weekly Schedule of Recent Experiences. These results 
apply to ovulatory cycles only. Only for the dependent measure i~oos ~later 
Retention a ma.in effect was found for month~ .E_ (2, 16) = 5.107, E..= .02, 
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Subjects reported more Water Retention during the first month they were 
studied ex:; 8.884} than during succeeding months ex= 7.418). 
These results indicate th&t no practice effect occurred for the 
repeated measures of the dependent variable from month to month, with 
the exception of Moos Water Retention which was greatest for the first 
month of study. However, the same two-repeated measure analysis of 
variance also shows no significa}1t differences in anv of the mood 
measures from one stage of the menstrua 1 cycle to the next. That is~ 
when the subjects were repeatedly measured on the STAI-1, POMS, Moos MDQ, 
and WSRE variables, no significant differences occurred between these 
measurements taken at the menstrual, ovulatory, high progesterone, or 
premenstrual stages of the ovulatory cycles. Table 4 shows the mean 
values of each of the dependent variables measured at each of the four 
stages of the menstrual cycle, collapsed across three months of observa-
tion. In contrast to the large body of literature repot·ting increased 
menstrual and premenstrual negative affect, no significant changes in 
negative affect between different stages of the menstrual cycle were 
found for this group of ovulatory epileptic women. He have already 
determined that this group of epileptic women has a seizure peak at 
menstruation. Comparison of scores on a variety of mood measures taken 
at different stages of the menstrual cycle shows no corresponding 
increase in negative affect at the same time that seizure frequency 
increases. Another possible hypothesis is that increased negntive affect 
and stress £!.'€Cedes increased seizure frequency, and this hypothesis 
will be examined shortly. 
To investigate the hypothesis that increased negative affect and 
stress precede increased seizure fl~cquency, stt'ess measured ·in 0. st~ge 
Table 4 
Mean Vah:es of Dependent Variables t4easured at the Four Defined Stages of the Menstrual Cycle, Ovulatorx_ Cycles Only 
Varia!:1<.> Menstruation Ovulation High Progesterone Premenses Overa11 
Mean S.D. Mean S.D. Mean S.D. Mean 
£-Test 
S.D. 
Moos Pain 10.065 4.310 10.879 5.547 10.467 4.897 9.148 3.817 0.688 Moos Cnn~entration 13.613 5.723 12.818 5.072 13.367 5.805 12.815 4.00\J 0.173 Moos Behavior Change 7.065 3.037 7.152 2.583 7.467 3.074 7.704 3.838 0.249 Moos Autonomic Reactions 4. 710 1.570 4.788 1.683 4.967 2.025 4.556 1.423 0.282 
Moos water Retention 7. 774 2.904 7.424 2.903 7.667 3.004 7.481 3.084 0.090 Moos ~e~~tive Affect 16.253 8.242 16.818 8.215 16.833 8.637 16.407 8.283 0.036 
ll:oos Ar·ousa i 13.097 5.063 13.273 4.514 12.533 4.787 13.296 4.935 0.157 ll,oos Con l ro 1 7.645 2.322 8.303 3.030 7.567 2.565 8.444 3.270 0. 729 Spie!ber'qer State Anxiety 40.300 12.223 42.788 11.729 44.900 12.472 42.889 13.635 0.659 
POI·iS lens ion 38.267 9 .£l51 39.394 9.726 38.500 7.393 37.444 8.621 0.237 POHS Depiession 40.267 8.664 39.424 8.414 39.167 7.385 39.185 8.464 0.113 
ror,:s Ang•·r 45.900 9.988 44.121 8.260 45.867 10.095 46.222 9.628 0.306 
PO:·lS Vigor 55.467 9.653 55.061 11.786 53.600 9.708 55.111 11.419 0.173 POi·iS Fat i gOJe 43.200 8.215 43.000 7.935 44.500 9.625 43.074 J .107 0.213 
P01·1S Confusion 40.300 7.448 39.545 6.184 40.567 7.517 41.037 6.856 0.233 POi·lS Total T-Score 152.467 38.191 150.970 37.560 155.000 38,374 151.852 39.088 0.060 WSRE No. of Occurrences 3.187 5.065 3.879 3.699 3.767 4.645 3.259 4.195 0.188 WSRE Weighted Scores 71.562 109.538 91.909 86.831 78.300 95.234 63.667 78.914 0.431 
Note. Number of cycles = 33. 
,_. 
w 
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of the menstrual cycle immediately prior to the major· se-lzul~e flurry in 
a given cycle \ltaS compared to stress in the middle of a. seizure--free 
stage. Since most of the mood variables were measured only four times 
a month for each subject, an attempt was made to find a testing session 
for each menstrual cycle that was no more than five days prior to the 
major seizure flurry of that cyc1e. A testing session that occlwred 
in the middle of a seizure--free period was also identified for each 
cycle. Since some women had no seizures during a given menstrual cycle, 
that cycle was eliminated from the analysis. A toV:~l of 36 cycles were 
included in the analysis that had one period of seizure flurries and one 
period of no ~eizures during that cycle. Most of the periods of seizure 
flurries were during menstruation. Matched t-tests were performed to 
test the difference in scores on each of the dependent variables between 
a testing session just prior to a seizure flurry and a testing session 
that occurred during the midpoint of a seizure-free period. No signifi-
cant differences were found on the STAl-l scores, WSRE scores, any of the 
POMS scores, and any of the Moos MDQ scores when a testing session prior 
to a seizure flurry was compared to a midpoint seizure-free testing 
session. Table 5 shows the results of the matched t-tests performed on 
these variables. 
Despite all the negative results in predicting seizure flurries 
\'lith the standardized mood tests, the Diary of Life Events which the 
author devised was useful in predicting seizure flurries dur·ing m~:~nstrual 
cyc·les. For each menstrual cycle in which at least one seizure occw·red, 
two time periods were identified. The first time period was three days 
immediately prior to the gr·eatest seizure flur·ry of rhat cycle and the 
second time period was the midpoint of a period of no seizures during 
Table 5 
Matched ~T2sts for the Difference in Scores on Each of the Dependent Variables Between a Testing Session Just Prior 
to a Seizure Flurry and a Testing Session That Occurred During the Midpoint of a Seizure-Free Period·(~= 36 cycles) 
Variable Mean Difference Standard Deviation n t-Test 
~:oos Pain - 0.882 4.770 34 _, 1.063 
Moos Concentration 0.735 3.657 34 1.155 
Moos Behavior Change 0.265 2.524 34 0.602 
Noos Autonomic Reactions - 0.088 2.214 34 - 0.229 
Moos Water Retention - 0.853 2.912 34 - 1.683 
Moos Negative Affect - 0.529 4.603 34 - 0.661 
Mocs Ar·ousa 1 - 0.059 3.115 34 - 0.108 
Noos Control - 0.059 1.882 34 - 1.616 
Spie1berger State Anxiety - 0.483 9.027 29 - 0.?83 
P0i·1S Tension 0.793 7.097 29 0.591 
POt·lS De pre~ s ion 0.345 4.245 29 0.430 
P0f1S Anger 1.897 7.443 29 1. 348 
Pat1S Vigor 1.345 6.900 29 1.031 
POt~S Fatigue 0.172 5.896 29 0.155 
P01·1S Confusion 1.655 5.390 29 1.625 
PO~lS Tota 1 T -Score 3.517 23.252 29 0.800 
WSRE Weighted Scores 
- 16.629 65.460 35 - 1.481 
1-' 
w 
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the same cycle. The mean score of all diary ratings was calculated for 
each individual cycle, The mean wa:; of a rating on a 6-point scale of 
all the significant life events that the subjects mentioned during a 
particular menstrual cycle. Next, the mean score for the diary ratings 
for the three days prior to a seizure flurry and the three days in the 
midpoint of no seizures was ca·lculated for each cycle. The mean overall 
diary rating for a given cycle was subtracted from the mean diary score 
prior to a seizure flurry. The mean overall diary rating for a given 
cyc"le was next subtracted from the mean diary score for the midpoint of 
no seizures for that cycle. Thus each subject's self-rated life stress 
before a seizure flurr·y, as well as during a period of no seizures, \'tas 
compared to her 0\'ln over~ll life stress for that pat'ticular cycle. 
A matdu~d p~ir t-test \'Jas perforn:ed to test the difference betv1e2n 
self-rated life stress prior to seizures versus life stress during no 
seizures for all cycles. Since directional hypotheses were made, a one-
tailed test was used. The subjects reported significantly more stress 
in the stage immediately prior to a seizure flurry (x· = 0.1308) than 
during a period of no seizures (X=- 0.0928),! (35) = 1.7508, £ L .05. 
This result suggests that a woman's own identification of personally 
upsetting life events and evaluation of the relative importance of those 
events is more useful in predicting seizures than any of the standardized 
mood or stressful life event scales. 
Anovulatory Cycles 
The fourteen anovulatory cycles were analyzed by assigning each 
testing session to one of four time periods that would be equivalent to 
the follicula}', periovulatory, high progester·one, and premenstr'ual times 
of an ovulatm'y cycle. That is, if a subject was seen during menstruation, 
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that testing session would be assigned to the follicular-equivalent time 
period; if she was seen midcycle, that testing session would be assigned 
to the periovulatm·y-equivalent time period, and so on. 
A one-wc.:y repeated measure analysis of variance was perfor·rned, in 
\•thich the repeated measure factor was "stage of the menstrual cycler: and 
the factor levels were follicular-equivalent, periovulatory-equivalent, 
high progesterone-equivalent, and premenstrual-equivalent testing sessions. 
The dependent variables were STAl-l, each of the POMS scores, each of the 
Moos MDQ scores, and the WSRE. The unit of analysis was measurements 
taken on the dependent variables for one subject during one unovulatot·y 
cycle. Separate analyses were done for each dependent variable. Results 
of the one-way repeated measure ANOVA showed no significant main effects 
of stage of the menstrual cycle for any of the mood measures. These 
results appear in Table 6. 
Co!r!eari son of Ovulatory and Anovul atory_i,tcl es 
As previously noted, we found that subjects had twice as many 
seizures during anovulatory cycles as they did during ovulatory cycles. 
Also, subjects had their greatest seizure peaks during the menstrual 
stage and a smaller seizure peak during the high progesterone stage for 
both ovulatory and anovulatory cycles. In this section the differences 
in response to the mood !:.cales between the ovulatory and anovulatory 
cycles is examined. 
A one-way repeated measure factor analysis of variance with one 
grouping factor WclS rer-f'ormed, in. which the repeated measure factor was 
11 Stage of the menstrual cycle" and the factor levels were menstruation, 
ovulation, high progesterone, and premenses. The grouping factor was 
11 Cycle status:'1 which had two categoY'ies: ovulatory cycles a11d anovulutory 
Table 6 
Me'ln Values of Dependent Variables Measured at Four Defined Stages of the t4enstrual Cycle • .t\novu1atory Cycles Only (~~ = 14) 
Variable .Menstruation Ovulation High Progesterone Premenses Ov~rall 
F-Test 
Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
~1oos Pain 12.000 5.930 11.000 7.055 9.556 5.014 13.700 6.827 0.667 
Moos Concentration 15.500 5.979 15.333 8.069 14.667 5.676 18.100 8.893 0.383 
Moos Behavior Change 9.417 4.821 7.333 2.667 8.667 5.850 10.900 6.057 0.7-16 
Moos Autonomic Reactions 4.333 0.624 5,556 3.236 5.111 1.449 5.200 1. 778 0.693 
Moos Water Retention 5.417 2.060 5.222 1.227 4.567 1.247 6.400 4.079 0.736 
Moos Negative Affect 20.833 11.950 16.444 10.584 18.333 10.077 22.500 13.640 0.450 
~lcos /l.ro'rsal 11.833 4.687 9.111 3.635 10.667 4.163 12.500 5.971 0.8.:',9 
Noos Contr·o1 9.250 4.284 s. 5~)6 3.890 8.222 3.010 9.700 4.562 0.23':l Spielberger State Anxiety 47.500 13.763 48.222 14.420 44.667 12.587 46.8CO 15.854 0.096 
PO:·lS Tens ion 40.417 11.856 39.667 11.508 38.778 8.753 43.000 12.736 0.221 
PCWS Depression 43.417 11.332 41.667 11.557 41.000 9.274 45.600 12.737 0.234 
PO~~S Anger 51.833 10.286 45.778 9.343 49.444 10.678 51.800 12.711 0.602 
P0:1S '/igor 52.500 10.650 46.778 6. 729 50.222 6.696 52.300 12.946 O.G39 
PO:·lS Fatigue 47.000 12.007 48.889 12.095 47.222 11.183 47.400 11.324 0.046 
POi~S Confusion 41.417 6.409 43.000 9.345 43.667 6.848 44.200 8.885 0.233 
POt·IS Total T-Score 171.583 36.167 172.000 46.414 169.8!39 37.793 179.700 51.500 0.091 
WSRE No. of Occurrences 1. 538 2.308 1.300 1.487 1.000 1.054 2.500 2.975 0.820 
WSRE Weighted Scores 34.ll62 49.598 31.300 36.017 25.222 27.680 50.700 65.131 0.464 
!-• 
w 
0"1 
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cycles. The dependent variables were STAl-l scores, each of the POMS 
scales, each of the Moos MDQ scales, and the Schedule of Recent 
Experiences. The unit of analysis was measurements taken on the depen-
dent variables for one subject during one ovulatory or anovulatory cycle. 
Rcsul ts of the one-way repeated measure factor· ANOVA with one 
grouping factor indicated three statistically significant findings. 
During anovulatory cycles subjects experienced significantly more anger, 
as measured by POMS Anger(!= 51.253), than during ovulatory cycles 
(! = 45.374), f (1, 44) = 3.999, £ = .052. Subjects also experienced 
significantly more fatigue dur·ing anovulatory cycles, as measured by 
POMS Fatigue CK = 48.997) compared to ovulatory cycles(!;_= 43.309), 
£ {1~ 44} = 4.222, £ = .046. Finally, subjects reported experiencing 
significantly more water retention during ovulatory cycles CK = 7.638) 
compat~ed to anovulatory cycles ex= 5.876)' as measured by tvloos ~~ater 
Retention, f {1, 44) = 4.582, £ = .038. 
Su~oarizing the results of this section, subjects experienced 
significantly more anger and fatigue during anovulatory cycles, while 
experiencing more water retention during ovulatory cycles. Perhaps 
significant amounts of anger and fatigue are in part responsible for the 
phenomenon of anovulatot~ cycles. 
Hypothesi~: A Combination of Low Levels of Progesterone and High 
Levels of Stress Is Associated with the Hi_g_hest Seizure Frequency 
~lulti p 1 e. Reqres s ion_ Ana 1 ys is 
The next s~ep in the a~alysis was an attempt to predict the depen-
dent variabie, seizure frequency, from the seve~·al independent variables: 
anticonvulsant blood levels, estrogen and progesterone levels, POMS 
Profile of r~ood States, Spielberger State Anxiety Inventory, r1oos r•Jenstrual 
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Distress Questionnaire, and the Holmes and Rahe Schedule of Recent Exper-
iences. r~'Jltiple regress·ion analyses \•Jere performed in order to 
develop prediction equations which would mathematically relate the 
independent variables to the dependent variable~ seizure frequency. 
The form of multiple reg~ession equation that was used was a step-wise 
solution; that is, for a given dependent variable, the independent 
variables are introduced into the equation one at a time until the iast 
step increases the m~ltiple correlation squared by less than 0.01. The 
multiple regression equations were done using the DATA-TEXT System 
statistical package (Armor & Couch, 1972). All calculations were done 
in the double-precision mode since independent variable correlations 
were very high. Product-moment correlations among all the variables 
were tested for significance. The predicted and actual scores for the 
dependent variables for each unit of ana1ysis were printed. 
The purpose of the initial multiple regression analysis was to 
predict the total seizure frequency that might occur at any stage of the 
cycle from the group of independent variables that were measured at 
that same stage. The dependent variable, therefore, was total seizure 
frequency at a given stage of the menstrual cycle while the 21 independ-
ent variables were the following measures associated with that stage: 
total Di1antin level, expressed as~~g/ml; estradiol level, expressed as 
pg/m1; 17-0HP progesterone, expressed as ng/ml; Spielberger State Anxiety; 
POMS Profile of Mood States Tension, Depression~ Anger, Vigor, Fatigue, 
Confusion, and Total T-Scores; Moos MDQ Pain, Concentration, Behavior 
Change, Autonomic Reactions, Water Retention. Negative Affect, Arousal, 
and Control scores; and the Holmes and Rahe Weekly Schedule of Recent 
Experiences weighted score. The unit of analysis used for this multiple 
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regression analysis was one testing session for one subject. A total of 
168 units of analysis were used for the multiple regression, representing 
168 testing sessions for the 14 subjects. Since normative and ipsative 
values were mixed in the multiple regression analyses, probability state-
ments could not be made: the usual ! or [with its associated probability 
statements could not be used. Therefore, only ! values and unique variance 
are given in reporting the results of the multiple regression analyses. 
For this same reason, the mixing of normative and ipsative measures, no 
£values or statement of statistical significance for the overall multi-
ple regression analyses could be made. The decision about further inter-
pretation was made on the basis of the magnitude of the multiple R. 
P.esults of the la~t step of th·is l"egr·ession analysis appear in 
Table 7 and the associated correlation matrix appears in Table 8. The 
multiple correlation squared·(lt) is 0.329. This coefficient seems to 
merit further analysis and indicates that 32.9% of the variation of the 
de~endent variable total seizure frequency is explained by association 
with the independent variables POr~s Fatigue, State Anxiety, POf1S Anget, 
POMS Vigor, POMS Depression, Holmes and Rahe Weekly Schedule of Recent 
Experiences, and Moos Pain. Inspection of the standardized regression 
coefficients indicate that the variables POMS Anger, ! (160) = 4.24, 
unique variance = .076, and POMS Fatigue, 1 (160) = 3.31, unique variance 
= .046~ have the greatest relative power to predict the dependent variable 
seizure frequency. Other significant predictive variables are POMS Vigor, 
!_ (160} = ·· 2.49, unique variance= .026, and POf.1S Depression,! (160} = 
- 2.22 5 unique variance = .021. However, since the multiple correlation 
squared is relatively low, the group of variables that appear in Table 7, 
including POMS Anger and POMS Fatigue~ are not good predictors of total 
Table 7 
Mult1p1e Regression Analysis to Predict the Dependent Variable Total Seizure Frequency Occurring at Any Stage of the 
Menstrual Cycle from the Group of Independent Variables That Were Measured at That Same Stage of the' Cycle (lis 163) 
Variable Description 
i'Oi~S Fatigue 
Spielberger State Anxiety 
ro:1s Anger 
POt·:s Vigor 
?01·!5 Depression 
WSRE Weiohted Scores 
11oos Pain 
Regression Constant 
Multiple Correlation Squared 
Multiple Correlation 
St0ndard Deviation of Residuals 
Regression 
Coefficient 
0.2801 
- 0.1654 
0.3976 
- 0.1672 
- 0.3172 
- 0.0143 
0.1637 
1.602 
0.329 
0.573 
7.540 
Std. Error of Standardized Unique 
Coefficient Coefficient t-Test df Variance 
0.085 0.295 3.31 160 .046 
0.086 - 0.242 - 1.92 160 .015 
0.094 0.448 4.24 160 .076 
0.067 - 0.199 - 2.49 160 .026 
0.143 - 0.328 - 2.22 160 .021 
0.007 - 0.138 - 1. 91 160 .015 
0.152 0.096 1.07 160 .005 
F • 11.20 with 7 and 160 Degrees of Freedom (£under .001) 
Partial Correlations with Dependent Variable for Variables Not Entered 
DilM1tin Levels 
Estrogen Levels 
ProgPsterone Levels 
P0t·1S Ter~sio:1 
POt·:s Confusion 
PQ;·!S Tota1 T -Score 
Moos Concentration 
1~oos Beila vi or· C~~ange 
l,joos Autonomic Reacti or.s 
0.012 
- 0.088 
- 0.030 
0.017 
- 0.047 
- 0.018 
0.052 
- 0.009 
- 0.042 ,_. 
.;::. 
0 
Tab1e 8 
Pearson's Product-Moment Correlation Coefficients Between the Dependent Variable Total Seizure Frequency 
Occurring at Any Stage of the Menstrual Cycle and the Independent Variables ~1easured at the Same Cycle Stage 
Seizure Dilantin 
Variable Description Frequency Levels 
Seizure Frequency 1.000 
- 0.092 
Diiantin Levels 
- 0.092 1.000 
Estrogen Level:; 
- 0.096 - 0.111 
Progesterone Levels 
- 0.005 .. 0.252 
Spielberger Stnte Anxiety 
- 0.080 0,061 
POHS Tt•ns ion 
- 0.117 0.145 
POi·iS Dc>rress;on 
- 0.022 O.OB7 
P0i1S An qe I' 0.292 
- 0,123 
PO>iS v·i qor 
- 0.126 - 0.271 
POi·1S Fatigue 0.330 ... 0,096 
POI·1S Control 
- 0.068 0.060 
POMS Total T-Score 0.148 0,085 
f.ioos rcl'i n 0.168 .- 0.170 
Moos Concentration 0.126 ... 0.106 
~1oos Bc-h(lvior Change 0.153 
- 0.051 
Moos Autonomic Reactions 
- 0.016 .. 0,000 
Moos Water Retention 
- 0.091 
- 0.147 
Moos Ne~at1vc Affect 
- 0.011 
- 0.092 
Moos .l\rousa 1 
- 0.051 
- 0.386 Moos Control 
- 0.009 
- 0.085 WSRE Weighted Scores 
- 0.129 0.087 
Note. Number of cycle stages measured = 168. 
Estrogen 
Levels 
- 0,096 
- 0,111 
1.000 
0.299 
- 0.062 
- 0.052 
- 0, 114 
- 0.119 
- 0,041 
- 0,160 
- 0,154 
- 0. 121 
0,058 
- 0.098 . 
- 0,079 
0.045 
0.117 
- 0.031 
0.049 
- O,Otl2 
- 0.051 
Progesterone 
Levels 
- 0,005 
- 0,252 
0.299 
1.000 
- 0.110 
- 0.157 
- 0.136 
0,012 
0.170 
- 0.072 
- 0.168 
- 0,159 
0.057 
- 0.094 
- 0. 011 
.. 0.025 
0.104 
- 0.019 
0.243 
.. 0.005 
0,056 
1--" 
.p.. 
._. 
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Predicting S~j z~re_2 _ _ill_2..~fy_en l"ier.s truaJ_iXC~ St~ge by the Independent 
Variables Associated Hith Tha.t Stage 
Another way of determining the predictors of seizure frequency 
is to look at the dependent variable, seizure frequency, separately for 
each of the four stages of the menstrual cycle for which data was 
collected: menstruation, ovulation, high progesterone, and premenses 
during ovulatory cycles. Four simultaneous multiple regression analyses 
were computed. For each of these multiple regression analyses, the 
dependent measure was total seizure frequency at a given stage of the 
menstrual cycle (for example, the menstrual stage), and the independent 
variables were the 21 previously mentioned measures collected at the same 
stage of the cycle (for example, all the hormonal and mood measures 
collected at the menstrual stage). The r·eason for structuring the analyses 
this way was the cons·ideration that hormone levels and mood states that 
a woman is experiencing during menstruation might logically be expected 
to influence seizure frequency at menstruation, while hormone levels and 
mood states at another stage of the same cycle might 1 ogi ca lly influence 
seizure frequency at that other· stage. Another way of making this same 
point is that a totally different weighted set of independent variables 
might predict seizure frequency at menstruation v'lhen hormone values are 
within a certain range, as compared to seizure fr·equency at another stage 
of the cycle when hor·rnone values are within an entirely different range. 
Each of these four simultaneous multiple regression equations will 
be described separately. 
The first multiple regression analysis predicts seizure frequency 
at menstruation for only ovulatory cycles by the 2.1 independent variables 
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measured at menstruation and previously described. The unit uf analys1s 
for this multiple regression analysis was one testing session at the 
menstrual stage of the cycle for one subject. A total of 32 units of 
analysis were included, representing observations during menstruation 
for 32 ovulatory cycles of a group of 14 subjects, 
Result!> for the l~st step of this r~gression analysis appeal' in 
Table 9 and the associated correlation matrix appears in Table 10. The 
multiple correlation squat~e:d (R2) is 0.588, indicating that 58.8~£ of the 
dependent variable, total seizure frequency at menstruation during 
ovulatory cyc1es, is explained by asscciatio!l Hith the independent 
variables POMS Fatigue, POHS Confusion, Moos Behavior Change) f·1oos Po.in, 
Moos Negative Affect, progesterone levels, f'loos Concentration, Moos 
Control, Moos Autonomic Reactions, and the Weekly Schedule of Recent 
Experiences, all measured at the menstrual stage of the cycle. Inspect·ion 
of the standardized regression coefficient indicates that POMS Fatigue, 
1 (21) = 3.38, unique variance= .224, and POMS Confusion,! (21) =- 2.15, 
unique variance = .090, in order, have the greatest power to predict 
seizure frequency at menstruation during ovulatory cycles. 
The second multiple regression analysis predicts seizure frequency 
at ovulation, for ovulatory cycles only, by the 21 independent variables 
measured at ovulation. These 21 independent variables have been previous-
ly described in the paragraphs discussing the initial multiple regression 
analysis. A total of 32 units of analysis were included, representing 
observations during ovulation for 32 cycles of a group of 14 subjects. 
Results for the last step of this regression analysis appear in 
Table 11 and the associated correlation matrix awears in Table 12. For 
'h·· 1 . R2 0 R65 t ,'iS ana YSlS~ -- = .u) • Inspection of the standardized regression 
Tab1e 9 
M11 1 tiple Regression Analysis to Predict the Dependent Variable Total Seizure Frequency Occurring at Menstruation 
from the Gr,up of Ir.dep~ndent Variables MP.asured at Menstruation, Ovulatory Cycles Only (!:!. = 32) 
Reg1·ess ion Std. Erro1· of Standardized Unique 
V.:1riable Des:ripticn Coefficient Coefficient Coefficient t-Test df Vat'i a~ce 
?Ot1S Fatigue at Menses 0.7296 0.216 0.629 3.38 21 .224 
P0MS Confusio>1 at f.1enses 
- 0.5072 0.236 - 0.394 
- 2.15 21 .090 Moos Behavior Change at Menles 
- 0.4408 0. 771 - 0.140 
- 0.57 21 .. 005 
Moos Pain at Menses 0.9440 0.532 0,428 1.77 21 .062 
M0os Negative Affect at !1enses 
- 0.5724 0.343 - 0.498 - 1.67 21 .055 
Pr')-J•:s t.erone c; t ~~enses 
- 1. 6063 1.359 - 0.190 - 1.18 21 .027 
MJo~ Concentration ht Menses 
- 0.5482 0.441 - 0.330 
- 1.24 L1 .030 
Moos Control at Menses 1.1615 1.093 0.282 1.06 21 .022 
f·iJos r\utonof'lic ReJctions at f~enses 0.9885 1.401 0.163 0.71 21 .010 
WSRE ~~ighted Scores at ~enses 
- 0.0071 0.015 
- 0.081 - 0.48 21 .004 
Regr·es~ion Constant 
- 5.231 
Mu1tip1e i.orrelation Squared • 
Multipl£ Correlation a 
Standard Devi~~ion of Residuals = 
0.588 
0.767 
7.639 
F = 3.00 with 10 and 21 Degrees of Freedom (R • .017} 
Partial Conelc.t1ons with Dependent Variable for Variables Not Entered 
Dilantin levels dt M~nses 
Estrcgen Levels at Menses 
Spielberger State Anxiety, Menses 
PO~'.S Tl?nsion at !<lenses 
POMS Oepres~ion at Menses 
POMS Anger at Menses 
POMS Vigor at Menses 
!'OMS Total T-Scor~ at M~nses 
Moos Water Retention at Menses 
0.031 
- 0.059 
- O.Ofi3 
0.061 
• 0.075 
0.046 
- 0.026 
0.036 
- 0.029 
Stepping stopped -- last step inct·eased t.:...2 by less than 0.010. 
...... 
.p. 
..p. 
Table 10 
Pearson's Product-Moment Correlation Coefficients Between the Dependent Variable Total Seizure Frequency Occurring at 
Menstruation and the Independent Variables Heasured at.Menstruatfon 
Variable Description Dilantin Estrogen Prog?sterone State POf·IS Pm4S POMS POMS POMS 
Levels Levels Levels An xi cty Tension Depression Anger Viger Fatigue 
Oilantin Levels 1.000 - 0.219 0.074 0.143 0.200 0.200 0.033 
- 0.233 - 0.087 Estrogen Levels 
- 0.219 1.000 0.136 0.108 0.196 0.033 
- 0.036 - 0.170 - 0.054 Progesterone Levels 0.074 0.136 1.000 - 0.226 - 0.101 0.006 0.060 0.316 - 0.002 Splelberger State Anxiety 0.143 O.lOR - 0.226 1.000 0. 785 0.794 0.396 
- 0.595 0.502 POi· IS Tens i en 0.200 0.196 - 0.101 0.785 1.000 0. 789 0.459 
- 0.262 0.502 PO:·iS DEpression 0.200 0.033 0.006 0. 794 0. 739 1.000 0.750 - 0.177 0.664 Pc:r·1S ,'\nger'" 0.033 - 0.036 0.060 0.396 0.459 0.750 1.000 0.196 0. 745 PQ~lS Vigor 
- 0.233 - 0.170 0.316 - 0.595 - 0.262 - 0.177 0.196 1.000 - 0.066 POi·1S Fatigue 
- 0.037 - 0.054 - 0.002 0.502 0.502 0.664 0.745 
- 0.066 1.000 POHS Confusion 0.099 0.087 
- 0.213 0.665 0.616 0.545 0.188 - 0.426 0.325 !'OMS Total T-Scot·e 0.163 0.095 - 0.131 0.866 0.841 0.913 0.694 . - 0.404 0.}66 
~1oos Pain 
- 0.255 0.247 0.011 0.468 :>.469 0.578 0.475 - 0. 140 0.474 
~oos Ctncentration 
- 0.211 0.129 - 0.19·~ 0.675 :>.555 0.53! 0.347 - 0.367 0.449 MJos Eehavior Change 
- 0.167 0.034 0 122 0.442 0.360 0.667 0. 760 0.082 0.518 Moos Autonomic fleact1ons 
- 0.343 0.384 - 0.227 0.318 0.231 0.066 - 0.122 - 0.4S6 0.079 
f·1ofl" \~a ter Petention 
- 0.314 0.017 - 0.237 - 0.113 - 0.210 - 0.098 0.079 0.134 
- 0.192 Moo~ ~eqative Affect 0.090 0.080 - 0.04?. 0.554 0.607 0.302 0.699 
- 0.001 0.511 1·1oos Control 0.113 0.122 0.091 0.426 0.398 0.748 0.804 0.172 0.459 
\.ISR::: ~!e i ghte<.l Scor·es 0.130 - 0.285 0.359 0.012 0.005 0.164 0.328 0.349 0.1l5 
Seizure Frequency 
- 0.176 0.015 - O.C76 - 0. 162 - 0. 072 - 0.027 0.207 0.050 0.362 
Note. 1!. = 32 cycles. 
POMS 
Confusion 
o.o9g 
0.087 
- 0.213 
0.655 
0.616 
0.545 
0.185 
- 0.426 
0.325 
1.000 
0.697 
0.243 
G.60J 
0.267 
0.305 
- 0.030 
0.255 
0.242 
- 0.053 
- 0.285 
..... 
~ 
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Table lO.(Continued) 
?~arson's Product-Moment Correlation Coefficients Between the Dependent Variable Total Se1zure Frequency Occurring at 
Men~truation and the Independent Variables Measured at Menstruation 
Vc~.r1ab1e Oes;;.dptiorl PONS Moos Moos · ~laos ~loos t1oos ~loos Moos WSRE 
Tota r Pain Concentration Behavlo~ Autonomic Water Negative Control Weighted 
T-Score Change Reactions Retention Affect Scores 
Di1antin Levels 0.163 - 0.225 - c. 211 - 0.167 - 0.343 - 0.314 0.090 0.113 0.130 Estrogen LevEls 0.095 0.247 0.129 0.034 0.384 0.017 0.080 0.122 - 0.285 Progesterone Levels 
- 0.131 0.011 - 0.19·1 0.122 - 0.227 - 0.237 - 0.042 0.091 0.359 Spielberger Statu Anxiety 0.866 0.468 0.675 0.442 0.318 - 0.113 0.654 0.426 0.012 Por~s Tension 0.8'H 0.469 0.555 0.360 0.231 - 0.210 0.607 0.398 0.005 POW.i Depre•;sio~t 0.913 0.578 0.531 0.667 0.066 - 0.098 0.802 0.748 0.164 POi-15 AngEr 0.694 0.475 0.347 0.760 . - 0.122 0.079 0.699 0.804 0.328 POt'S Vigor 
- 0.404 - 0.140 - 0.367 0.082 - 0.456 0.134 
- 0.001 0.172 0.349 
P01·1S f.: ti gue 0.766 0.474 0.499 0.518 0.079 - 0.192 0.511 0.459 0.115 POr-tS Confusion 0.697 0.243 o.c.oo 0.267 0.305 • 0.080 0.255 0.242 - 0.058 
P0:·1S Tctal T-Score 1.000 0.557 0.655 0.583 0.232 
- 0.145 0.676 0.581 0.050 t~oos Pain 0.557 1.000 0.606 0.428 0.548 0.317 0.583 0.474 0.239 Moos Concentration 0.655 0.606 1.000 0.470 0.610 0.332 0.526 0.336 0.047 Moos Behavior Change 0.583 0.428 0.470 1.000 0.035 0.166 0.755 0.740 0.356 
t•hos Autonondc Reactions 0.232 0.548 0.610 0.035 1.000 0.333 0.128 0.005 - 0.185 Moos Water Retention 
- 0.145 0.317 0.332 0.166 0.333 1.000 0.160 0.197 0.194 Moos Negative Affect 0.676 0.583 0.526 0.755 0.128 0.160 1.000 0.813 0.303 ~laos Control 0.581 0.474 0.386 0.740 0.005 0.197 0.813 1.000 0.374 WSRE Weighted Scores 0.050 0.239 0.047 0.356 
- 0.185 0.194 0. 303 0.374 1.000 Seizure Frequency 0.040 0.281 
- 0.111 -0.105 0.117 
- 0.040 - 0.073 - 0.005 - 0.093 
Note. N = 32 cycles. 
Seizure 
Frequency 
- 0.176 
0.015 
- 0.076 
- 0.162 
- 0.072 
- 0.027 
0.207 
0.050 
0. 362 
- 0.285 
0.040 
0.231 
- O.lll 
- 0.105 
0.117 
- 0.040 
- 0.073 
- O.OC5 
- 0.093 
1.000 
,_. 
.r:.. 
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Tab1e 11 
Multiple Regression Analysis to Predict the Dependent Var~able Total Seizure Frequency Occurring at Ovulation 
from the Group of Independent Variables Measured at Ovulation, Ovulatory Cycles Only (~ • 32) 
Regression Std. Error of Standardized Unique 
Var1ab1e Description Coefficient Coefficient Coefficient t-Test df Variance 
Estrogen at Ovulation 0.0200 0.003 0.671 6.79 19 .328 
POt-IS Vigor at Ovulation 
- 0.0181 0.025 
- 0.075 - 0.73 19 .00:1 
WSRE Weighted Scores at Ovulation 
- 0.0098 0.004 - 0.299 - 2.43 19 .042 
Moos Behavior Change at Ovulation 0.9460 0.205 0.863 4.61 19 .151 
Moos Control at Ovulation 
- 0.6136 0.142 - 0.658 
- 4.34 19 .133 
Moos Autonomic Reactions, Ovulation 
- 0.4871 0.193 - 0.292 - 2.52 19 .045 
Progesterone Levels at Ovulation 
- 0.0787 0.020 - 0.406 - 4.01 19 .114 
Dilantin Levels at Ovulation 
- 0.0713 0.032 - 0.235 - 2.20 19 .834 
Moos Water Retention at Ovulation - 0.2025 0.129 - 0.207 
- 1. 57 19 .Gl6 
POt~S Tension at Ovulation 
- 0.1253 0.043 - 0.434 - 2.92 19 .060 
Moos Concentration at Ovulation 0.1640 0.095 0.293 1. 73 19 .021 
Moos Pain at Ovulation 
- 0.0784 0.095 - 0.154 - 0.83 19 .005 
Regression Ccn~tant 
Multiple Correlation Squared • 
Multiple Correlation • 
7.129 
0.865 
0.9.30 
1.3S6 
F .. 10.15 with 12 and 19 Degrees of Freedom (.2, under .!'01) 
Standard Deviation of Residuals = 
Partiai Correlations with Dependent Variables Not Entered 
Spielberger State Anxiety, Ovulation - 0.098 
PGMS Depression at Ovulation 0.026 
POMS Anger at Ovulation 0.079 
POMS Fatigue at Ovulation 0 185 
POMS Confusion at Ovulation - 0.054 
PDr·1S Totdl 1-Sr.ore at Ovulation 0.064 
Moos Negative Affect at Ovulation 0.109 
Steppino stopped -- 'last step increased r2 by less than 0.010. 
J -
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Tab1~ 12 
Pearson's Product-Moment Correlation Coefficients Between the Dependent Variable Total Seizure Frequency Occurring at 
Ovulation and the Indepenrlent Variables ~leasured at Qvulation 
Variable D~scription on ar~ti n Estr·ogen Prooesterone State ?OMS POMS POMS ?OMS PO~lS 
Levels Levels Levels Anxiety Tension Depression Anger Vigor Fatigue 
Dihntin Lev21s 1.000 - 0.182 
- 0."34 0.094 0.264 0.115 - 0.056 - 0.174 - 0.039 
Estrog~n Lev~1s 
- 0.182 1.000 - 0.034 - 0.128 - 0.094 - 0.077 0.086 - 0.147 - 0.174 
Progesterone Levels 
- 0. 43~ - 0.034 1.000 - 0.151 - 0.275 - 0.172 0.059 0.222 
- 0.061 Spielberser State Anxiety 0.094 - 0.128 - 0.151 1.000 0.736 0.872 0.506 - 0.439 0.463 POt·1S Tension 0.264 - 0.094 - 0.275 0.736 1.000 0.733 0.406 - 0.249 0.?54 
POf·lS Depression O.llS - 0.077 - 0.172 0.872 0.733 1.000 0.645 - 0.477 0.535 
POl-lS J\nge .-
- 0.056 0.086 0.059 0.506 0.406 0.645 1.000 0.093 0.450 
PQt~S Vi<JOI' 
- 0.174 - 0. 14 7 0.222 - 0.439 - 0.249 - 0.477 0.093 1.000 - 0.375 
P0;·1S Fatigue 
- 0.039 - 0.174 - 0.061 0.463 0.254 0.535 0.450 - 0.375 1.000 
PO!·~S Ccn fU'; ion 0.081 - 0.171 - 0.244 0. 776 0.631 0.735 0.271 - 0.543 0.277 
PO:·~S Tctal T-Score 0. 141 - 0.047 - 0.231 0.884 0. 751 0.935 0.577 - 0.632 0.648 
~~oos Pain 
- 0. 145 0.188 - 0.055 0.098 - 0.083 0.235 0.536 0.176 0.339 
Moos Co~centration 0.010 - 0.012 - 0.220 0.805 0.686 0.752 0.438 
- 0.323 0.292 Moos Beh~vior Change 0.032 - 0.096 - 0.102 0.577 0.381 0.657 0. 756 
- 0.025 0.585 
Moos Autonomic React1onc; 0.021 0.268 - 0.]92 0.211 0. 3'13 0.226 0.011 
- 0.132 - 0.106 Moos Wdter Retention 
- 0.133 0.051 - 0.103 0.057 - 0.009 0.142 0.291 0.105 0.120 
Moos Negative Affect 0.016 0.033 - 0.066 0. 716 0.670 0.696 0.697 0.021 0.284 
~laos Con t t'o 1 
- 0.193 - 0.003 0.013 0.327 0.029 O.t:41 0.671 0.153 0. 371 
~SRE W~ighted Scores 0.181 - 0.055 - 0.231 0.241 0.331 0.365 0.438 0.156 0.255 Seizure Frequ~ncy 
- 0.135 0.592 - 0.229 O.Oll - 0.111 - 0.031 - 0.059 - 0.388 0.098 
Note. N = 32 cycles. 
PO~IS 
Contusion 
0.081 
- 0.171 
- 0.244 
0. 776 
0.631 
0.735 
G.£'71 
- 0.543 
0.277 
! . 000 
0. 78S 
(1,019 
0. 717 
O.t1SO 
0.325 
0.187 
0.466 
0.038 
0.122 
0.124 
...... 
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Table 12 (Continued) 
Pearson's Product-Moment Correlation Coefficients Between the Dependent Variable Total Seizure Frequency Occurring at 
Ovulation and the Inde~er.rlent Variables Measured at Ovu1ation 
Variable Description pm;,s Moos t1oos Moos Moos Hoos Moos Moos WSRE 
Total Pain Concentration Behavior Autonomic Water Negative Control Weighted 
T-Score Change Reaction;; Retention Affect Scores 
Di1antin Levels 0. 141 - 0.145 0.010 0.032 0.021 - 0.133 0.016 
- 0.193 0.181 Estrogen Leveis 
- 0.047 0.188 - 0.012 - 0.096 0.268 0.061 0.033 
- 0.003 - 0.055 Progesterone Levels 
- 0.231 - 0.055 - 0.220 - 0.102 - 0.192 - 0.108 - 0.066 b.013 - 0.231 Spielberger State Anxiety 0.864 0.098 0.805 0.577 0.211 0.057 0.716 0.327 0.241 
P0f1S Tension 0. 751 - 0.083 0.686 0.331 0.373 - 0.009 0.670 0.029 0.331 
POns IJ.:press ion 0.935 0.235 0.752 0.657 0.226 0.142 0.695 0.441 0.365 
PO:'<S Anger 0.577 0.536 0.4~S 0.756 0.011 0.291 0.697 0.671 0.438 PO~iS Vigor 
- 0.632 0.176 - 0.323 - 0.025 - 0.112 0.105 0.021 0.153 0.155 
POi·1S Fatigue 0.648 0.339 0.2')2 O.b85 
- 0. 106 0.120 0.284 0. 371 0.256 
FGr·lS Confusion 0.785 0.019 0. 717 0.450 0.326 0.187 0.466 0.038 0.122 PO~S Total T-Score 1.000 0.160 0. 717 0.610 0.216 0.105 O.li05 0.281 0.299 1-loos Pilin 0.160 1. 000 0.254 0.653 0.016 0.703 0.407 0.695 0.4S6 Moos Concentration 0. 717 0.254 1.000 0.577 0.455 0.212 0. 790 0.346 0.264 
Moos B0havior Change 0.610 0.653 0. 577 1.000 - 0.026 0.473 0. 712 0. 716 0.617 Moos Autonomic Reactions 0.216 0.016 0.455 
- 0.:126 1.000 - 0.088 0.248 - 0.029 - 0.024 Maos Wdter Retention 0.105 0. 703 0.212 0.478 - 0.088 1.000 0.300 0.380 0.410 
Moos Negative Affect 0.605 OAO? 0.790 o. 712 0.248 0. 300 1.000 0.587 0. 4t,6 
i·lcrJS Cont. ro 1 0.281 0.695 O.Yf5 0.715 - 0.089 0.380 0.587 1.000 0.4S7 ¥1SRE \.;r:i<:itted Scores 0.299 0.456 0.264 0.617 
- 0.024 0.410 0.'146 0.457 1.000 Seizure frequency 0.108 - 0.055 0.074 
- 0.010 o .orn - 0.076 - 0.105 - 0.221 - 0.279 
Note. N -= 32 cycles. 
Seiz'.lre 
Frequency 
- 0.135 
0.592 
- 0.22;} 
O.Gll 
- 0.111 
- 0.031 
- 0.059 
- 0.333 
0.09S 
0. i24 
0' 103 
- 0.055 
0.07-1 
- O.OlO 
0.001 
- 0.075 
- 0 .lOS 
- 0.221 
- 0.279 
1.00() 
....... 
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coefficients indicates that the follcwing independent variables are 
associated with seizure frequency at ovulation, in order of their 
relative predictive power: estrogen,! (19) = 6.79, unique variance= .328; 
Moos Behavior Change, 1 (19) = 4.61, unique variance= .151; Moos Control: 
! (19) =- 4.34, unique variance= .13~; progesterone, t (19) -- 4.01, 
unique variance= .114; POMS Tension, 1 (19) = - 2.92, unique variance= 
.060; Weekly Schedule of R2cent Experiences, 1 (19) = - 2.43, unique 
variance = .042; Moos Autonomic Reactions, t (19) = - 2.52, unique var-
ia.nce = .045; and Dilantint !_ {19) = - 2.20, unique var·iance = .034. 
The third multiple regression analysis predicts seizure frequency 
at the high progestel·one stage of the cycle~ for ovulatory cycles only, 
by the 21 independent variables measured at the high progesterone stage 
of the cycle. As with the previous t'IIO multiple regt~ession analyses, a 
total of 32 units of analysis were included, representing observations 
during the high progesterone stage of the cycle for 32 ovulatory cycles 
of a group of 14 subjects. 
Results for the last step of this regression analysis appear in 
Table 13 and the associated correlation matrix appears in Table 14. For 
this analysis, R2 = 0.734. Inspection of the standardized regression 
coefficients indicates that the following independent variables are 
associated with seizure frequency at the high progesterone stage of the 
cycle, in order of their relative pt~edictive pmver: POMS Anger, t (17) = 
2.31~ unique variance = .083; POMS Tension, ! (17) = - 2.24, unique 
variance = .078; Moos Concentration,! (17) = 2.61, unique variance = .107; 
Moos Autonomic Reactions, ! (17) = - 2.85, unique variance = .127; 
progesterone, !_ (17) = 2.38, unique variance = .089; and Dilantin, !_ (17) = 
2.39, unique variance = .089. 
Table 13 
Mu1tiple Regression A.1a1ys·is to Predict the Deper>de~1t Variable :Total Seizure- Frequency Occurring at High Progesterone 
f1·cm the Group of Independent Variables Mea!;ured at High Progesterone, Ovulatory Cycles Only (!i = 32) 
Regression Std. Error of Standardized Unique 
Variable Description Coeff1cient Coefficient Coefficient t-Test df Variance 
POMS Anger at High Progesterone 0.5320 0.231 0.589 2.31 17 .033 POi~S Tension at High Progesterone 
- 1. 7615 0.787 - l. 416 - 2.24 17 .078 Moos Control at High Progesterone 0.8771 0.873 0.247 l.OO 17 .016 
Moos Water Retention at High Progesteron! 0.9391 0.459 0.308 2.05 17 .065 
Moos Concentration at Hiy~ Progesterone l, 7549 0.672 1.111 2.61 17 .107 PO~S Fatigue at High Progesterone 0.2642 0.288 0.2?9 0.92 17 .013 
Moos Negative Affect at High Progesterone 0.0998 0.443 0.094 0.23 17 .001 
l~oos f,utonomi c Reaction'> ~ t High Progesterone - 4. 5279 1.589 
- 1.011 - 2.85 17 .127 
ProgEsterone Levels at High Progesterone 0.2020 0.085 0.457 2.38 17 .089 
Dilantin Levels at High Progesterone 0.6223 0.260 0.533 2.19 17 .089 
POMS Confusion at High Progesterone 0.9259 0.641 0.757 1.44 17 .033 
Moos Behctvior Change at High Progesterone 
- 2.1427 1.208 
- 0.721 
- 1. 77 17 .049. PO~S Depression at High Progesterone 
- 1. 2502 0.785 
- 1.013 - 1.59 17 .040 
PDMS Total T-Score at High Progesterone 0.2268 o. J 71 0.938 1.33 17 .027 
Regression Constant 
Multiple Correlation Squared 
Multiple Correlation 
- 3.171 
0, 734 
0.857 
6.511 
F = 3.35 with 14 and 17 Degrees of Freedom (~a .011) 
Standard Deviation of Residuals 
Partial Correlation with Dependent llar1able for Variables Not Entered 
Estrogen L~vels at High Progesterone 0.247 
Sp!elb~rger State Anxiety, High Progesterone 0.260 
POMS Vigor at High Progesterone 0.000 
Moos Pain at High Progesterone 0.037 
WSRE Weighted Scores at High Progesterone 0.106 
Stepping storped -- detenninant at next step = 0.000000006, which is too small to avoid numerical instability 1n the solution. 
..... 
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Table 14 
Pearson's Product-Moment Correlation Coefficients Between the D~·pendent Variable Total Seizure Frequency Occurring at 
Hlgh Proqesterone t~nd the Independent Variab1es Mea!iured at H_igh Progesterone 
v~riable Description Dllantin Estrogen Progesteron~ State P0~1S Por~s PO~lS POMS POMS 
Levels levels Levels Anxiety Tension O~pression Anger Vigor Fatigue 
Oilantin Levels 1.000 - 0.464 - 0.516 0.079 0.245 0.235 - 0.057 - 0.016 - 0.100 Estrogen Levels 
- 0.464 1.000 0,408 
- 0.053 - 0.175 - 0.172 - 0.195 - 0.087 - 0.234 Progesterone Levels 
- 0.516 0.408 1.000 - 0.229 - 0.261 - 0.120 0.174 0.224 - 0.160 Spielberger State Anxiety o.on - 0.053 - 0.229 1.000 0.809 0.790 0.402 
- 0.365 0.539 
PQt~S fens i en 0.2~5 - 0.175 - 0.261 0.809 1.000 0,890 0.405 
- 0.327 0.565 PQ1\S Depression 0.235 - 0.172 - 0. 120 0.790 0.890 1.000 0.565 - 0.254 0.579 POMS .l\nyer 
- 0.057 - 0.195 0.174 0.402 0.405 0.565 1.000 0.021 0.324 POMS V19or 
- 0.016 - 0.087 0.224 - 0.365 - 0.327 - 0.254 0.021 1.000 - 0.247 PGr1S Fatil)ue 
- 0.100 - 0.234 - 0.160 0.539 0.565 0.579 0.324 . - 0.247 1.000 Pons Contusion 0.122 - 0.252 - 0.229 0.741 0.871 0.765 0. 545 
- 0.408 0.457 
POi·lS Total T-Score 0.081 - 0.208 - 0.171 0.796 0.875 0.883 0.642 - 0.504 0. 718 Moos Pain 
- 0. 189 0.1% 0.308 0.374 0.313 0.498 0.596 
- 0.117 0.468 Moos Concentration 
- 0.078 - 0.046 0.052 0.759 0.794 0.736 0.531 - 0.281 0.392 
Moos Behavior Change 0.011 - 0.178 0.092 0.616 0.539 0.733 0. 763 - 0.060 0.500 
Moos Autonomic Reactions 
- 0.086 0.012 0.052 0.409 0.422 0.239 0.3;'6 
- 0.454 0.123 11oos \-later Retention 
- 0.009 0.358 0.057 0.112 0.221 0.170 0.096 - 0.094 0.045 
Moos Negative Affect 
- 0.148 - 0.039 0.087 0.792 0. 706 0. 745 0.649 - 0.238 0.566 Moos Control 
- 0.032 - 0.044 0.148 0.507 0.417 0.646 0.492 - 0.046 0.460 
~JSRE Weighted Scores 0.320 - 0.149 o.oso 0.090 0.114 0.367 0.398 0.051 0.089 Seizure Frequency 
- 0.212 0.036 0.398 - 0.036 - 0.144 0.029 0.471 0.104 0.110 
Note. !i = 32 cycles. 
P0.\15 
Confusion 
0.122 
- 0.252 
- 0.229 
0.741 
0.871 
0.765 
0.545 
- 0.408 
0.457 
1.000 
0.882 
0.250 
0.769 
0.531 
0.645 
0.032 
0.674 
0.252 
0.107 
- 0.043 
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Ta~le 14 (Continued) 
Pear~on's Product-Moment Correlation Coefficients Between the Dependent Variable Total Seizure Frequency Occurring at 
H1gi: Proq_esteror.e and the Independent Variables Measured at Hicrh Progesterone 
Vartabie Cescr!ption POMS Moos Moos ~1oos Hoos Moos Moos Moos wsn: 
Total . Pa·fn Concentration Behavior Autonomic Water Negative Control Weighted 
T-Score Chan9e Reactions Retention Affect Scon?s 
D!1antin Lev~:"is 0.081 - 0.1:39 - 0.078 0.011 - 0.086 - 0.009 - 0.148 - 0.032 0.320 Fs':roger. L<>v~1s 
- 0.208 0.196 - 0.046 - 0.178 0.01?. 0.358 - 0.039 - 0.044 - 0.149 Progestero;•" Levels 
- 0.171 0.308 0.052 0.092 0.052 0.057 0.087 0.148 0.050 So'elberger State Anxiety 0.786 0.374 0. 759 0.616 0.409 0.112 0.792 0.507 0.090 
PQr·t:. Tension 0.876 0.313 O.i94 0.539 0.442 0.221 0. 705 0.417 0. 114 
P01·1S DePress ion 0.833 0.498 0.736 0.733 0.239 0.170 0.745 0.646 0.357 
PQrt.s An9er 0.642 0.596 0.531 0. 763 0.376 0.096 0.649 0.492 0.393 
PC'i·lS Vi gc r 
- 0.504 - 0.117 - 0.281 - 0,060 - 0.454 - 0.094 - 0.238 - 0.046 0.05! 
PfJr.~S ~3 ti gue 0. 7l8 0.468 0. 3')2 0. 500 0.123 0.045 0.566 0.460 C.089 
p:~~~·F' Confusion 0.8B2 0.!50 0.769 0.531 0.645 0.08:? 0.674 0.252 0.1\17 
Pr,;;.) Tctal ~·-score 1.000 0.516 0.764 0. 700 0.506 0.153 0.794 0.513 0.(31 
~:cos Pa; :-. 0.516 1.000 0.419 0.697 0.186 0.510 0.603 0.625 0.531 
Moos Concantration 0.764 0.419 1.000 0.656 0.587 0.169 0.855 0.528 0.049 
~!oos ~,~f;c:vi .:Jr Cr1ange 0. 700 0.697 0.666 l.GOO 0.147 0.188 0.792 0.667 0.504 
~!cos 1\t:~or:omk Reactions O.S06 0.186 0.587 0. 14? 1.000 0.056 0.511 - 0.026 - 0.052 
!~ocs \:il ter P.:--ten t ion 0.153 0.5l0 0.169 0.138 0.056 1.000 0.153 0.116 0.242 
t~oos N!?C!a t i ve 1\ ffect 0. 794 0.603 0.855 0.792 0.511 0,153 1.000 0.571 0.219 
tl.oos Coiit.rc1 0.518 0.625 0.528 0.667 - 0.026 0.116 0. 571 1.000 0.262 
WSRt We:0hted Scores 0.231 0.531 0.049 0.504 - 0.062 0.242 0.219 0.262 1.000 
Sei1.urc Frequency 0.097 0.399 0.135 0.358 - 0.077 0.158 0.150 0.370 0.162 
Note. N = :12 cycles. 
Seizure 
Frequency 
- 0.212 
0.035 
0.398 
- O.OYi 
- 0. 144 
0.029 
0.471 
0. 104 
0. 110 
- 0.043 
0.097 
0. 399 
0.135 
0.358 
- 0.077 
0. 15El 
0.150 
0.370 
0.162 
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The fourth multiple regn:ssion analysis predicts seizure frequency 
at the premenstrual stage of the cycle, for ovulatory cycles only, by the 
21 independent variables n10i'ISUI'ed at the premenstrual stage of the cycle. 
A total of 32 units of analysis were included, representing observations 
during the premenstr~ua1 stage of the cycle for 32 ovulatory cycles of a 
group of 14 subjects. 
Results for the final step of this regression analysis appear in 
Table 15, and the associated correlation matrix appears in Table 16. 
? 
For this analysis, R'- = 0.668. Inspection of the standal~dized regression 
coefficients shows that only estrogen levels, 1 (16) = - 2.24, unique 
variance= .104, are significantly associated \vith seizure frequency at 
the premenstrual stage of ovulatory cycles. 
Table 17 is a summary table shmving the significant results of a11 
the multiple regression analyses. Summarizing the results of the multiple 
regression analyses described so far and their associated co~relation 
matrices yields the following information: 
1. During the menstrual phase of ovulatory cycles, POMS Fatigu~ 
positively predicts seizure frequency (standardized coefficient i-8 7 = 
-1 -
0.629), while POMS Confusion negatively predicts seizure frequency 
(standardized coefficient L/3_! =- 0.394). 
2. During the ovulatory phase of ovulatory cycles, estrogen levels 
positively pi~edict seizure frequency ( (3 = 0.671), \vhi1e progesterone 
((3 = - 0.406) and Dilantin levels (/3 ::: - 0.235) negative·ly predict 
seizure frequency. Hith respect to the mood scales measured at ovulations 
~1oos Ber1avior Change positively predicts seizure frequency (;3 = 0.863), 
Vlhile t~oos Control CB = - 0.658), f•1oos Autonomic Reactions (p = - 0.292), 
POMS Tension ( !:3 == - 0.434), and the t~cekly Schedule of Recent Exper·iences 
I 
Table 15 
Multiple Regression Analysis to Predict the Dependent Variable Total Seizure Frequency Occurring Premenstrually 
from the Group of Independent Variables Measured Premenstrcally, Ovulatory Cycles Only (~ • 32) 
Regression Std. Error of Standardized Unique Variable Gescript1on Coefficient Coefficient Coefficient t-Test elf Variance 
P011S Fatigue at Premenses O.H14 0.074 0.589 1.92 16 .076 
r~oos Negative Affect at Premenses 
- 0.1167 0.112 - 0.568 
- 1.04 16 .022 
POMS Anger at Premenses 
- 0.0124 0.057 - 0.070 - 0.22 J6 .001 
POi~S Tension at Premenses 
- 0.0660 0.127 - 0.333 
- 0.52 16 .006 
Estrogen Levels at Premcnses 
- 0.0122 0.005 - 0.434 - 2.24 16 .104 
POI~S Total T-Score at P;·emenses 0.0027 0.035 0.060 0.08 16 .ooa 
Moos Behavior Change at Premenses 0.4159 0.198 0.940 2. ]0 16 .092 
11oos Autonomic Reactions at Premenses 
- 0.4670 0.269 - 0.394 
- 1. 73 16 .062 
Sriclbergcr Stete Anxiety at Premenses 0.0490 0.070 0.:386 0.70 16 .010 
POMS Confusion at Premenses 0.0781 0.105 0.310 0. 74 16 .011 
\~SRE Weighted Scores at Premenses 
- 0.0073 0.006 - 0.338 - 1.32 16 .036 
Moos Water Retention at Pre~enses 0.2215 0.141 0.404 1.58 16 .052 
POMS D~pression at Premenses 
- 0.1502 0.126 
- 0.745 - 1.20 16 .030 
Progesterone Levels at Premenses 
- 0.0522 0.047 - 0.274 - 1.11 16 .026 
Moos Pain at Premenses 
- 0.1860 0.169 
- 0.420 - 1.10 16 .025 
Regression Constant 1.233 
Multiple Correlation Squared 
Multiple Correlation 
• 0.688 
O.l:l18 
1. 401 
F ,. 2.15 with 15 and 16 Degrees of Freedom (.2, • .070) 
Standard Deviotion of Residuals • 
Partial Correlations with Dependent Variable for Variables Not Entered 
Dilantin Levels at Premenses 
POr~s lfi gor at Premt>nses 
Moos Ccrcentr3tion at Premenses 
Moos Control at Premenses 
- 0.028 
- 0.000 
- 0.110 
() .118 
Stepping stopped-- determinant at next step= 0.000000007, which is too small to avoid n~meric~l instability 
in the solution. 
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Table 16 
Pea!"son's Product-Moment Correlation Coefficients Between the Dependent Var~able Total Seizure Frequency Occurring at 
Pr~menses and the Independent Variables Measured at Pre'!l~ 
Variable Description Dilant1n Estrogen Progesterone State PCMS P0~1S POMS PO~IS POMS Levels Levels Levels Anxiet.y Tension Depressi0n Anger Viger i-dtigue 
Di1antin Levels 1.000 .. 0.284 
- 0.124 0.194 0.384 0.351 
- 0.122 
- 0.388 - 0.044 Estrogen Levels 
- 0.2M 1.000 0.094 
- 0.137 - O.O~i - 0.057 0.110 - 0.083 0.311 Progesterone LevPls 
- 0.124 0.094 1.000 
- 0.320 - 0.162 - 0.283 - 0.144 0.430 0.018 Spielberger State Anxiety 0.194 - 0.137 - 0.320 1 .000 0.849 0.867 0.531 - 0.461 0.487 POi·~S Tens; on 0.384 
- 0.041 - 0.162 0.849 1.000 0.878 0.407 
- 0.407 0.395 f'Ci!·lS D<.:pression 0.351 
- 0.057 - 0.283 0.867 0.8713 1.000 0.625 
- 0.317 0.474 PO!•IS AnSJC:t' 
- 0.122 0.110 - 0.144 0.531 0.407 0.625 1.000 0.009 0.569 P0~1S Vigor 
- 0.388 - 0.083 0.430 
- 0.46! - 0.407 - 0.317 0.009 1.000 
- 0.272 PG1S F<J tigue 
- 0.044 0.311 0.018 0.487 0.395 0.474 0.569 - 0.272 1.000 POns Ccnfusion 0.407 
- 0.045 - 0.262 0.753 0.874 0.828 0.363 
- 0.382 0.381 POI·!S Tc.t,;l T-Score 0.317 o.oso 
- 0.304 0.877 0.870 0.906 0.650 
- 0.569 0.671 ~·:oos 1\; in 
- 0.019 0.132 0.029 0.21i 0.137 0.383 0.570 0.082 0.436 ~0os Concentration 0.239 
- 0.249 - 0.297 0.780 0. 711 0.819 0.500 
- 0.230 0.335 Moos Be~Jvior Change 0.174 0.184 0.043 0.51\9 0.62! 0.728 0.538 -0.129 0.551 ~1oos 1\utonomic Rt~actions 0.461 
- 0.340 - 0.175 0.247 0.2S2 0.194 - 0.027 - 0.236 •. 0.032 t~oos \~a tL:.r R1~tention 0.190 0.065 0.226 
- 0.043 - 0.087 0.111 0.199 0.075 0.204 M')os flccptive Affect 
- 0.030 - 0.019 - 0.085 0. 770 0.646 0.831 0. 716 - 0.048 0.454 f·~oos Ccntrul 
- 0.036 0.096 - 0.026 O,l\78 0.376 0.599 0.700 0.140 0.534 ~/SEE ::r~i <Jilted Scores 0.294 
- 0.048 0.104 0.451 0.583 0.650 0.493 0.053 0.384 Sei mr e Frequency 
- 0.054 0.014 - 0.051 - 0.138 - 0.257 - 0.252 - 0.203 - 0.205 0.315 
Note. N = 32 cycles. 
POMS 
Confusio•\ 
0.407 
- 0.045 
- 0.252 
0.753 
0.874 
0.828 
0.3G~ 
- 0.382 
0.381 
1.000 
0.832 
0.165 
0. 785 
0.810 
0.437 
0.031 
0. 591 
0.333 
0.586 
- 0.155 
.... 
l.M 
0"'1 
Tab1e 15 (Continued) 
?earson's Product-Moment Co .. reiat~on Coefficients Betwe(:n the Dependent Variable Total Seizut·e Frequency Occurring at 
Premenses and the Independent V~riables Measured at Prem2nses 
Vat"iable ~scription POMS Hoos Moos Moos Moos Moos ~loos Moos WSRE 
Toti!l Pain Concentrat1o~ Behavior Autonomic Water Negative Control Weighted 
T-Srorc Change Reactions Retention Affect Scores 
::lilantin Levels 0. 3"17 - 0.019 1).239 0.174 0.461 0.190 
- 0.030 - 0.036 0.294 Estrogen Levels 0.080 0.132 - 0.249 0.184 - 0.340 0.065 - 0.019 0.095 - 0.048 Progesterone Levels 
- 0.304 a.o2~ - 0.297 0.043 - 0.175 0.226 - 0.085 -· 0.026 0.104 Spielb?rger State Anxiety 0.877 0.2]7 0.780 0.549 0.247 - 0.043 0. 770 0.478 0.451 
PC~1S Tension 0.870 0. )37 0. 711 0.621 0.292 - 0.087 0.646 0. 375 0.583 POMS Depression G; 906 0.38.3 0.819 0. 728 0.194 0.111 0.831 0.599 0.650 
P0>1S Anger 0.650 0.570 0.500 0.538 - 0.027 0.199 0. 716 0.700 0.493 
P0'·1S Vigor .. 0.569 0.082 - 0.230 - 0.129 - 0.286 0.075 - 0.048 0.140 0.053 
rm1s Fatigue 0.671 0.436 0.335 0.551 - 0.032 0.204 0.454 0.534 0.384 
P0~1S Ccnfushm 0.8::.2 0.165 0. 785 0.610 0.437 0.031 0.591 0.338 0.585 
POt•IS Tota I T-Score 1.000 0.346 0. 737 O.C86 0.2S7 0.077 0. 715 0.513 0.560 
~1vos Pain 0.3•:6 1.000 0.429 0. 725 0.004 0.600 0.543 0.678 0.~65 
Moos Concentration 0.737 0.429 1.000 0.629 0.410 0.180 0./88 0.642 0.555 Moos B2havlor Change 0.686 0.725 0.629 1.000 0.102 0.304 0.750 0.641 0.661 
!'ioos A:.Jtonomic Reactions 0.257 0.004 0.410 0.102 l. 000 0.110 - 0.057 - 0.089 0.155 Moos Wdter Retention 0.077 0.600 0.180 0.304 O.llO 1.000 0.128 0.349 0.331 
Moos Neg~tive Affect 0.715 0.5B 0.788 0.750 - 0.057 0.128 1.000 0.742 0.:187 
M.JGS Contt·ol 0.513 O.G78 0.6!12 0.641 
- 0.089 0.349 0. 742 1.000 0.521 WSRE W~ighted Scores o.5nO 0.465 0.555 0.667 0.156 0.381 0.587 0.521 1.000 Seizure Frequency 
- 0.075 0.015 - 0.236 - 0.044 - 0.092 0.154 
- 0.275 - 0.089 - 0.251 
Note. N = J2 cycles. 
Seizure 
Ft·equency 
- 0.054 
o.og 
- 0.051 
- 0. !36 
- 0.257 
- 0.252 
- 0.203 
- 0.205 
0 . .315 
- 0.1S5 
- 0.07~' 
0.015 
- 0.236 
- 0.044 
- 0.092 
0.154 
- 0.275 
- O.Ofl9 
- 0.251 
1.000 
-
tT1 
""-' 
Table 17 
Summary cf the Significant Results of All the Multiple Regression Analyses and Their Associated Correlation Matrices 
Hultlple Regression Analysis 
l. SelztJres at any Cycle Stage 
Pt·edicted by Independent 
Variables Me~surcd at the 
Same Cyc'i e Stage 
2. Se~zures at Henstruation 
Pr~dicted hy Independent 
Vdriables Measured at 
~~ens tru~ t ion, Ovulatory 
and Anovulatory Cycles Ooly 
3. Seizures at Ovulation 
Prt~di cter: by J nd?pendent 
Vdriables M~asurtd at 
Ovulation, Ovubtery and 
Ar,t.P;ulatory Cycles Only 
4. St i lltr'es at High Proges-
te r0r.e h~t! ic ted hy ! ndepen-
.:!ent Vuriables M;:asut·e·j 4t 
l!igh ProgE:stl'ruroe, Ovuhtory 
'-"0 ;\l"ollulatory Cycles Only 
5. S~izures at Premenses 
PrNti c ted by ! nd·?pt:n!leut 
Ycriob1es Mr.a~ured at 
?r"emenses, OvtJ 1 d tory dnd 
il.r.ovu1atory Cycles Only 
Pearson r 
POMS Anger 0.292 
POMS Fatigue 0.380 
P~~s Fatigue 0.559 
PONS Vigor· 0.382 
POt-IS F3t igue 0. 365 
WSRE - 0.354 
Multiple Star.dar~1zed Coefficients 
n~gt·ess ion 
R 
0.329 Prn-1S Ar·ger, 0.448, t • 4.24 
P011S Fat1Ql!e, 0.295-;- t .. 3.31 
Por~s Depression, - 0.328, t • - 2.22 
POHS Vi<nr, - 0.199, !. = --2.49 
0.629 POHS Fatig~e, 0.582, t = 4.75 
0. 752 
POMS Confusion, - 0. 35.2, t = - 2, 92 
~oos Pain, 0.473, ! = 2.9; 
1'01'.5 V!qiJr, - 0.690, t a - 3.34 
PO~S Anger, 0.658, t ~ 2.91 
Proqesterune, - o.:fTl, t = - 3.42 
Moo; Control,- 0.551, £ •- 2.86 
WSRE, - 0.282, t = - 2.Il 
~i1antin, - o.zgo, t = - 2.49 
t·1no$ Concr;ntration,-0.459, t " 2.11 
Moos ileh.w 1 or Change, 0. 592-;- t = 2. 52 
Hoos >!;ner Retention, - 0.247:-!_• • 2.07 
POHS Anger 0.532 0.63:1 PWiS Anger, 0.659, t • 4.49 
Moos Pain 0.371 
Moos Behavior !:l:ange 0.394 
Moos Control 0.324 
PGMS Fatigue 0.488 0.771 
PO!!S Tension, - O.llS2, t = - 4.52 
Moos Co~ce~trdtion, 0.615, t • 3.02 
Moos Control, 0.363, t = 2.33 
Pm·1S Fatigue, 0.353, t: 2.69 
Moos Negative Affect,-- 0.523, ! • - 2.24 
POMS Fatigue, 0.710, t = 6.39 
Moo~ !li.'havior Chofi<Je,-0.672, t 2 3.78 
Estrogen, - 0.330, t = - 3.23-
PrQgesterone, - 0.240, t = - 2.31 
Moos Autor,omic, - 0.294~ .!_ = - 2.42 
OF Regress~on Correlations Between 
Constant 
160 1.602 
160 
160 
160 
37 11.296 
37 
37 
31 16.935 
31 
31 
31 
3J. 
31 
31 
31 
31 
38- 12.196 
38 
38 
39 
38 
38 
35 
35 
35 
35 
35 
0.583 
Oilant!n, Estrogen, 
and Proge~terone 
DPH X Prog, - 0.252 
Est X Prog, 0.299 
DPH X Prog, 0.419 
DPH X Prog, - 0.41~ 
.Est X OPH, • 0.388 
OPH X Prog, - 0.458 
Est X Prog, 0.405 
1-' 
(.J1 
OJ 
Table 17 (Continued) 
Summary of the Sfgnfffca~t Results of All the Multiple Regression An~lyses and Their Associated Correlation Matrices 
Multlp:e Regresslon An~lysfs 
6. Sellurcs at Menstrt•atfon 
Predi<:"trd by lncependent 
Varidbles Measured at 
:·lt:nstr·uation, Anovulat_qry 
Cy.1t,> (lnly 
7. Seizures at ~enstruation 
Predicted ~y Independent 
V~riabies Measured ~t 
M0~:truation, Ovulatorv 
Cycles Only ----
B. Seilures at Ovulation 
Predicted by Independent 
Variables Measured at 
Ovu 1 at ion, Anovu 1~t__2!.i'_ 
Cvc;es Only 
9. Seizures at Ovulation 
P.·ed i .: ted by 1 nJependent 
'/,:o latiles tkasure1 at 
Ovu 1 at i un, Px~J.il.!2rL 
[yc.~% Only 
10. Seizures at High Proges· 
terone Predicted by lnde-
penJent VariJblcs M~asured 
't High ProgPsterone, 
~_!'ovu}E-~2!.1. Cycles On1y 
Pearson r 
POMS Fatigue 0.778 
Estrogen 0.592 
POMS Vigor • 0.3BB 
POMS Anger 0.678 
!'0:1> Fatigue 0.890 
Multiple Standardized Coefficients 
R~gression 
R 
0.588 
0.865 
POMS Fatigue, 0.629, t • 3.38 
Pa1S Confusion, • 0.3~4. i • · 2.15 
Estrogen, 0.671, t • 6.79 
t1oos Behavior Chanqe, 0.863, t .. 4.61 
Moos Control, • 0.558, t • • if.34 
Progesterone, • 0.405, t • · 4.01 
PG:1s Tension, - 0.434, t R • 2.92 
WSRE, · 0.299, t = ~ 2.43 
~1oos Autonr,mic 'R"eactions - 0.292, t • 
Dflar.tin, - 0.235. ! = - 2.20 -
OF Regression Cor~elatfon~ Between 
Constant Oilantin, Estrogen, 
and Progesterone 
21 - 5.231 
21 
19 
19 
19 
19 
19 
19 
• 2.52 19 
19 
7.129 
DPH X Proges., 0.774 
OPH X Proses.,- 0.434 
...... 
U'1 
1.0 
Table 17 (Continued) 
s~ry of the Significant Results of All the Multiple Regression Analyses and Their Associated Correlation Matrices 
Multiple R~g1·ession Analysis 
11. Seizures ilt High Proges-
terone Predicted by Jnde· 
ccnde~t Variables Measured 
~t High Progesterone, 
Qy_•-!_1_atory Cycles Only 
12. Sei zu:-es at Pr~:nenses 
Predicted by lndtpendent 
Variables Measured at 
Prernenses, ~_Qvul ato_!Y 
Cycles Only 
13. SeizurEs at Premenses 
Predicted by Independent 
~driables Measured at 
Pre:~Enses, QI:.!I_l~o_rj'_ 
t:y~l~~ on;y 
14. se::c'Jn.~c; at Menstn;aticn 
Pn'rJ ic t~d by l nrlependent 
Varii1Llc~ Measured at 
the Prtvious Premenses, 
0vulatory & Anovulator1 
Cycles 
Pears·on r Multiple- Standardized Coefficients 
R~gression 
R 
OF Regre>si~n Correlations Between 
ConstJnt Dilantin, Estrogen, 
and Progeste~one 
Progesterone, 0.398 
POMS Anger, 0.47l. 
~1oos Pain, 0.399 
Moos Control, 0.370 
?Ot~S Depression, 0.632 
PO~:s Anger. 0. 542 
POMS Fatigue, 0.569 
PQr'<S Total Score, 0.555 
Moos Pain, 0.8J5 
0. 734 
0.668 
Moo~ Concentration, 0.648 
Moos Behavior Change, 0.826 
Moos Autonomic React., 0.640 
Moos Negative Affect, 0.681 
P0t1S Anger, 0.589, t • 2.31 17 
P0~1S Tension, - 1.4T6, t • - 2.24 17 
Moos Concentration, 1.111, t • 2.61 17 
Moos Autonomic React.,- 1.IT11, t •- 2.85 i7 
Progesterone, 0.457, t • 2.38 - 17. 
Dilantin, 0.533, !. = 2".39 17 
Estrogen, - 0.434, t • - 2.24 16 1.233 
DPH X Estrogen, - 0.464 
DPH X Proges.,- O.Si6 
Estrogen X Proges., 0.40C 
1-' 
en 
0 
Table 17 {Continued) 
Summary of t~e Significant Results of All the Multiple Regr~sslon Analyses and Their Associated Correlation Matrices 
Multiple Regression Analysis Pearson !. 
15. Seizures at High Proges- r~oos Pain, 0.336 
t~rone Predicted ~y Inde-
perldent Vari~btes Measured 
at the Previous Ovulation, 
(}~u1 d tor-y and Anovu1 a tory 
Cyc1f's 
]6. Seizures at Premenses PGt~S Fatiguta, 0.399 
Predicted ily lnde~endent 
Variables Measured at the 
Previous High Progesterone, 
'jvu1atory ano Anovulatory 
Cycles 
Multiple Standardl~~d Coefficients 
:2gresslon 
OF Regression Correlations Between 
Constant Oilantin, Estrogen, 
and Progesterone 
0.516 
0. 71i4 
State Anxiety, - 1.137, t •- 4.16 37 28.372 
Moos Behavior Change, O.it7, t • 2.74 37 
t·1oos Concent,·ation·, 0. 700, t ;- 2.68 37 
~1oos Wat€1' r.et~>ntion, - 0.345, t" - 2.19 37 
~loos Autonor:dc RedeL •• - 0.333,-!. • - 2.04 37 
POMS Fcltjgu~. 0.612, t " 3.5:! 
Progesterone, - 0.310~ t •.- 2.75 
Estrogen, 0.3A9, t = 3.~1 
Moas PJin, - 0.521~ t • - 2.98 
Moos Behavior Change~ 0.551, t • 2.51 
f.1o0s Negative Affect, - 0.600:!. • - 2.<:5 
32 - 2.565 
32 
32 
32 
32 
32 
....... 
0"1 
...... 
(p =- 0,299} negatively predict seizure frequency. POMS Vigor is 
negatively correlated with seizure frequency (~ = - 0.388). 
162 
3. During the high progesterone phase of ovulatory cycles, proges-
terone levels positively predict seizure frequency ((3 = 0.457}. The 
mood measures POMS Anger (f-3 = 0.589) and Moos Concentration ((3 = 1.111) 
positively predict seizure frequency, while POMS Tension (;3 - - 1.416) 
and Moos Autonomic Reactions (~ = - 1.011) negatively predict seizure 
frequency. Moos Pain (~ = 0.399} and Moos Control (~ = 0.370) are 
positively correlated with seizure frequency. 
4. During the premenstrual phase of ovulatory cycles, estrogen 
negatively predicts seizure frequency (;.3 =- 0.434). 
5. Dilantin levels and progesterone levels are positively cor-
related during anovulatory cycles at menstruation (~ = 0.774). However, 
Dilantin levels and progesterone levels are negatively correlated at the 
ovulatory (~ = - 0.434) and high progesterone (~ = - 0.516} phases of 
ovulatory cycles. 
These results suggest several possible relationships between seizure 
frequency and the independent variables during ovulatory cycles. If we 
assume that estrogen and progesterone levels measured at a given phase of 
the cycle act upon seizure frequency at that same stage of the cycle, no 
statistically significant relationship between hormone levels and seizure 
frequency is apparent at menstruation, even though seizures occur more 
frequently at menstruation than at any other stage of the cycle. Never-
theless, inspection of the absolute levels of progesterone at each stage 
of the cycle (Figure 1) shows clearly that seizure frequency is highest 
when progesterone levels are lowest. At ovulation, however, if the ratio 
of estrogen to progesterone is high, seizure frequency is high (that is, 
1C3 
as estrogen increases and progesterone decreases at ovulation, seizure 
frequency increases). 
Surprisingly, at the high progesterone phase of the cycle, high 
levels of progesterone are positively correlated with increased seizure 
frequency. This relationship tends to disconfirm the hypothesis that 
progesterone protects against seizures when just the relationship 
betvteen progesterone and seizures is considered. However, at ovulation 
we previously noted that when the ratio of estrogen to progesterone iS 
high, seizure frequency is high. Estrogen remains high at the high 
progesterone stage of the cycle, while progesterone is at its peak 
{Figure 1). Estrogen by itself has long been considered to be a convulsant 
(Logothetis et al., 1959; Stitt & Kinnard, 1968; Thiry, Heusgem, & 
Legentil, 1954; Werboff & Corcoran, 1961). The mechanism of action here 
may be that the high levels of estrogen block some of the presumed pro-
tective effect of progesterone. This is an especially likely hypothesis 
since estrogen and progesterone are positively correlated at the high 
progesterone stage of the cycle, which means that the more progesterone 
present, the more estrogen present also. 
Another important relationship that exists at the high progester-
one phase of the cycle is the highly significant negative correlation 
between Dilantin and progesterone. Given the fact that the group of 
epileptic women in this study were compliant on their anticonvulsant 
medication, a possible interpretation is that the high levels of proges-
terone are binding Dilantin at the high progesterone phase of the cycle, 
removing ~he anticonvulsant effect of Dilantin, and causing women to 
seize. 
At the premenstrual phase of the cycle~ decreasing levels of 
estrogen are associated with increasing seizure frequency. 164 
In terms of the relationship between the various mood scales and 
seizure frequency, again assuming that moods measured at a given phase 
of the cycle act upon seizure frequency at the same stage of the cycle, 
no one mood scale is consistently associated with higher seizure frequency 
across all menstrual cycle stages. Increasing levels of POMS Fatigue are 
associated with increasing seizure frequency at menstruation; increasing 
levels of Moos Behavior Change are associated with increasing seizure 
frequency at ovulation; and increasing levels of POMS Anger, Moos Pain, 
Moos Concentration, and Moos Control are associated with increasing 
seizure frequency at the high progesterone stage of the cycle. Lower 
levels of POMS Tension and Moos Autonomic Reactions are associated with 
increased seizure frequency both at ovulation and at the high progesterone 
stage of the cycle. 
If one would want to speculate about cause-and-effect relationships, 
a possible interpretation is that fatigue influences seizures at menstru-
ation; low estrogen levels influence seizures premenstrually; and an 
interaction of hormone balance and a variety of dysphoric mood states 
influence seizures at ovulation and at the high progesterone stage of 
the cycle. Inspection of absolute levels of progesterone versus seizure 
frequency suggests that high seizure frequency at menstruation is 
associated with low levels of progesterone. At the high progesterone 
stage of the cycle, high levels of progesterone combined with high levels 
of estrogen result in a higher seizure frequency. Another relationship 
at the high progesterone stage of the cycle may be a possible binding 
effect between Dilantin and progesterone, in which the anticonvulsant 
properties of Dilantin are weakened resulting in more seizures; and in 
155 
those subjects who experienced more anger, pain, and concentration 
difficulties, an association between increased negative mood and inct·eased 
seizures. 
Table 17 also sho~Js significant correlations between seizure 
frequency and the 21 inder)endent variables for anovulatory cycles. The 
only strong relationships are that POMS Fatigue at menstruation is 
positiv1~1y co~related with seizure frequency at menstruation, ~ = 0.778; 
Dilantin and progesterone are positiveiy correlated at menstruation, 
! = 0.774; POMS Fatigue at high progesterone is positively correlated 
with seizure frequency at high progesterone, ! = 0.890; and POMS Anger 
at high progesterone is positively correlated with seizure frequency at 
high progesterone, ~ = 0.678. 
f~edic!in~ Seiz~res at a Given Menstrual Cycle Stage by the Indep~~~~nt 
y_ariabl~_£-~ssodated With the Prior Stage 
The previous group of multiple regression analyses examined the 
relationship between seizure frequency at a given stage of the menstrual 
cycle and the collection of variables measured at the same stage of the 
cycle. ~Jhat if a seizure flurry is caused by or related to hormonal 
and mood changes that occur a few days prior to the seizure flurry? 
To help answer this ql.!estion, three more analyses were performed. The 
first analysis was a product-moment correlation coefficient between 
seizure frequency at menstruation and the group of 21 independent var-
iables measured at the premenstrual phase of the previous cycle, defined 
as no mo1·e than foul' days before menst1·uati on occurs. A multiple regres-
sion analysis could not be done on this data because there were only 17 
units of analysis. The unit of analysis was defined as the menstrual 
phase of the cycle for a given subject for whom data was also available 
166 
on the immediately preceding premenstrual phase. The correlation matr·ix 
for this data appears in Table 18, and the significant co-r·relations are 
summat·ized in Table 17. Seizures at the menstl~ual phase of the cycle are 
strongly positively correlated with several variables measured during 
the premenstrual phase of the immediately preceding cycle. The correla-
tions with seizures at menstruation are premenstrual POMS Depression, 
!: = 0. 632; POMS Anger, !. = 0. 542; POMS Fatigue, !: = 0. 569; PDr1S Tota 1 
T-Score, !: = 0.555; Moos Pain, £ = 0.835; Moos Concentration, !: = 0.648; 
Moos Behavior Change,!:= 0.826; Moos Autonomic Reactions,!:= 0.640; 
and Moos Negative Affect, !: = 0.681. If we make the assumption that a 
flurry of seizures is related to events occurring shortly before the 
f1urry, then the majority of negative mood states measured by the P0~1S 
and Moos scales predict a flurry of seizures at menstruation. In other 
words, the more negative mood states a subject experiences before 
menstruation begins, the greater the number of seizures she is likely to 
experience during menstruation. 
The second analysis was a multiple regression analysis which 
attempted to predict seizure frequency dt the high progesterone stage 
of the cycle by the 21 independent variables measured at the ovulation 
stage of the same cycle. The measurements taken at ovulation occurred 
on the average a week before measurements taken at high progesterone. 
A total of 47 units of analysis were included, representing both ovula-
tory and anovulatory cycles. Results for the last step of this regres-
sior. analysis appeat' in Table J9. For this analysis, B..2 = 0.516. 
Inspection of the standardized regression coefficients indicates that 
the following independent variables measured at ovulation are associated 
vrith seizur·e frequency at the high progesterone stage of the cycle, in 
Table 13 
Pca~son's Product-Mo~ent Correlation Coefficients Between the Cependent Variable Total Seizure Frequency Occurring at 
~lenstruation and the Independent Variables Measured at the Previous Premenses 
Vt~.riab1e OP.scription Dil anti n Estrogen Progesterone State POt·lS PONS POMS POMS PCMS Levels Levels Levels Anxiety Tension Depression Anger Vigor Fatigue 
Oil anti n Levels 1.000 -0.121 - 0.249 - 0.071 0.129 0.019 - 0.295 - 0.441 - 0.266 Estr·ogen Leve1s 
- 0. 121 1.000 0.041J - 0. 192 - 0.057 - 0.176 - 0.063 - 0.125 0.061 
P~ogesternne Levels 
- 0.249 0.040 1.000 - 0.132 - 0.203 - 0.307 - 0.139 0.532 - 0.032 Spielberger State Anxiety 
- 0.071 - 0.192 - a .1e~ 1.000 0.914 0.826 0.515 -·0.202 0.590 
P0,'1S Tr.;n s ion 0.129 - 0.057 - 0.203 0.914 1.000 0.847 0.503 - 0.292 0.587 
POi~S Depression 0.019 - 0.176 - 0.307 0.826 0.847 1.000 0.811 - 0.154 0.783 POt'<S Anger 
- 0.295 - 0.063 - 0.139 0. !ii5 0.503 0.811 1.000 0.265 o. 745 
PorE Vigor 
- 0.441 - 0.125 0.532 - 0.202 - 0.292 - 0.154 0.266 1.000 . ,. 0.183 POf•iS Fatigue 
- 0.266 0.061 - 0.032 0.590 0.587 0.783 0./45 0.188 l.OJO 
FC-ti Cori I' us ion 0.030 0.131 - 0.195 C.755 0.847 0.822 0.531 - 0.487 0.£'.35 POMS Total T-Score 0.032 0.004 - 0.320 0.805 0.862 0.933 0.695 - 0.413 0.866 !·~nos ?din 
-0.177 - 0.195 - 0.099 0.498 0.518 0.827 0.850 0.129 0. 758 Moos Concentration 
- 0.038 - 0.216 -0.193 0.791 0.816 0.922 0.672 - 0.216 0.801 
Mo0s Behavior Ch~nge 
- 0.154 - 0.027 0.017 1).305 0.327 0.648 0.661 - 0.042 0.800 Moos Autoncmic Reactions 0.196 - 0.?.73 - 0.246 0.~23 0.671 0.706 0.518 - 0.216 0.483 Moos Water Retention 
- 0.335 - 0.157 0.271 - 0.016 - 0.003 0.219 0.529 0.565 0.157 Moos fh~gJt ive Affect 
- 0.238 - 0.234 - 0.078 0.725 0.671 0.902 0.833 0.146 0. 779 f·1oos Control 
- 0.147 - 0.113 0.005 0. 728 0.659 0. 786 0. 757 0.296 0.579 
WSRE ~eig~ted Scores 
- 0.389 - 0.046 0.250 0.116 0.004 0.272 0.621 0.755 0.262 Seizure Frequency 0.019 - 0.301 - 0.317 0.236 0.309 0;632 0.542 
- 0.136 0.569 
Note. N = 17 cycles. 
PW.S 
Confusior. 
0.030 
0.181 
- 0.195 
0.765 
0.847 
0.822 
0.531 
- 0.~87 
0.835 
1.000 
0.954 
0.580 
0.849 
0. 542 
0.599 
- 0.033 
0.657 
0.544 
- 0.055 
0.421 
..... 
0'1 
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Table 18 (Continued} 
Pearson's Product-Moment Correlation Coefficients Between the Dependent Variable Total Seizure Frequency Occurring at 
Menstruation and the Independent Variables Measured at the Previous Pr~m~nses 
Vari~b1e Description P01·1S Moos Moos Moos ~loos ~loos Mot~s Moos WSRE 
Total Pain Concentration Behavior Autonomic \~a ter Negative Control Weighted 
T-Score Change Reactions Retention Affect Scores 
Dilantin levels 0.032 
- 0.177 - 0.038 - 0.154 0.196 - 0.335 - 0.238 ·- 0.147 - 0.389 
Es troger. Leve 1 s 0.004 - 0.195 - 0.216 - 0.027 - 0.273 - 0.157 - 0.234 - 0.113 - 0.045 
Progesterone levels 
- 0.320 - 0.099 - 0.193 0.017 - 0.246 0.271 - 0.078 0.005 0.250 
Spielberger State Anxiety 0.805 0.498 0.791 0.305 0.523 - 0.016 0.725 o. 728 0.115 
P0r1S Terrs ion 0.862 0.518 0.816 0.327 0.671 - 0.003 0.671 0.659 0.004 
POr·1S Depression 0.933 0.827 0.922 O.ti48 0.706 0.2]9 0.902 0.786 0.272 
Pm·1S 1\nger 0.695 0.850 0.672 0.661 0.518 0.529 0.833 0.757 0.621 
?Oi•1S Vioor 
- 0.413 0.129 - 0.?.16 - 0.042 - 0.216 0.565 0.146 0.296 0.755 PO~lS Fatigue 0.866 0.758 0.801 0.800 0.483 0.157 0. 779 0.579 0.262 
POt·lS Confusion 0.954 0.580 0.849 0.542 0.599 - 0.033 0.6~7 0.544 - 0.065 
P01·1S Total T-Score 1.00!) 0. 713 0.901 0.632 0.680 0.053 0.772 0.629 0.054 
Moos PJin 0. 713 1.000 0.812 0.833 0.743 0.553 0.915 0. 714 0.494 
!·loos Concerrtra t ion 0.901 0.812 1.000 0.636 0.748 0.191 0.886 0. 725 0.139 
Moos B8havior Change 0.632 0.833 0.636 1.000 0.451 0.293 0.758 0 .48] 0.376 
Moos Autonomic Reactions 0.680 0.743 0.748 0.451 1.000 0.425 0.622 0.499 0.054 
Moos Wdter Retention 0.053 0.553 0.191 0.293 0.425 1.000 0.422 0.459 0.684 
Moos Negative Affect 0. 772 0.915 0.886 0.758 0.622 0.422 1.000 0.879 0.545 
f4L•os Control 0.6(9 0. 714 0.725 0.481 0.499 0.459 0.879 1.000 0.680 
WSRE Weighted Scores 0.054 0.494 0.139 0.376 0.054 0.684 0.545 0.680 1.000 
Seizure Frequency 0.555 0.835 0.648 0.826 0.040 0.305 0.681 0.315 0.165 
Note. N = 17 cycles. 
Seizu!'f! 
Frequency 
0.019 
- 0.301 
- 0.317 
0.236 
0.309 
0.632 
0.542 
- 0.136 
0.569 
0.421 
0.555 
0.!.135 
0.648 
0.325 
0.640 
0.305 
0.681 
0.315 
0.165 
1.000 
...... 
0'1 
co 
Table 19 
Multiple Regression Analysis to Predict the Dependent Variable Total Seizure Frequency Occurring at High Progesterone 
frvM the Group of Independent Variables ~leasured at the Previous Ovulation (!! = 47) 
Variable Description 
Moos Pa1n at Ovulation 
Spieiberger State Anxiety at Ovulation 
MoO$ Behavior Change at Ovulation 
WSRE Weighted Scores at Ovulat~on 
Moos Concentr~tion at Ovulation 
Moos Water Retention at Ovulation 
~oo~ Autonomic Reactions at Ovulation 
POMS Viner at Ovulation Di1anti~ at Ovulation 
Regression Constant 
Regression 
Coefficient 
0.5111 
- 0.8130 
2.4733 
- 0.0110 
1.0585 
- 1.1132 
- 1. 3966 
0.1358 
- 0.0973 
28.372 
Str:!. Error of 
Coefficient 
0.337 
0.195 
0.903 
0.017 
0.394 
0.507 
0.684 
0.112 
0.124 
Sta:'ldardized Unique 
Coefficient t-Test df Variance 
0.336 1.52 37 .030 
- 1. 137 - 4. ~.6 37 .227 
0.717 2.74 37 .098 
- 0.283 - 1.87 37 .046 
0.700 2.68 37 .094 
- 0.345 - 2.19 37 .063 
.. 0. 333 
- 2.04 37 .055 
- 0.173 
- 1.21 37 .019 
- 0.097 - 0.78 37 .008 
Multiple Correlation Squared = 0.515 
Multiple Correlation • 0.718 
F = 4. 38 w1 th 9. and 37 Degrees of Freedom (p_ • .001) 
Standard Deviation of Residuals = 7.0~0 
Partial Correlations with Dependent Variable for Variab1es Not Entered 
Estrogen at Ovulation 
Progesterone at Ovulation 
PO:~s Tension at Ovulation 
POMS Depression at Ovulation 
POt·1S f,nger at Ovulation 
POMS Fatigue at Ovulation 
POMS Confusion at Ovulation 
PONS Total T-Score at Ovulation 
Moos Negative Affect at Ovulation 
Moos Contro1 at Ovulation 
- 0.068 
- 0.017 
0.114 
- 0.057 
0.032 
0.045 
- 0.085 
0.056 
0.034 
- 0.062 
Stepping stopped -- iast step increased r2 by les~ than 0.010. 
~ .... 
C1\ 
1.0 
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order of their ·relative predictive power: Spielberger State Anxiety, 
1 (37) = - 4.16, unique variance= .030; Moos Behavior Change, 1 (37) = 
2.74, unique variance = .098; Moos Concentration, 1 (37) = 2.68, unique 
variance = .094; Moos Water Retention, 1 (37) = - 2.19, unique variance = 
.063; and Moos Autonomic Reactions,! (37) = - 2.04, unique variance = 
.055. Only Moos Behavior Change and Concentration difficulties at 
ovulation are positively corre·lated with seizures at the high progester-
one stage of the cycle. 
The third of this group of analyses was a final multiple regression 
analysis which attempted to predict premenstrua 1 seizure ft~equency from 
the 21 independent variables measured at the high progesterone phase of 
the same cycle. The measurements taken at the high progesterone phase 
of the cycle occurred an average of five days before measurements taken 
premenstrually. A total of 47 units of analysis were included. Results 
for the last step of this regression analysis appear in Table 20. For 
this ana·lysis, R2 = 0.764. The follmling independent variables measured 
at the :1i gh progesterone stage of the cycle are associ a ted with premen-
strual seizure frequency, in order of their relative pt~edictive po\'Jer: 
POMS Fatigue, ! (32) = 3.52, unique variance = .092; progesterone, 
! (32) = 2.75, unique variance = .056; estrogen,! (32) = 3.44, unique 
variance - .087; Moos Pain, ! (32) = - 2.98, unique variance = .065; 
Moos Behavior Change, t (32) = 2.51, unique variance = .047; and Moos 
. --
Negative Affect, ! (32) = - 2.25t unique variance = .037. In this instance, 
lower levels of progesterone and higher levels of estrogen at the high 
progesterone stage of the cycle are related to increased premenstrual 
seizures. 
Jf the assumption is valid that seizure flurries are caused by 
prior events, so that a time lag exists between a precipitating event and 
Table 20 
Multiple Regression Analysis to Predict the Dependent Variable Tota1 Seizure Frequency Occurring at Premenses 
from the Group of Independent Var1able5 Measured at the Previous High Progesterone (~ • 47) 
Regression Std. Error of Standardized Unique Vcriab1~ Description Coeff1 ci ent Coefficient Coefficient .!.-Test c!f Variance 
POt-IS Fatigue at High Progesterone 0.1924 0.055 0.512 3.52 32 .092 
POMS Tension at High Progesterone 
- 0.1462 0.127 - 0.3:>7 ~ 1.15 32 .010 
Progesterone at High Progesterone 
- 0.0492 0.018 - 0.310 ~ 2.75 32 .056 
POMS Total T-Score at High-Progesterone 0.0408 0.034 0.500 1. 21 32 .011 
E~.trogen at High Progesterone 0.0100 0,003 0.389 3.44 32 .037 
State Anxiety at High Progesterone 
- 0.0826 0.051 - 0.326 
- 1.62 32 .019 
Moos Pain at High Progesterone 
- 0.3340 0.112 - 0.521 - 2.98 32 .065 
Noos Water Retention at High Progesterone 0.1585 C.lJl 0.149 1. 21 32 .011 
!~oc~s Concc11tration at High ?rogesterone 0.1862 0.120 0.341 1.55 32 .018 
!-laos Behavior· Change at High Progesterone 0.4124 0.180 0.561 2.51 32 .047 
Moos Ne~ative Affect at High Progesterone 
- 0.2107 0.094 
- 0.600 - 2.25 32 .037 
1•ioos .ll.utonomic Reactions at High Progesterone 0.5037 0.255 0.304 1.97 32 .029 
P~IS Confusion at High Progesterone 
- 0.1815 O.C97 - 0.429 
- 1.87 32 .026 
PC:·iS Anger ilt Hi CJh Progesterone 0.0508 0.05•S 0.166 0.93 32 .006 
Regression Constant 
- 2.565 
~ultiple Correlation Squared 
Multiple Correlation = 
0.764 
0.874 
1.369 
F • 7.38 with 14 and 32 Degrees of Freedom (£under .001) 
Standard Deviation of Residuals 
Partial Correlations with Dependent Variables for Variables Not Entered 
D11antin at High Progesterone 0.049 
PQ~!S Depre-;5ion at High Progestero11e - 0.074 
POMS Vigor at High Progesterone - 0.074 
Moo~ Control at High Progesterone ~ 0.007 
WSRE Weighted Scores at High Progesterone - 0.135 
Stepping stopped -- last step increased r..2 by less than 0.010. 
..... 
'i 
..... 
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the seizures, then a variety of previously existing dysphoric mood states 
would seem to be related to seizures that occur at menstruation and at 
the high progesterone phase of the cycle. Notably, estrogen and proges-
terone levels were not found to be related to seizures at menstruation 
and at high progesterone in this last set of analyses. However', lm·:er 
levels of progesterone and higher levels of estrogen, as well as in-
creased fatigue and behavior change at the high progesterone stage of 
the cycle are related to premenstrual seizures. 
Conclusions and Discussion 
This study obtained detailed infor1 mation about the circumstances 
surrounding epileptic seizures by studying frequency of seizure occurrence 
in relation to stage of the menstrual cycle; frequency of seizure 
occurrence in relation to changes in estrogen and progesterone levels 
during the different stages of the menstrual cycle; and changes in 
emotional states and stressful life experiences with respect to stage 
of the menstrual cycle. 
The main findings were: 
1. Seizure frequency peaks at menstruation for epileptic women. 
Seizures occur at menstruation more frequently than they do at any 
other stage of the merstrual cycle. 
2. Seizures increase fo.llowing_ a period of stressful life events 
independently of st3.ge of the menstrual cycle, as measured by the Life 
Events Diary; but no significant dif·~erences in any of the standardized 
mood measures were found from one stage of the menstrual cycle to the 
next. 
3. Measurement of hcrmonal 1evels at different stages of the men-
strual cycle allowed us to distingt.dsh a group of ovulatory cycles from 
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an unexpectedly large number of anovulatory cycles. At all stages of the 
menstrual cycle, seizure frequency was much greater for anovulatory 
cycles than for ovulatory cycles. 
4. Seizures were most common when progesterone levels were lowest. 
5. We found that an increase in seizure frequency occurred in 
association with a fall in progesterone levels. 
One of the most striking findings of this study was that thirty 
percent of all the menstrual cycles of the epileptic sample were 
anovulatory or showed inadequate luteal production, and sixty percent of 
the subjects had at least one anovulatory cycle. In addition, seizure 
frequency during anovulatory cycles was twice as high as during ovulatory 
cycles. Furthermore, during anovulatory cycles the subjects experienced 
more overall life stress than during ovulatory cycles. I propose the 
following mechanisms to explain these findings: 
1. Psychological or physical stress results in increased activity 
of the adrenal glands. While the adrenal gland does not secrete 
appreciable amounts of estrogen into the circulation under non-stressful 
circumstances, its normal function does contribute to the total circulating 
levels of estrogen. This is accomplished by the extragonadal peripheral 
conversion of C-19 androgenic precursors, such as androstenedione, to 
estrogens. In this manner, psychological or physical stress may increase 
the adrenal contribution of estrogenic precursor, and subsequent conver-
sion to estrogen may sustain the blood level of estrogen at a time when 
a decline is necessary for successful recycling of the menstrual system 
including a high production of progesterone. Anovulatory cycles will 
result. 
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2. This study suggests that progesterone protects against 
seizures. Anovulatory cycles are by definition deficient in progesterone. 
When anovulatory cycles are caused by stress, the extragonadal estrogen 
produced by the adrena1s blocks the normal drop in estrogen levels 
nec~ssar.y for the pr·oduction of pr·ngesterone and the nor·mal recycling of 
the menstrual system. Greater reported stress would therefore result 
in a larger number of anovulatory cycles for the epileptic women in this 
study, and a larget' number of seizures during these anovulatory cycles 
when progesterone is virtually absent. Also, since high estrogen levels 
are associated with an increased frequency of seizures among epileptic 
women, one could expect a higher incidence of seizw~es in anovulatory 
cycles than in ovulatory cycles where the protective effect of proges-
terone is present. 
3. Therefore, if stress produces anovulatory cycles which are 
characterized by high levels of estrogen and low levels of progestel·one, 
and if high levels of estrogen and low levels of progesterone produce 
seizures (because the normal protective effect of progesterone during 
the luteal phase of ovulatory cycles is removed), then high levels of 
stress should be associated with a high frequency of seizures. 
4. The basic mechanism therefore is: increased stress leads to 
increased adrenal production of extragonadal estrogen; increased adrenal 
production of extragonadal estrogen leads to anovulatory cycles; and 
anovulatory cycles are deficient in p;·oges tercne and have an excess of 
estrogen, vJhi ch 1 eads to increased sei zurc: frequency. Jl.novul a tory cyc1 es 
should therefore be associ a ted \'Jith i nct·eased seizure frequency, and by 
this mechanism increased seizure frequency should be highly correlated 
with emotional distress. 
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In this study, no changes in mood across the four defined stages of 
the menstrual cyc1e \'Jere found vJhen the scores of the subjects were 
averaged. If individual patterns of mood changes were examined with a 
large enough sample size in a future study, however, two main groups 
might hypothetically be identified: women who have the highest number of 
menstrual seizures may also have a significant. m.:>od change between 
menstruation and the other stages of the cycle; while women \·Jho have the 
fewest seizures may not have any mood changes at all between menstruation 
and the other stages of the cycle. In the present study, all subjects 
had more seizures at menstruation than at any other stage of the cycle. 
Future studies might reveal two distinct groups: women who seize primar-
ily at menstruation and women who seize irregularly. Questions for such 
future studies might be: Are there differences in the incidence of 
complaints of physical discomfort and psychological stress between women 
who seize at menstruation as opposed to those who seize irregularly? Do 
women who complain of the most physical discomfort and psychological 
stress during menstruation also tend to report more seizures? 
Analysis of mood changes and changes in stressful life events 
before seizures as opposed to changes after seizures for each subject 
would be very useful in the clinical management of individual cases. 
Such an analysis would ~elp women become aware of what situations in 
their particular case predispose to or precipitate seizures. 
An important result of this study was that according to the analysis 
of the Life Events Diary scores, epileptic women do have changes in mood 
that are not related in a systematic way to the stage of the menstrual 
cycle, but which do predict seizures. Specifically, changes in mood 
as measured by stressful life events and a woman's reaction to them, 
176 
which are independent of changes in the stage of the menstrual cycle, 
do predict seizures. Also, analysis of the Life Events Diary scores 
shows that epileptic women have more negative stressful life events 
prior to a seizure flurry. The Life Events Diary has the capability of 
measuring extremely positive life events as wel"l as extremely negative 
life events, and the relationship that was shown was between negative 
life events and seizure flurries. An important future project would be 
to do a qualitative analysis of the Life Events Diary and to look fer 
those specific events that the epileptic women indicated were highly 
pleasant or highly unpleasant, and particularly those events that preceded 
seizures. This information could be used to construct a new questionnaire 
having a standardized item content. Using such a questionnaire, a 
~loman could indicate on a day by day basis which types of life events 
happened to her, rate those life events, and simultaneously keep an 
independent record of her seizures. 
A limitation of the present study is the smE•ll sample size. l\ 
bettei' future study might follov; larg~r gl'OU;JS of patients and make 
comparisons between pat·i ents \'lith different types of seizures. Si nee 
this study was a prospective study of affective and seizure f"luctuations 
during the menstrual cycle, the sample size was smail of necessity and 
consequently the sample is more likely to be biased. This type of 
investigation requires highly motivated and cooperative women. The 
subjects in this study were motivated to participate because they 
experienced a significant number of seizures despite optimal therapeutic 
doses of their regular anticonvulsant medication. Many epileptics are 
completely controlled on their anticonvulsant medication, so this 
sample cannot be considered to be representative of all epileptic women. 
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The validity of self-report as a tool to reflect the symptoms 
accompanying the menstrual cycle can be questioned. In this study, my 
objectives needed to be revealed to the subjects to some extent in order 
to elicit their cooperation throughout the course of a lengthy study. 
The subjects were told that I was investigating whether seizures occurred 
at a particular time during their menstrual cycle, with the exact time 
that more seizures were expected to occur being left unspecified. The 
subjects 1tlere also told that depending on the type of seizure pattern 
they had during their menstrual cycles, additional medication would be 
offered that might help control their seizures better. The pattern that 
was expected was not specified in detail until the study was over and 
some women were offered the medication {oral Provera). 
Fluctuations in steroid hormones must be assessed during the 
menstrual cycle in order to correlate any changes in behavior patterns 
with the variations in levels of ovarian and pituitary hormones. This 
was done in this study, and led to the identification of a significant 
number of anov•.;lato!"y cycles in wh·kh seizure frequency was double that 
of ovulatory cycles. 
Future studies in this area may be more useful in elucidating the 
hormonal and life stress eticlogy of epilept·ic se1z11res if they meet 
the following criteria: experimental studies designed for subjects to 
keep an accu,·ate reco;~d of seizures as they occur each day; adequate 
definition and measurement of subj,~ctive changes; deter·mination of 
each woman's pattern over several cycles; correlation of affective 
changes with day by day plasma levels of endogenous hormones; and 
double-blind investigations of subsequent hypotheses. 
A final disclaimer needs to be made about the results of the 
multiple regression analyses. Since the multiple regression approach 
mathematically maximizes the amount of variability in the dependent 
variable which is accounted for by taking advantage of both sample 
specific and population variation, considerable shrinkage, i.e., 
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decrease in variance accounted for, would be expected on cross validation. 
Furthermore, the strength of any particular predictor can vary consider-
ably so that the relative importance of predictors may vary quite a bit. 
The design of this study is essentially a correlational design 
because seizure frequency and progesterone level were not manipulated by 
the experimenter as true independent variables. Therefore, results of 
these analyses cannot be interpreted in cause-and-effect terms. 
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APPUi~IX 
~en~trual Distress Questionnaire 
Form A. 
Name Marital Status 
--------· 
Age Uumber of Children ------
lcday's Date Occup;. t I on 
Write the approximate dates of your li'tOSt recent menstrual period (flO\-!) ir. the 
space marked "A" below. Then writ:e the dates of the menstrual period which 
preceded the most recent one in the space marked "D". 
fro!:l 
to 
other times during 
most recent cycle 
c 
week before most 
recent flo.,.,. 
s 
most recent flo.,.; 
from 
to 
A 
On the next t\-.'0 pages is a list of symptoms which ...,"Omen sometimes exoc:-ience. 
Please describe your experience of each of these symptoms during the thtee 
different time periods 1 isted below: 
Col. 1 
Col. 2 
Col. 3 
durinCJ your most recent menstrual flow (the dates del ineate.c! 
by area A on the diagram above), 
durinq the one week before your most recent menstrual flow 
(area"s on the diagra~). 
during the remainder oi your most recent menstrual cycle 
(area c). 
Note: The answers you put In columns t, 2, and 3 should be accurate for 
your.- experience specifically durinq your most recent menstrual eye!.:;. 
Please do not simply report your general exoerience. Also, please report 
any experience of these sy:npto!Tls v1hether or not they see!Tl to you to be 
related to your menstru3l cycle. 
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For each answer chcose the descriptive category listed which bL.t describes your 
experience of th~t symptc.)m during that tiMe. 'w'rite the number of that 
description in t~e 5pace provided. Even if none of the descriptions arc 
exactly correct, c:Kose the one that best describes your experience. Do 
not leave any blank spaces. 
~e~criptive Categories 
1 .. no exvP.dencc of symptom 
2 " barely r.cticeable 
4 - present, moderate 
5 - present, strong 
) -present, mild 6- acute 01 partially dlsdbling 
1. 2. 3. 
most week re~ainder 
recent before of cycle 
------------~fl~o_w~(A.~) ______ (B) _______ (~C) 
1. \le~ght garn ••••••••••••••••••••••••••••••••• 
2. I nsom11 i a, ...................................... . 
3. Crying .••••••••••••••••••••••••••••••••••••• 
lj. Lowered schooi or work performance •••••••••• 
$. Huscle stiffness •••••••••••••••••••••••••••• 
6. Forgetfulness ••••••••••• ~ ••••••••••••••••••• 
7. Confusion ... e••····~························ 
6. lake naps or stay in bed ••••••••••••••• ." •.•• 
9. Headache •••••••••••••••••••••••••••••••••••• 
10. Skin disorders ••••••.••••••••••••••••••••••• 
11 • lone 1 i ness •••••••••••••••••••••••••••••••••• 
12. Feelings of suffocation ••••••••••••••••••••• 
13. Affectionate .••••••••••••••••••••••••••••••• 
1~. Orderliness •••••.••••••••••••••••••••••••••• 
15. Stay home from work or school •••••••••••••.• 
16. Cramps (uterine or pelvic) •••.••••••.••••••• 
17. Dizziness or faintness •••••••••.••••.••••••• 
13.. E,.~citcment ... ................................ .. 
19. Chest pains ••••••••••••••••••••••••••••••••• 
20. Avoid soclal activlties .•••••••••••••••••••• 
21. Anxiety .............. ~·················· ..... ... 
22. Backache ••.•••.••••••••••••••••••••••••••••• 
23. Cold swe.ats ••••••••••••••••••••••••••••••••• 
-·--
·~---------·---· 
24. l0\-1cred juCgr,1ent ............................. . 
25. fatigue .. ~·································· 
26. Naus2a o; vom1tlng .••••.••.••••••••••••••••• 
27. Restles5ness~ .. ...............•.......•••••• 
28. Hot flashe~ ......................• . · ••.•..••• 
29. Difficulty In concentration •.••••••••••••••• 
]0. Painful or tender breasts .••..•••••••••••••• 
31. Feelings of we.11-being •••••••••••••••••••••• 
32. Buzzing or ringing in ears ••.••••••••••••••• 
33. Olstractable •••..••.•••••••••••••••••••••••• 
34. Swelling {e:g. abdomen, breasts or ankles) •• 
35. Accidents (e.g. cut finger, break dish) ••••• 
36. Irritability ••.•• ~·························· 
37. General aches and pains ••••••••••••••••••••• 
38. Hood swings .••••••••.••••••••••••••••••••••• 
39. Heart pounding •.•.•••••••••••••••••••••••••• 
Jj(j, Depression (feeling sad or blue) ••.••••••••• 
41. Decreased efficiency .•••.••••••••••••••••••• 
42. lowered motor coordination •••.•••••••••••••• 
-3. Nu~bness or tingling in hands or feet ••••••• 
44. Change in eatlng habits ••••••••••••••••••••• 
.liS. Tens ion •....•.•••••••••••••••••••••••••••••• 
46. Blind spots or fuzzy vision •..••.••••.•.•••• 
47. Bursts of energy or activity .••••••.••.••••• 
·-·-·-------------
1. 
most 
recent 
flow (A) 
2. 
week 
before 
(B) 
lrt what ways, If any, \"las your most recent menstrual cycle unusual? 
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3. 
remainder 
of cycle 
(C) 
Today's Oate 
---
MENSTRUAL DISTRESS QUESTIONNAIKt 
form T 
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On the next two pages Is a list of symptoms which ~<IOmen sometirn.es experience. 
For each symptom choose the descriptive catcqor·y listed below which best describes 
your experience~of that symptom today. Circle the number of the category which 
best describes your ex;:Jerience ot tne symptorr-;-today-.-Even If none cf thecate-
gories Is exactly ::orrect, choose the one thatom de:Scribes your experience. 
Please be sure to circle one number for each symptom. Please dlso remember to 
put your n~me and the date In the blank spaces at the top of this page. 
Oescrlptive Cateoories 
1. No reaction at all 
2. Bare1y noticeable 
3. Present, mild 
------·-·------
1. We!ght ga1n •••••••••• ••••••••••••••••• 
2. Insomnia .....•.•...•..•••.•.•••.••.... 
3. Crying ......••.....•...••..•..•••...•• 
4. lowered school or work performance •••• 
5. ~luscle stIffness •••••••••••••••••••••• 
6. Forgetfulness ••••••••••••••••••••••••• 
7. Confusion ..•...••.•••..••.•••••.••••.. 
8. Take naps or stay In bed •••••••••••••• 
9. Headache ....••••••.••••••••••••••••••• 
tO. Skin disorders •••••••••••••••••••••••• 
11. loneliness •••••••••••••••••••••••••••• 
12. Feelings of suffocation ••••••••••••••• 
13. Affectionate .••••••••••••••••••••••••• 
1~. Orderliness ..•••••••..•••••••••••••••• 
15. Stay home from work or school ••••••••• 
16. Cramps (uterine or pelvic) •••••••••••• 
17. Dizziness or f~intness •••••••••••••••• 
13. Er..c I temerat •••••••••••••••••••••••••• •, 
1 9. C. he s t P<l I n s ••••••••••••••••••••••••••• 
4. Present, moderate 
5. Present, strong 
6. Acute or partially disabl in~ 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 .. 
2 
2 
2 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
s 
5 
s 
5 
6 
6 
6 
6 
6 
6 
E 
6 
(, 
6 
6 
6 
6 
6 
6 
• 
No B~re1y HJid 
reaction noticeable 
20. Avo!d so~lal actlvJtles .•••••••••••••• 1 2 
21 ... P..nx t e t· •t • •• o ........... " ......... , ••••••••••• 
22. !:\ar.k<~che .••••••••••••••••••••••••••••• 
23. Co} d s wei: t s .... *' r ••••• ~ •••••• ~ ..... '* •••• 
2:~. l<)4i'l\"!red Judgment ...................... . 
25. Fat:gtJe ••.••• ~Q ....................... . 
26. Nausea or vo:nlt!ng •••••••••••••••••••• 
27. Restlessness •.•.••• c ••••••• ~ •••••••••• 
28. Hot flastles ••• ~······················· 
Z9. Clfficulty In concentration ••••••••••• 
30. Painful or tender brea~ts ••••••••••••• 
31. Feelings of well-being •••••••••••••••• 
32. Duzzing or ringing in ears •••••••••••• 
33. Cistractdble •.•.•••••••••••••••••••••• 
3~. Swelling (e.g. abdomen, breasts, ankle)l 
35. Accidents (e.g. cut finger, break dlsh)l 
)6. lrritabil~ty ........... r••••••••••••••• 
37. General aches and pains •••.••••••••••• 
38. t\ocd S\"tngs ............................ . 
39. ~icart pouna1n~·····•••·••••••••••••••• 
~0. !'C!'res:;ion (feeling sad or blue) •••••• 
41. Uecrea~~d efficiency .••••••••••••••••• 
42. lm-!<Ored motor cood lnc:t io'l •••••••••••• 
~3. Numbness or tingling In hands or fe~t. 
~~. Change in eating habits ••••••••••••••• 
ItS. Tensior •••••••••••••••••••••••••••••••• 
~6. Blinu soots or fuzzy vision ••••••••••• 
47. t~rsts or t"ergy or activity .••••••••• 
2 
2 
2 
2. 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
... 
.. 
.. 2 
2 
2 
2 
2 
3 
; 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
HoderateStrong 
lt 5 
5 
s 
s 
5 
5 
s 
5 
5 
5 
s 
5 
5 
5 
5 
s 
5 
5 
5 
5 
.5 
5 
5 
s 
s 
s 
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Acute 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
T 
0 
A 
v 
Below is a list of words that dt'scribc feel inns pcop!o:: have. Pie"se 
read each one care!uiiy. !"hen fiil 1:1 ONE spa-::c unacr tr,o answer to 
the right whic.h best describe.; HOW YOU HAVE r,F.:EN FEELII\iG OUR· 
lNG THE PAST WEEK INCLUDi~-JG TODAY. 
The numbers refer 
to these phrases. 
O=Nct at all 
1 ""A little 
2- Moderately 
3-Qu!te a bit 
4 • Extremely 
21. Hopeless . 
24. Spiteful 
~ ?t ~ 
u ~~ 
9 ), ~ ~ 
~ u u u 
0 1 ~ ~ 4 
. ;l d 
45. Desperate 
46 Sluggish . 
47. Rebellious 
48. Helpless 
. - 211 
-· 
.... 
c ... 
~ ~ 0 ::; 
z. < 
~ 
'J IJ u 
0 I. 2 3 • 
0 I 2 3 4 
1. Friendly 
2. Tense 
c " il 25. Sympathetic 49. Weary .. I 
f: ~ U 4 26. Uneasy ~ G 50. Bewildered 0 '· 2 3 ~ 1 
~---------------------~0~~~2~3-.~~~-----·---------------·~?~.~~~~J~~~--+------------·------------~O~t~·z-3~1 
3. Angry ~ il 27. Res!less J u ;; u 51. Alert ~ , , 
0 I 2 3 
4. Womout 28. Unable to concentrate · . 'i 52. Deceived . 
5. Unhappy . 
~ I 2 3 4 
ti ~ J 29. Fatigued 53. Furious 0 I 2 ~ 4 
6. Clear-headed 
0 ~ ~ c 
_ J 30. Helpful 2 3 4 . n n 54. Efficient 
~--------------------~0~~!.~2~3·~.-------------·-----------~o~,~, ~f~,~-~.·--l-------------------------~o~I~2~J~~,• 
7. Lively j u J 31. Annc>yed . ~ 0 U 55. Trusting . ~ J ., t• 
8. Confused . 
9. Sorry for things done 
.J :.. 
10. Shaky 
0 1. 2 3 4 
H. Listless 
C! ' ~ 4 
32. Discouraged 
-·-----------:0:-. -:~:-. 2 ~ 4 
33. Resentful . J ,, 
34. Nervo•Js 
35. Lo11ely ~ .\ 2 ,, u 
56. Full of pep 
ls7. Sad-ternf:·ered 0 I 2 3 4 
58. Worthless 
] . 
59. Forgetful 
'• 36. Miscrr..ble F 12. Peeved 60. Carefr.::e 
~ ~ z 3 4 
'i l_i 
t----------- ----,--.,.-rl--4- -
13. Considerate 
14. Sad. 
c 15. Active 
16. On edge 
" " 37. Muddle-d 
0 
fl 
~ J, 4 
Q I 2 l 4 
38. Chee;lul 
39. Bitter 
0 ~; i 3 4 
IJ J :1 61. Terrified 
62. Guilty 
6.3. Vigorous . 
0 I 
z 3 ·' I 
'.i :.: 
0 I 2 3 4 
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POMS PROHlE SHEET 
FEMALe (Of') 
Name:------
---------·---- Oa~;-----------------·-------
Ff,CTOR 
~:____ :~~~----... ::_!~-~::--+-2 r T Vig Fat Con Sc:ore 8-2··--···· ~ ......... ·----··8·-· ---·-··--·-··--·· -----ao+ 
79 
78 47 27 78 
77 1.6 26 77 
76 45 76 
75 44 25 75 
74 4:?-3 74 
73 41 24 73 
72 40 23 28 72 
71 39 71 
70.-·-··· ·······-------·--- ····-----.£0 ......... ···········38-···-·· ...... . --22·-···-- ···-·--· .. -----· ···-·- 27----·-· -----70 
69 5&9 37 21 26 69 
~ 5&7 ~ 28 68 
67 36 55 :~4-5 20 27 25 57 
66 35 &3·4 33 19 26 24 66 
65 34 52 32 25 65 
64 33 50-1 3i 18 23 54 
63 32 48-9 30 24 22 63 
62 31 47 29 
61 30 45-s 21-s 1 
~---- --- ~:-·--- ··-·-:ir------ ----------~~-------r--··· 
17 23 62 
16 22 21 61 
--------¥-· -------;~---·-···,···-··-20.·-····- ·-·----60 I 
15 5~ 
14 19 58 
57 27 39 23 19 18 57 
56 25 37-8 22 13 18 56 
55 25 36 21 17 17 55 
54 24 34-5 19-0 12 16 16 54 
53 23 32-3 18 j 1 53 
52 22 31 17 15 15 52 
51 29-C 16 
so -21 28 --1GT9 13 .....__50 
49 20 2&7 t4 12 13 49 
43 19 24-5 13 8 11 12 48 
47 18 23 11-2 47 
10 14 14 51 i 
46 17 21-2 10 7 10 11 46 
45 16 20 9 6 9 10 45 
44 15 18-9 8 8 44 
43 17 7 5 7 9 43 
42 14 15-6 6 4 6 8 42 
41 13 1:54 5 I 41 
40------ ----··12····--· ···-··---12---- .l.---·····3 4---··-·········--3···-·-·· ····--5--- ··-··-··1·-··-- ---40 
Js 11 10-1 · I 2 4 6 39 
3a to s 1 1 2 3 3s 
37 9 7-!s I o 1 2 s 37 
36 8 s-e 4 36 
35 7 "' I o 1 35 
34 2-:S 0 3 34 ~----~-1-i--~--1---- ··-·--·-r-·---t----~----~ I rs=--~--==~J~I -=-=- I ~~=---- ·-~-=~-l __ -l-- TS-::ore i
1 flaw S.:ore ---- ------ I ----·- , ___ I ___ ---- Raw Score 
_____ j__~~------l- D(.'p __ .J_~~-_j Vig ! Fat --- Cnt_l ______ _j 
& COI'liciG!iT \e 1,;}1 by EOUCATIGf-JA~. & INOL'S\HIAL TESTING SEAVICE, SAN DIEGO. CALIH.l'-!~~~.1\ '}2,07 w f'OM 040 ~C:I'ROOUCTIO"J OF I HIS FORM r'Y ANY MEAI>S STAICTL Y l' ROHI£\ITtO 
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SCHLDUl.E OF RECENT F.XPERIENCE (SRE) 
Part A (Items 1 through 12) 
Jnst_tuc tions 
For e.ach life event i.tena listed belc,w please do the following: 
Think back on the event and decide if it happened to you and when it happened. 
If the event did h~ppcn, place a check mark in the appropriate time period to 
the right. The column-> are as follows: 
fj'i;![IJJff'~_ 0 to 6 months ~~ 6 months to 1 year ago 1 to 2 vears agq 2 to 3 yf!ar-s ~co 
If the event in question did not happen to you in any of th~ time periods, check 
und;?r "Does not apply." 
/'A=>f' 0-6 6 mo- 1-2 2-3 Does 
weei(.. mo 1 yr yrs yrs not 
-----..!.&£_ ~ 2R2_ -~ i!ER!Y 
1. A lot more or a lot less trouble with the 
boss. 
2. A major change in sleeping habits (sleeping 
a lot more or a lot less, or change in part 
.of day when asleep). 
3. 
4. 
5. 
6. 
7. 
A major change in eating habits (a lot more 
or a lot less food intake, or very different 
meal hours or surroundin,gs). 
A revision of personal habits (dress, manners, 
associations, etc.). 
A major change in your usual type and/or 
amount of recreation. 
A major change in your social activities 
(e.g., clubs, dancing, movies, visiting, 
etc.). 
---------
----
A major change in church activities (e. g •• a 
lot more ot· a lot less than usual). _ 
8. A major change i.n number of family-~et­
tor,ethers (e.g., a lot more or a lot less 
than usual}. 
9. A major change in financial state (e.g., a 
lot wors~ off or a lot better off tha~ 
usual). 
-----
10. In-law troubles. 
------
lJ. 
~..:rf" 
~~~ll-
--
A 111aj .. n change in the r.umber of arguments l.'ith 
spouse (e.g., either a lot more or a lot less 
than usual regardin~ child-rearing, personal 
h;.bits, etc.). 
--
0-6 
1110 
...!££... 
12. Sexual difficulties. 
----
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6 mo- 1·· 7. 2-3 Does 
1 yr yrs yrs not 
_J!g.Q_ _!!.~ ..J!.gQ_ a!lply_ 
--------------------------------------------------------------------
Part Uitems 13 through 42) 
This part is similar to Part A, except that you are now asked to indicate the 
!!_':Imber of t:!-_~ that an event happened in each of the appropriate time periods. 
----- -- .. ----------· 
ft'.-Jf' 
IP~ 
-
13. Major personal injury or illness. 
14. Death of a close family m.;mber (other than 
f'pO':.IS<!). 
1~. neath or spouse. 
16. Death of a close friecd. 
0-6 
mo 
2.&-CL. 
----
17. Gaining a nev family member (e.g., through 
birth. adoption, oldster moving in, etc.) ____ 
18. Major change in the health or behavior of a 
family mcm~er. ------
lY. Cl1ange in residence. 
20. Det~ntlon in jail cr other :institution. 
--21. Minor violations of the law (e.g., traffic 
tickets, jayvalking, disturbing the peace, 
etc.). 
--
22. Hajor business readjustrr.cnt (e.g., merger, 
reorg'lnization, bankruFtcy, ere.). _ 
2J. Uarriage. ...__ ____ _ 
2/j. Divorce:. 
------
25. Marit~l separation from spouse. 
26. Outstandin~ personal achievement. ..___ ...... ___ _ 
6 mo- 1-2 
1 yr yrs 
~ ~ 
2-3 Does 
yrs not 
~ applv 
2 i. 
28. 
29. 
30. 
(r.-r. 
(JJr,c-: ~: 
.....---' 
Son or dau~htcr leaving heme (e.g., marriage, 
nttcnding college, etc.). 
--
Retirement from work. 
Hajor change in vorking hours or conditions. 
-
Major chanF,e in responsibilities at work 
(e.g., promotion, demotion, lateral tnms!er). 
0-~) 
me• 
-1!£!!._ 
31. Being: fired from vot·k. 
----
32. Major change in living conditions (e.g., 
building a new home, remodeling, deteriora-
tion of home or neighborhood). __ 
33. Wife beginning or ceasing work outside 
the home. 
34. Takin~ on a mortgage ~reater than $10,000 
(e.~ •• purchasing. a home, business, etc.)~ 
35. Taking on a mortgage or loan less than 
$10,000 {e.g., purchasing a car, TV, freezer, 
etc.). _ 
36. Foreclosure on a mortga~e or loan. 
-
37. Vacatiot;. 
3S. Chnn~inr. ttl ll n'.:!w school . 
--
JY. ChanGin~ to ~ different line of work. 
40. beginning or ceasing formal schoolinf,:. 
·----
41. Nar.iuu reconciliation Wltll "m;:J.t.l.. 
42. }'regnancy. 
6 mo-
1 vr 
~ 
!Jcn:-trtr~•(:,•l of b;vchi2trv and ilchav~or:;:l Sciences 
~nivcrsi~v of W~shin~ton School of Medicine 
Seattle, ~ashi~rton 981~5 
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Name ---------------- Da tc ------ Session i ----· 
INSTRUCTIONS 
For each life event item listed below please do the following: 
Think back on the event and decide 1f it happened to you within the past week, 
including today. 
If, ~uring the course of the last week, any of the items applies to you, place 
a check mark in the appropriate space to the right. !f one of the items 
should apply more than o~ce during the week, indicate the number of times 
the event occurred to you within the past week. 
If the event in question did not happen to you during the past week, check 
under "Dce5 not apply.~ 
l. A lot more or a lot less trouble with the boss. 
2. A major change i1 sleeping hatits (sleeping 
a lot more or a lot less, or change in part of 
day when asleep). 
3. A major change in eating habits {a 1ot more 
or a lot less food intake, N' very different 
meal hours or surroundinys). 
4. A revision of pers0nal habits (dress, manners, 
associations, etc.). 
5. A majo~· change ir, your usual type and/or 
amount of recr~ation. 
6. A major change in your sbcial activities 
(e.g .• clubs, danci~g. movies, visiting, 
etc.). 
7. A major change fn church activfties (e.g •• a 
lot more or a lot less than usual). 
B. A major change i~ number of family-get-
togethers (e.g., a lot n1ore or' a lot 1!:!SS 
than usua 1). · 
9. A major change in financial state (e.g., a 
lot worse off or a lot better off tnan usual). 
Number of tim~s 
within past week 
Does 
not 
~ 
Page T\'tO 
10. I~a-1aw troubles. 
ll. A major cha~gc in the number of arguments with 
spouse (e.g •• either a lot more or a lot 1ess 
than usual regarding child-rearing, personal 
hab1 ts, etc.). 
12. Sexual difficulties. 
13. 
14. 
15. 
16. 
17. 
ts. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
2.7. 
28. 
~9. 
30. 
tlajor personal injury or illness. 
Death of close family member (other than 
spouse). 
Death of spouse. 
Death of a close friend. 
Gaining a new family member {e.g., throu9h 
birth, adoption, oldster moving in, etc.). 
Major change 1n the health or behavior of a 
family member. 
Change in residence. 
Detention in jai1 or other institution. 
Minor violations of the 1aw (e.g., traffic 
tickets, jaywalking, disturbing the peace, 
etc.). 
•tajor business readjustment (e.g., merger, 
reorganization, bankruptcy, etc.). 
Marriage. 
Divorce. 
Marital separation from spouse. 
Outstanding personal achievement. 
Son or daughter leaving home {e.g., marriage, 
attending college, etc.). 
Retirement from work. 
Major change tn working hours or conditions. 
Major change in responsibilities at work 
(e.g., promotior., demotion, 1atera1 tr~r.sfer). 
Number of times 
within D3St week 
---------
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Dor:s 
not 
a!Jpl.::_ 
Page Three 
31. Being fired from work. 
32. Major change in living conditions (e.g., 
building a new home, r~nodeling, deteriora-
tion of home or neighborhood). 
33. Wife beginning or ceasing work outside 
the home. 
34. Taking ou a n:ortgage greater then $1C,OOO 
(e.g., purchasing a heme, business, etc.). 
35. Taking on a mortgage or loan less than 
$10,000 (e.g., purchasing a car, TV, freezer, 
etc.). 
36. Foreclosure on a mortgage or loan. 
37. Vacation. 
38. Changing to a new school. 
39. Changing to a different line of work. 
40. Eleginning or ceasing formal schooling. 
41. Marital reconciliation with mate. 
42. Pregnancy. 
Nun T of times 
wit •• in past week 
---------
Copyrignt©1976 by Thorr~as H. Holmes, t,l.D. 
Oep)lrtment of Psychiatry anci 8ehaviora1 Sr:iet:<:e~ 
University of ~iashington School of :.:~Jidne 
Seattle, Washington 98195 
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Does 
not 
~ 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
VAL'q~§__OF QUESTIONS ON SCHEDULE OF REGEI·:T EXPERIENCE (SRE} 
SRE Question Hean Value 
·-------
Trouble 't,;rith boss • o ••• . . 
Change in s1eepinr, habits o • • . . 
Change in eating habits o • • • • • • • • 
Revision of personal habits • • • • •• 
Change in recreation o • • • • • • • • • • • o • • • • 
Chrutge in social activities •••••••• 
Change in church ;::.::tivities • • • • • • • • 
Change in nur.:ber of family gct-togethers . . . . 
Change in financial state •. . . .. . . . 
Trouble with in-laws • • • • • • • o o o • 0 
23 
16 
15 
24 
19 
18 
19 
15 
38 
29 
11 Change in number of argurJc;nts lvlth spouse • • • • o • 35 
12 Sex difficulties • • • • • • • • • • • • • • • 39 
13 Personal injury or illness • • o • • • • • • • 53 
ll• Death of close fard.ly member o • • • • 63 
15 Death of spouse •••• o • • • • • • .100 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
2~1 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
Death of close friend • o • • • • 
Gain of new family member • o • o 
Change in health of family member • • o •• 
Change in residence o • o o • • o • o o • • • • • • o 
Jail terru o • • • o • • o • 
runor violations of the lm.~ 0 
Business readjust~ent • 
Marriage • o • o • 
Divorce • o o o • • 
:-1arital separation 
Outstanding personal achievement 
Son or daughter leaving home 
Retirement • o • • • • • • • • • o 
Change in vork hours or conditio::1s 
Char..ge in responsibilit:I.es at \JOrk 
Fired at work • • • • • • • • • 
Change in l:i.ving conditions • 
Wife begin or step work • • o 
Mortgage over $10,000 
:-1ortgage or loan less than $10,000 
Foreclosure of mortgage or loan 
Vacation • • • o • 
• • It • 
• • 0 
0 • • 
. . . . . . . . . 
Change in schools • 
C1ance to different 
Begin or end school 
. . . . . . .. . . . . . . 
line of \o.'r rk 
Narital reconciliation 
Pregnancy • • • • • o • . . . .. . 
37 
39 
44 
20 
63 
11 
39 
50 
73 
65 
28 
29 
45 
20 
29 
47 
25 
26 
31 
17 
30 
13 
20 
~~6 
26 
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LIFE EVENTS DIARY 
The purpose of this diary is to write down events that happen to 
you during the day that cause you either a significant an~unt of upset 
or that give you a significont drnount of pleasure. The events v:hich 
we would like you to write down are experiences which involve either 
danger, pain, significant changes in health, status or way of life; the 
promise of these; or important fulfillments or disappoint~ents. 
Please record on the following pages, on a day by day basis, those 
events in your life that, for better or for worse, interrupted or 
changed your usual activities. 
For example, include events affecting your occupation, your 
physical health, your living arrangbneni..s, your relettions with other 
family membe:·s, your friends, Ot' your ;:JerS•)t~al values or· beliefs. 
Include your seizures in each daily list. 
Please record these life events, including your seizures, in the 
order in wh·ich they ccct.;rred during the day, ar.d pl~=;ase note them in 
the right hand colum~ according to the following scale: 
1 = Extremely Pleasurable -- terrific! 
2 = Moderately Pleasurable -- good 
3 -- Mildly Ple3surable -- nice 
4 = Mildly Upsetting -- not too bad 
5 = Moderately Upsettin3 -- bad 
6 = Extremely Upsetting ··-· just a\':ful! 
Here is a sample of the type of 1 ife events listing that a. \'JOman 
might record: 
~1a rch 1 , 1978 
1. Children missed school bus; had to drive them to school. 3 
2. Husband called from work; won•t be home until late tonight, 5 
dinner engagement cancelled. 
3. Best friend cailed to say she lean:ed she -is pn:gnant. 2 
4. Children came home for lunch arguing with each other. 4 
5. Mother-in-law called to say she wants to ccme for ~n 6 
extended visit. 
6. Had a seizure. 6 
7. Called best friend, she came over for rest of afternoon. 3 
SCLF-EVALUATION QUESTIONNAIRE 
Dcvdopcd by C. D. Spielberger, R. L. Gorsuch and H. Lushcne 
SIAl FORM X-1 
NAME------------------------ DATE----
DllU~CTIO.::~.: A n•<:r.h::r of shtrmmts which people have 
used to des~·rilw tl;t:n,sdv•.'.'i <H<' givC'n bdow. Head each stat.e-
ment and th(•fl blacken in t!w approvria tc circle to the ri;:ht. of 
the statement to inri!c:tte how you feel right now, that is, at 
this moment. Then• are no right or \\ runr. m1swcrs. Do not 
spend too mud: time r>n nny one ~tatcment but r,ivc the answer 
which seems to desr.rih~ yo'ur prr:~!.'nt feelings bc3t. 
1. I feel caln1 ......................................................................................................... . 
2. I feel secure ..................................................................................................... . 
3. I a.tn tense ............ ···-·····································································-··············-··· 
4. I am regretful .... ····-············-············································································· 
S. I feel at case ..................................................................................................... . 
6. I feel upset ...................................................................................................... _. 
7. I filll presently wor:ying over possible misforh.:nes ................................. _ .. . 
8. I feel rest.Nl ....................................................................................................... . 
9. I !eel anxious ..................................................................................... - ....•.....••. 
10. I fccl comfortable ............................................................................................. . 
11. I feel sell-confident ..................................................................... - .................. . 
12. I feel nervous .................................................................................................. .. 
13. I s.m jittery ....................................................................................................... . 
14. I feel "high strung" ........................................................................................ .. 
15. I am l"E'lax(;d ......................................................... _ .......................................... . 
IG. I fe-el content ............................................................................... - .................. . 
17. I am worried ............................................................................................... _ .... . 
lfl. I fed cvN-c-xcitcd an:l "rattled" ............................... _ .................................. . 
19. ! feel jc,yful ............................................... ----------------··-·--·--·--··--·----···------·-----
20. } {c<:!l plPllS.:Ul!- ............................................................................... - .................. . 
CON:3ULTH·JG PSYCHOLOGISTS PRESS 
511 C<)ifc!:a )\V(;Il!l'J, P<~lo Ailo, C.lli!omia S4306 
2 l!l ~ 11: 
• ~ ... 
• = I= ~ 
<D CD 
<D ® 
(i) CD 
<D ® 
<D ® 
<D CD 
<D ® 
<D cv 
<D ® 
<D ® 
<D ® 
<D ® 
<D ® 
<D ® 
<D <D 
<D Q) 
<D ® 
<D Q) 
<D ® 
(.t) Q) 
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II: ; 0 
"' 2 -1 :;;: ~ <: £ o( 
~ 8 
® 0 
G> @ 
® 0 
@ 0 
<V 0 
(j) 0 
® 0 
® ® 
® @ 
® G) 
® 0 
® ® 
® ® 
Q) @ 
® ® 
® 0 
® 0 
® 0 
G> @ 
® @ 
SELF-EV/1UJA":'lON QUESTION~U.!BE 
STIJ fORM X-2 
NAME __ _ DATE----------
DIRECTIONS: A number of r;tatcmcnls whic!-1 pcopk h;JVr 
used to describe themselves are given bdow. Read (•;,rh ;;tate-
ment and then blacken in the appropriate circle to the right of 
the statemC'nt to indicate how you {.!<'nerally feel. There are 110 
right or wrong answers. Do nGt spt•nd to0 much time on any 
one statement hut give the ailswer which seems to describe 
how you generally ieel. 
21. I feel pleasant ...................................... : ............................................................ . 
22. I tire quickly .................................................................................................. .. 
23. I feel like crying .............................................................................................. .. 
24. I wish I could be as happy as others seem to be ........................................... . 
25. I am losing out on things because I can't make up my mind soon enough .... 
26. I feel rested ....................................................................................................... . 
27. I am "cahn, cool, and collected" ..................................................................... . 
28. I feel that difficulties are piling up so that I cannot over~•)me them ......... . 
29. I worry too much 0ver something that r>}ally doesn't maLt!:'r .................... .. 
30. I am happy ........................................................................................................ . 
31. I am inclined to take things hard ................................................................ .. 
32. I lack self-confidence ....................................................................................... . 
33. I feel secure .................................................................................................... .. 
3-!. I t:-y to avoid facing a crisis or difficulty ...................................................... . 
35. I ferl blue ......................................................................................................... . 
36. I run content ..................................................................................................... . 
37. Some unimport.3.nt thought runs through my mintl and bothers me ......... . 
38. I take disappointments so keenly that I C>ln't put them out oi my mind .... 
39. I a1n a steady person ..................................................................................... .. 
40. I get in a state of t~nsion or tunnoil as I think over my rcccr;t concern;; and 
interests 
Copy•ighl ,f) }f.6.'i by Chw·lcs [). Spir/brr'/Pr. U•·prnductio!l .,f this '' -'! ur nny po~tion 
tlt.ercof l;y CJny pr.,cess u·ith<'t~t wriUI'n fwrmis ... ion !,f the Puhli~oth£1 i~-o pr0~1biet'd. 
~ ., 
0 0 ~ ::: 
'Z <'; 
a 
::l 
::: 
&l 
<D ® 
<D ® 
<D (2) 
<D ® 
<D 0 
<D "' "' 
<D ® 
CD <V 
(j) ® 
(!) (!) 
<D Q) 
<D (2) 
<D <D 
<D ® 
<D <D 
(j) <D 
<D (j) 
<D (j) 
(;) ® 
~ 
0 
~ 
> 
0 .,.. 
~ :.; )-
-< z ., 
® 0 
<D 0 
<D 0 
@ 0 
cv 0 
@ 0 
® @ 
<V 0 
<V 0 
cv l'9 
® 0 
<V 0 
(!\ @ 
(j) @ 
® @ 
Q) 0 
® 0 
<D 0 
(!) 0 
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Patient's Name 
.~ECTJON A. TillS IS A.~ EPILEPSY QUESTIONNAIRE. IT IS DESIGNED TO HELP US UNDER-
STANO AS FULLY AS POSSIBLE 111E SEIZURES TilA.T YOU ARE HAVING, PLEASE REL..U .A.'W 
TAKE YOUR TIME. 
2. Date of Birth: (Mo) (Day) (Yr) 
3. Age: __ years 
4. Sex: ~lale Female 
s. Race: 
1. White 4. American Indian 
2. Black 5. Spanish A~erican 
3. Asian 6. Other (specify) 
6. Marital Status: 
1. Single 4 •. Divorced 
2. Married 5. Wido~o:ed 
3. Separated 6. Living as married 
7. Veteran: 1. Yes 2. No 
8. Ed.lcation (check patient's highest level): 
1. Completed postgraduate tra.ining 
2. Attended postgrac.uat·~ training 
3. Completed college or equivalent 
4. Attended college or equivalent 
S. Completed high school or equivalent 
6. Attended high school (9-12) 
7. Completed grammar school 
8. Attended grammar school (1-8) 
9. No schoolins: 
SECTION B. THERE ARE H.A..NY DIFFERE/I.'T KINDS OF SEIZURES; THEPEFORE, SmP- OR 1--'.,.\h'Y OF 
WE FOLLOWING QUESTIONS WILL l:OT APPEAR TO RELATE TO YOU!'< CASE. 00 NOT LET TiiJS 
CONFUSE YOU, SUlPLY ANSWER ALL QUESTI0:\5 A5 ACCURATELY AS YOU CA.~. 
11. How old were you when you had your first spell or seizure? ------years 
12. Do you have stari~g spells where you lose contact with people aro~~d you for 
just a few seconds? 
], Yes (Go to Question 13) :::=: 2. No (Go to Section C, page 4) 
13. How long are your staring spells? 
1. Less than l second 
2. 1 to 10 seconds 
3. 11 to 120 seconds 
4. 2 to 10 minutes 
S. Greatcx· than 10 minutes 
14. Are there any movements observed during youi· st:~:ring spells'! 
1. Yes 2. No 
STIJDY '118 - FOR'! 1 ~Continued) Patient Study No. ____ / ____ _ 
15. During your staring spc 1!. s, h.::vc your friends or family described you to: 
!. Smack your lips or ru~.:,e your lips? ! . Ye£. 2. 
2. Lick your lips? L Yei 2. 
3. f.luttC'r your e-yelids'? 1. Yes 2. 
4. }iove your hands and plny with chject,;? 1. Yes 2. 
s. Talk during )'Otlr st:nir;g spells? l. Yes 2. 
6. Walk d11ring ycu;: scariog sr·el!s '! 1. Yes 2. 
16. Have you fcum~ yourself 1vaking up fr0:n a spell in a strange place or in an 
area distant f=om the area you had been in when your spell started? 
1. Yes 2. No 
No 
No 
No 
N::> 
No 
No 
17. Hava you ever attad:cd and b1Jrt other human beings during your starir.g spells? 
1. Yes 2. No 
18. Do your staring spells suddenly end in a matter of a split second? 
1. Yes 2. No 
19. Do you remain confused after your staring spells? 
1. Yes 2. No 
20. Describe your feelings immediately preceding your staring spells. 
1. Happy 
---2. Sad 
3. No change 
4. Fearful 
5. Other (specify) 
21. Do you remember events irmaediate ly preceding your staring spells? 
1. Yes 2. No 
22. Do you remember l'Vents during your staring spells? 
1. Yes 2. No 
23. Do you remember cwnts during the period of confusion that follows your 
staring spells? 
1. Yes 2. No 
24. Hmv rr.any staring S?ells h:>'Je ycu haJ in youz, lifetilile? 
1. Less than 10 
2. 11 to lOJ 
3. Greater than 100 
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2S. \'ihe:n did your first staring spe 11 occur? 
l. __ __ days ago 
2. __ __ weeks ago 
3. _____ months ago 
4 • __ ___ years ago 
26. ~ihcn was your Inost t·ccent staring spell? 
1. 
----
days age 
2. 
----
weeks ago 
3. months 
----
ago 
4. years ago 
----
27. Are your spe 1ls becoming more frequent? 
1. Yes, they arc more frequent 
2. No, they arc remaining the same 
3. No, they arc becoming less frequent 
4. It is difficult to tell 
28. How m&ny spells have you had this week? 
1. None 
2. Once or twice this week 
3. About every other day 
4. Once a day 
5. Several times a day 
29. How many spells have you had this past month? 
1. None 
2. Less than once a week 
3. Once a \veek 
4. Several times a week 
5. Or.ce a day or more 
:;o. How many spells have you had this past year? 
1. None 
2. 1 to 3 
3. 4 to 12 
4. 13 to 24 
5. Greater than ?4 
SECTION C. TilE FOLLO\HNG QUESTIO~'S WILL ASK ABOlTI' OTiiER WPES OF SEIZURES 'mAT 
YOi.fFIAY HAVE HAD. 
31. Do you have falling spells l>here yc-u lo~·e consciousness, shake your arms or 
legs, or wet your ?:mts? 
1. Yes (Go to Qt:estion 32) 
2. No (Go to Section D, ?age 6) 
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32. Do you lose consciousness with your attacks? 
1. Yes, inrnediatcly at the start of an attack 
2. Yes, during tl1e attack 
3. No 
33. How often have you lost consciousness? 
1. Not applicable 
2. With one attack only 
3. tli th less than half of my atta-:ks 
4. With more than half of my attacks 
s. tli th every attack 
34. How long do you remain unconscious? 
1. Not applicable 
2. A few seconds 
3. A few minutes 
4. 15 to 45 minutes 
S. Greater than one hour 
IF YOU OlECKED ITEMS 2 OR 3 OF QIJESTI.ON 32, CONTINUE TO QUESTION 35. IF YOU 
Q!ECKED ITH1 1 OF QUESTION 32, GO TO SECTION E, PAGE 8. 
35. Do the first events of an attack consist of unusual movements of a part o-F 
the body? 
1. Yes (Go to Question 36) 
2. No (Go to Section D, page 6) 
36. How long do the movements last? 
1. Less tha:i one minute 
2. 1 to 5 minutes 
3. 6 to 10 ~inutes 
4. Creater than 10 minutes 
37. W'nere does this movement start? (Chcc.k all that apply) 
1. Foot or leg 
2. Arm or hand 
----- 3. Side of face 
4. Other (specify) 
38. On which side docs this·movement start? 
1. Right sid.;! 
7. J.eft ~ide 
3. Right and left sides 
39. Does this movement spre~d to o!her parts of the body? (Check all that apply) 
1. Not applicable 
2. Foot or leg 
3. Hand or ann 
4. Side of face 
5. Other (speci~;~ ________ , ___ ,. __ . ______________ _ 
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40. J f the movement ~as ,;prcaJ, where is it located? 
I. Not <!pp!icable 
2. Right s!.d,! 
3. Left sid~ 
4. Right a.-,d left sides 
t.l. Do your head and/or eyes turn to one side? 
l. Yes, to the right side 
2. Yes, to the left side 
3. Yes, :;ometin.es to the right or left side 
4. No 
SECTION D. 
42. Are there any unusual sensations, feelings, dizziness, s~ells or tastes with 
your attacks? 
lh Yes (Go to Question 43) 
----- 2. No (Go to Section E, page 8) 
43. Have you had any of the following sensations at the start of an attack? 
(Check all that apply) 
1. Numbness 
2. Tingling or pins and needles 
3. Feelings of hot cr cold 
4. Pain 
5. No~e of these (Go to Question 46) 
44. Where do these sensations occur? (Check all that apply) 
1. Face 
2. Trunk 
3. Arms or hands 
4. Legs or feet 
45. On which side do these sensatic.ns occur? 
1. On the right side 
2. On the left side 
3. On the right and left sides 
46. Have you experienced any of the following sen.;ations at the start of an 
attack? (Check all that apply) 
1. II cart boa:. slowing do'!.'Tl or speedj ng up 
2. Increa5ed perspiraticn 
3. Nausea or vo~iting 
4. None of these 
47. Hav~ you cxpcri<-nccd an unusual s£nsation of smell at the beginning of an 
attack? 
1. Yes 2. No 
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48. Can you describe this smell? 
l. Yes, (describe) 
2. No, but it is .:1 fo.ulsmcTi-- · 
3. No, but it is a pleasant srilcll 
4. N0t applicable 
49. Have you experienced an unusual sen~ation of taste at the beginning of an 
attack? 
1. Yes 2. ~0 
SO. Can you describe this taste? 
1. Yes, (describe) 
2. No, but it is a foul-taste-
3. No, but it is a plcasa..&t taste! 
4. Not applicoble 
51. Have you experienced an unusual s~r,s.:.tion in your stomach? 
1. Yes 2. No 
52. How wculd you describe this sensation in your stomach? (Check all that apply) 
I. Not applicable 
2. Nausea 
3. Sinking sensation 
4. Ris1ng sensation 
5. Pain or discomfort 
6. Other (specify) 
53. Have you experienced any dizziness? 
I. Yes 2. No 
54. H0\'1 WOtlld you describe this dizzincs:~ '! (Check all that apply) 
I. Not applicable 
2. Sense of turning or spinn1ng 
3. Movcmen'c of objects around you 
4, Defective balance or staggering 
5. Fedings of llghthcadedness, that I am about to faint 
6. Other (specify) ---··-·-· 
55. Have you exper1e;1ced any hcanng changes? 
1. Yes 2. No 
56. How would you describe these h~;;aring cl:angcs? (C1wck all that apply) 
1. Not applicable 
2. R1ncin~ in my cars 
3. Nc1scs !;1 my cars 
4. Sotmds set'!m lotll1r::t tr:;m tl'-t::li. 
~. Sounds seem s0ft~r than usual 
6. Distortion o( sounds 
7. Other (specify) ------------------·---
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57. Have you experienced any visual changes? 
I. Yes 2. No 
58. How would you describe these visual changes? (Check all that apply) 
1. Not applicable 
2. Blurred vision 
3. Double vision 
4. Sensation of light 
5. Sensation of dark 
6. Sen sat ion of color 
7. Objects appear larger 
- 8. Objects appear smaller 
9. Shapes are distorted 
--10. Hallucinations (visions) 
--11. Other (specify) 
59. Do you have ~~y other unusual sensations not mentioned above? 
1. Yes (describe) 
2. No 
SECTION E. 
60. Have you had any of the fol101ving experiences at the start of an attack? 
(Check all that aprly) 
I. A feellng of familiarity when I was in •'!1far:1iliar circumstances 
2. A feeling of ne\er having seen something befo•t: when it was very 
fa.11il.i.ar to me 
3. Unexplained fear 
4. 1hlr.king ~.bout one thing continuously 
5. None of these 
61. Have you had any of the following experiences at the start of an attack? 
(Check all that apply) 
1. Loss of speech or understanding but a;iare of people around me 
2. Not being in control of my behavior 
3. Hearing ;:. musical theme over and over 
4. None oi these 
62. Have you ever had (as described by family or friends) prolonged states of 
behavior changes that you do not remember? 
!. Hours 
-2. Days 
3. 1\'eeks 
4. None of these 
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63. Have you experienced any of the following at the start of an attack? 
(Check all that apply) 
1 . Goose bumps 
2. Headachf.)S 
3. Bright spots in front of you 
4. Sehsation of floating or being lifted up in the air 
5. None of these 
64. Have you experienced any of the follo~>·ing at the start of an al:tack? 
(Check all that aprly) 
1. Difficulty judging distance 
2. Ceiling looks deeper and farther 
3. Wall looks deeper and fa~thcr 
4. People look farther or nearer than usual 
5. None of these 
· 65. Have you experienced any of the following at the start of an attack? 
(Check al1 that apply) 
1. Difficulty understanding spoken language 
2. Difficulty explaining your thoughts through the spoken la.11guage 
3. Difficulty understanding Hritten 1vords 
4. Dif~iculty naming objects 
5. None l)f these 
66. Have your family or friends described a prolonged state of confusion where 
you are noted to perfonn c.ompl ex purposeful Jr.ovements, l.Jalk around and 
exhibit usual eati.ng habits l'ILile you appear to be dazed and in a dreamy 
twilight :;tate? 
1. Yes 2. No 
If yes. for how long a time? hours 
67. Have you been to!d that ycu cry out during an attack? 
L Yes :l. No 
68. Ht~.\·l' you been told that your arms or legs jerk d•1rin5 an attz.;:k after you 
ha-.rc 1 ;>S t consciousn.Jss? 
1. Yes 
2. No 
3. N~t applicable 
69. How long do these movc:n<;:'nts last? 
1. Not applicable 
Z. A few seconds 
3. Up to 3 minutes 
4. 3 to 10 minute~ 
S. 11 to 30 minutes 
6. More than an hour 
7. It ch~nges from seizure to seizure 
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70. 1\'hich limbs are involved? 
1. Not arplicable 
2. Arms 
3. Legs 
4. Arms and legs 
71. ~~ich side is involved in this jerking? 
1. Not applicable 
2. Right side 
3. Left side 
4. Right and left sides, 
72. Hav.- you ever done any of the following during an at tack? (Oteck all that 
apply) 
1. Bitten your tongue 
2. Lost control of yoer bladder 
3. Lost control of your bowels 
4. Foam at the mouth 
5. Become stiif all over 
6. Roll your eyes upward 
7. None of these 
73. H::tv~ you ever injured yourself? !. Yes 2. No 
74. How severe was this injury'? 
1. Not applicable 
2. Minor injury that did not require a doctor 
3. Required a doctor but was not serious 
4. Serious injury such as a bone fracture 
75. Have others described you as being t-.wake but confused during an attack? 
1. Yes 2. No 
76. How long does this last? 
1. Not applicable 
2. A few seconds 
3. A few mim.:tes 
4. An hour 
5. ~lore than an hour 
.. 
77. Have others descr.ibed you as e:1~;aging i!l purposeless ~ctiv:i.ty ,luring an attack? 
1. Yes 2. No 
78. How long does this behavior last? 
1. Not applic~;l, le 
2. A. few sec~mtls 
3. A fc1• minutes 
4. Ait hour 
s. ~lore than an hour 
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79. Have others described you as having great changes ln emotion duriP-g an attack? 
1. Yes 2. No 
80. Do any of the following describe these emotions? (Check all that apply) 
1. Not applicable 
2. Rage or anger 
3. Severe depression 
4. Fear 
5. Pleasure 
81. After an attack, do )'OU suffer from (check all that apply): 
1. ~luscle soreness 
2. Headaches 
3. Confusion/Disorientation 
4. Tiredness 
5. Anxiety 
6. Combativeness 
7. None of these 
82. Do you sleep after an attack? 
1. Yes, for less than an hour 
2. Yes, for an hour or longer 
3. Yes, for the whole day 
4, No 
83. Other than your staring spells, when did your first seizure occur? 
1. days ago 
----2. weeks ago 
----3. 
----
months ago 
4. 
----
years ago 
84. How many major attacks have you had (other than your staring spells)? 
major attacks 
85. tihcn was ymn· mo5t recent attack? 
). days ago 
----2. 
-----
weeks ago 
3. months ago 
----4. 
----
years ago 
(IF LESS UlAN FOUR ATTACKS, GO TO SECTION F, PAGE 12) 
86. Are your attacks becoming more frequent? 
1. Yes, they are more frequent 
2. Nu, they are remaining the same 
3. N''• they are less frcq'-"ent 
4. It is difficult to tell 
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87. How rna:1y attacks h:~ve you had this past week? 
1. Not applicable 
2. Several times a day 
3. One;~ a day 
4. About every other day 
5. Once or tH.icc this week 
88. How rtany at;tacks l.a·,·(; you La·:l this past month? 
1. Not applicable 
2. Once a day 0r more 
3. Several t1~es a week 
4. Once a \<i<::ck 
5. Less thaa once a week 
SECTION F. 
89. On days when I have a major attack: 
1. I go back to :1hat I was doing within an hour after an attack 
2. It takes several hours to recover from an attack 
3. It takt:s a day or longer to r.ecover from an at tack 
90. On days when I have short lapses of consciousness: 
1. I go back to what 1 was doing ~ii thin an hour after an attack 
2. It takes several hours to recover from an attack 
3. It takes a day or longer to recover from an attack 
91. Which of the following describe your situation? 
1. I ~m not restricted as to the type of work I can do 
2. I can 1-1ork ln:t there are restrictions 
3. I ca..·mot work at all 
92. On the average, hov; much l':ork do you miss in a month because of your seizures? 
(Enter NA if patient is retired, unemployed, etc.) 
days 
93. Which of ti1e follu1ling describe your situation? 
I. f.ty at tad s tlo not prevent me from enjoying myself in large crowds 
or being with people I do not knov; well 
2. Because of my seizures, there are times when I must limit my 
social activities outside my heme 
3. Because 0f my sei z.ures, I cio not fee 1 comfortable around others 
and must sP-vcrely limit .ny contact with oth·~r people 
94. Have you had a se•·cre he<~.d injury? 
1. Yes 2. No 
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95. What tnle of head injury .,..,as tnis? 
1. Not applicable 
2. Auto accident 
3. Fall 
4. Blow to her.n 
5. Military inJ ttr)' (\wund) 
6. Other (specify) 
96. Did you have a skull fracture? 
1. Yes 
2. No 
3. Not applicable 
97. Did /O'.J. lus ~ consciousne:'>s '! 
1. Yes 
2. No 
3. Not applicahJ~ 
98. How long did you remain ur..ccr.s cious? 
1. Not applicable 
2. A few seconns 
3. A few minutes 
4. An hour 
5. Several hours 
6. A day or l)ngcr 
99. How long after your head injury rlid the seizures begin? 
1. Not applicable 
2. My seizures began before I had the head injury 
3. Hours later 
4. Days later 
S. Weeks later 
6. ~~nths later 
7. Years later 
100. Have you had any of the following illnesses? (Check all that apply) 
1. Meningitis 
------ 2. Encephalitis 
3. Other brain fever 
4. Stroke 
5. Tumor 
6. None of these 
101. If you had a stroke, how long after your stroke did the seizures begin? 
1. Not applicaGle 
2. Several days later 
3. Several ~eeks later 
4. Several nonths later 
5. Several years later 
6. ~~ sci:ures beg~~ before had the stroke 
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102. Was the onset of your seizures associated with anoth~.· illn~ss? 
1. Yes (spcci fy) 
2. No -------------·--------------
103. Were you suffering from any of the following with the onset of your seizures? 
(Check all that apply) 
1. Unusual fatigue 
2. Emotional tension or stress 
3. Poor nutrition or lack of meals 
4. None of these 
104. What, if anything, can you do to stop a seizure? (Check all that apply) 
1. Nothing 6. Concentrate - mind 
2. Walk around 7. Stop talking 
3. Stop moving 8. Close eyes 
4. Sit do~o.n 
5. Go to bed 
9. Hold self tightly 
--10. Other (specify) ---·------
lOS. Do you have sudden attacks where you drop to the floor with unconsciousness? 
1. Yes 2. No 
106. Do you have sudden attacks where you drop to the floor but do not lose 
consciousness? 
1. Yes 2. No 
107. Do you have sudden attacks were you fall to the floor during short lapses of 
unconsciousness? 
1. Yes 2. No 
108. Which one of these attacks is most common to you? 
1. Short lapses of consciousness 
2. Drop attacks 
3. Unconscious spells with generalized stiffening 
4. Unconscious spells \dth generalized stiffening followed by jerking 
movements 
S. Spells with generalized jerking irovements alone 
109. DQes anyone else in your family have spells or seizures? (Check all that apply) 
Relationshi.p 
Son ••• 
Daughter 
U:Jthcr 
Father . 
Sister . 
Brother. 
Maternal Grandparent 
Patern.:ll Grandpar;)nt 
Aunt • 
Uncle. 
Cousin 
Minor Spells ~faj or Attacks 
Yes No NA Yes No NA 
ST'JJjY llllll - FOR;'.t 1 (Cont.i11ucd) l'atient Study No. -· __ / ____ _ 
~E~E!.~~~· WE i10lJ!.D LIKE TO l\QCm·U2NT W DETi\lL TIWSE FACTCRS, IF ANY, I'.'HIQ! SEEM 
TO TUGGER, INCREASE, DECREASE OR W A'IN Ol11ER WAY mDIFY TilE TYPE OF FREQU'Ei'~CY OF 
YOUf( SEIZUi<l:S. PLEA.C:;E ANSi'itR Tilli FOLLOiliNG QUESTIONS A.'> ACCURATELY AS YOU CA.\!. 
C:> 
_.t.- 4. ~ ~... ~ ..., 4.'? ~~ ~((,- ~~(; .;;,"?-" .:r;."r 
~~ e:.o o"- .;:,c; <rr" 
I 2 3 4 S 
110. Is there any cycle your seizures seem to follow? • . • 0 I I I 
DO YOUR SEIZUP£S SEEM TO FOLLOW: 
111. ft~ hourly ~ycle? • 
112. A daily cycle? • 
11.3. A weekly cycle? .• 
114. A monthly cycle? • 
115. A seasonal cycle?. 
116. M. irr~gular flu:rr.y? 
117. Other cycle? 
118. 
ll!J. 
Do your seiz:.rres occur only upon ;;wakening?. 
Do yr.ur seizures occur only during sleep'?. 
120. Do your seizures cccur either upon awakening 
or during sleep? . . . . . . . . . . 
00 YOUR SEG'.UFES TEND TO OCCUR AT M<Y OF THE 
FOLLO\'iiNG THIES? 
121. Horning .. 
172. Noon ... 
123. Afternoon. 
124. 
125. 
Evening .. 
Oozing off to sleep. 
126. F.n.rly slee-p •• 
127. Late !:lcep .• 
128. On aw::lkeni -:1g (1·1i th.b fiy·:;:: hour) 
. . . . . 
129. Other (specify) ----·-----------------
1 2 3 4 s 
~ 1-· 
. 
1 2 3 4 5 
I 
.. 
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00 YOUR SEIZUf<ES TE~D TO OCCUR UNDER A.'N 
OF 1llE FOLLCI'iJNG CI W.:U~1STA:,iL.>:S? 
130. Mentally al~rt and thinking actively 
131. Awake but relaxed with mind not actively 
working on a particular topic .. 
1S2. Drowsy . • • • . • • . • . • • . • • • 
133. 
134. 
135. 
136. 
137. 
138. 
139. 
140. 
141. 
142. 
143. 
144. 
During active exercising such as walking, 
ronnir.g, etc. . . • . • • • • • . • • • • • 
Inunediately after exerdse, while "catching 
your bx·eath" • . . . • . . • • . • • • 
When physically fatigued from muscular work. 
Shortly before meals 
Du-ring meals 
Af·ter meals. 
\'.'hen bored . 
Other (specify) 
Is your seizure frequency affected by whether 
you are working or otherwise actively being 
kept busy? • . . . . • • • . • • • • • • • • • 
In the past 3 months, have you lost sleep some 
nights (not in bed more than 3 hours)? . 
Does lost sleep have any effect on your 
seizure frequency? •....••••. 
Do you tend to gain weight or 5well up for any 
reason?. . . . . . . . . . . . . . . . . . 
145. Does weight gain or swelling have any effect on 
your .seizures? ••.••..••.•••••••• 
146. In the past 2 years, h:lVP. you had any illness 
where you had a f~ver of greater th~n 100 degrees? 
14 7. Does a fever have any effect on your attacks?. . . 
148. Have you had other illnesses during the past 2 
years such as stomach upsets, broken bones, etc.?. 
149. Have rou'!" seizures been affected by other 
illnesses? .•..•. , ••••••••. 
I 
I 
-
--1---
~ ---f--
--'-
1 2 3 4 5 ~~~ 
-
I I 
I 
~~ 
. I 
LU I 
--1---t±l I 
_IJ j 
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150. 
151. 
152. 
D" ym1 smoke?. . . • • • • • • • • 
Does s:nokin~ afft:ct you1· sp~lls? 
Have you missed your n1eciication at times?. 
. . . 
153. Do you notice an increase in the r.u•1her of 
seizures you have if you miss your medication? 
154. Has the use or excess use of any kind of medicine 
(including anticonvulsant.;) seemed to increase 
your seizures? • . . . . . • • • • • • • 
155. Have you used alcohol in the past 2 years? .. 
156. How often do you use alcohol? 
1. Do not use alcohol 
2. Rare (as on rare social occasions) 
3. Infrequent (1-2 times per month) 
4. t.ioderate frequency (1-2 times per week) 
5. Frequent (3-4 times per week) 
- 6. V'3ry frequent (5 or more times per week) 
157. Estimate total ounces of alcohol consumed: 
1. Do not usc alcohol 
2. Beer 
3. Wine 
4. Liquor 
5. Other (specify) 
lSS. Was your alcohol intake or the effects of the alcohol on your seizures 
different in earlier years? 
1. Yes 2. No 
15S. Do various type.:; of alcohol (i.e., beer, wine, liquor) seem to have a 
different effect on your seizures? 
1. Y~s 2. No 
1f yes, explain 
____ , ___ _ 
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160. Docs the use of alcohol at any time seem to 
increase or decrease the frequency of your 
seizures?. • . • • • . ••• 
161. Do you have seizures while under the influence 
162. 
163. 
164. 
165. 
166. 
167. 
168. 
169. 
170. 
171. 
of alcohol? . .................... . 
Do you have seizures after having alcohol to 
drink but no longer under the influence of 
alcohol (i.e., morning after)'? .•..••• 
Does your er.totional state seem to influence 
the freq1;1ency of your seizures? ....• 
DO Al'f'f OF lliE FOLLOWING TEND TO INCREASE 
---YOUR SEIZURE FREQUENCY? 
Sudden emotion of any kind (within 1-2 seconds). 
A sense of fr~stration .. 
Following an e:>~otionally stimulating experience 
(i.e., argument, exciting sports event) ..•.• 
[luring a period of fearfulness, ~lol"ry cr anxiety 
During a time of s~dness, weeping or depression. 
During a period of anger or hostility •• 
l'lhen feeling quite happ/ 11r joyful . . . 
During excitement as in anticipation of some 
event or when many stimulating things are 
occurring at the same time ...•.•• 
DO mY OF niE FOLWW'ING TEND TO DECREASE 
YOUR SEIZURE FREQUENCY? 
li2. Sudden emotion of any kind (Hithin 1-2 sc::onds). 
173. A sens¢ of fn1s trat ion . • 
174. Following an enotionally stimulating experience 
(i.e., argument, exciting sports event) . . . • . 
!75. £h.1ring a period of fearfulness, l·iOITY or anxiety 
176. ThJring a tine of sadness, wccpi~g or depression. 
177. During a period cf anger or hostility .. 
178. !'.'hen feeling quite happy or joyful ... 
179. Du:ri.ng excitement ~s in :.J.!"1ticipation of so1~c 
event or ,.·hen many stimulating t~ings are 
occurring at the same time . • • , • • • • • 
1 2 3 4 5 
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ST(]!)';' 013 - FOP.M 1 (Continued) Patient Study No. ___ ! __ ___ _ 
J -·~ 
CN~ /lJJ A'fT1\CK BEGIN OR BE BROUQIT ON BY: 
1£0. Any specif:i.c kind of movement, such as moving 
one hand, etc.? ..••••••••••••••• 
181. Contact w:i.th a part of the body (rubbing of the 
hand, leg or other part of tile ·body by clothing, 
t:tc.)? . ....••.•..•• 
182. vJud noises (no specific type)?. 
133. A specific kind of noise such as music or 
bells, etc.? . . • • • • •.• 
184. Suddenly going into an area that is sunny or 
brightly lit?. • ••• 
185. Fl~~slL~ng lights? 
186. ExposurP. to a particular type of odor or taste?. 
187. Sexual activiiy? 
188. Bc1ng startled?. 
189. 
190. 
191. 
192. 
Do your &ttacks occur while reading? . . . 
Does the type of diet you follow have any 
effe-ct oa your seizures? ..••• 
Do allergies affect your seizures? 
Does bcMel irregularity affect the 
of your seizures? ....••••• 
frequency 
193. Does the use of coffee or tea affect the 
frequency of your seizures?. . •..•. 
194. Do you have periods of thirst related to the 
occurrence of your seizures? • . . .•• 
SECTIO~ H. TO BE CmtPLETED BY WOHEN ONLY. 
195. Have you note.:! a definite relationship of your 
seizures to the oc:urrcnce or appearance of 
yot.n· menstrual pe!'iod? .•••...••••••••• 
196. Do your seizures occur before your menstrual period? • 
197. Do rour sd:z:ures occur during your menstrual period? 
1S8. L'o your sci:t•n·;,s occur fol101dng your 
mr.nstrual peric,d"?. . . . ... ,. ..• .. Ill • ,. • 
199. Do yol•r ~eizures occur in-between your 
mcn5 t1-ual pez·lod? . ......... . 
I 
I 
1-- --
i 
1---
-fffi 
2 3 4 5 
I 
--rl 
1-- i 
1 
' 
I I 
1 2 3 4 5 
f I 
H r 
~-J 
241 
242 
STIWY I 118 - fORN 1 (Conti wet!) Patient Study No. __ :_I _____ _ 
200. Have you ever been prc~r.ant? 
1. Yes 2. No 
HAVE YOUR SEIZURES BEEN DIFFERENT IN Ff<EQUENC'Y OR CHAF.ACI'ER DURING ANY OF 
'!liE FOLLOWING; 
201. Early pregnancy? 
l. Yes 
202. Mid pregnancy? 
l. Yes 
2. No 
2. No 
203. At the time of delivery? 
1. Yes 2. No 
204. Within two weeks following delivuy? 
1. Yes 2. No 
3. Not applicable 
3. Not applicable 
3. Not applicable 
3. Not applicable 
205. Did you nvtice an increase in yo~r seizure frequency while pregnant? 
1. Yes 2. No 3. Not applicable 
206. Did you notice a decrease in your seizure frequency while pregnant? 
207. 
1. Yes 2. No __ 3. Not applicable 
Did your seizures begin about the same year your menstrual period began 
or stopped? 
1. Yes 2. No 
208. Have you ever used birth cor.trol pills? 
1. Yes 2. No 
209. Has the use of birth control pills had v.:oy eff.ect on your seizures? 
1. Yes .2. No 3. Not applicable 
DATE CmiPLETt:D: / I FOR'-! C01·!PLETED BY: 
-r~GY {Da.;r -cvrr 
EPILEPSY Aim TliE XENSTRUJ'l.L CYCLE 
PATIEtiT INFOR~tATlON 
Name Study No. ______ _ 
Addr·css 
le 1 ephonc (.:.:.h.::.:om"". e:.<.. )_______ __.;__ 
(work) 
Date of birth. _________ _ 
Socia 1 Security # ________ _ 
Seizure classification 
(list controlled and 
U!lcontro 11 ed types) 
Previous seizure frequency 
for each type 
ACJe at menarche 
(year menstruation began) 
1. 
2. 
3. 
1. 
2. 
-
3. 
_..vears 
_#/wk., 
#/wk., 
1/'rrk. , 
mo., yr. 
lilO., yr. 
mo., yr. 
Do you have regular menstrual cycles? 
always ~ua11v rarely 
Do you have menstrual cramps? 
Do you feel tense just before your period starts? __ _ 
Have you ever used oral contraceptives (the pill)? yes ___ no __ _ 
If ye\ name of dt·uCJ ________ ------
dates of use ~__,_ __ _months/years 
Have you ever used other steroid drugs regularly? yes 
---
Have you ever beer• pregnant? yes ____ no ---· I pre~manci e_s _ 
C:c•mpleted form 1: [pilcosy Background and Histo1·y yes 
---
no 
--·-~---
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YALE UNIVERSITY SCHOOL OF MEDIClNE 
DEPARTMENT OF OBSTETRICS AND GYNECOLOGY 
INFERTILITY AND ENDOCRINE CLlNJ:CS 
Basz.l Temperature Record 
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NHIII _____ History Nvmber _____ _ 
Basal Te:mperature Record 
History Number 
PLEASE BRING 'l'!lJS 1'\:SCORD iliTH YOU. 'i'O CLINIC: RAC:E VISIT! 
1. Place the thermometer under the toneue for at least a full t;;o minutea 
immediately after wo.king ir, the morning ;wd befor.:J arising, 3eting, 
drinking or smoking. (Do this every morning). 
2, Record the reading on the graph by pladng a dot or X at tha proper 
location (be accurate). 
245 
3· Insert the date at the top of col= in space pro·tiiled for conth and <!ate.. 
Also, insert the day of the week (Monday, Tuesday, Wednesday, etc.) in the 
epace provided. 
4. The firf!t day or me:natl"'.t.'3.l flow is considered to be th<J start of a C"'J'cle. 
Each day of flo·.: shoula be indicated uith an X on the g::-aph starting at 
extreme left ur,;ier number one day of cycle. 
5·. Any obvious reasons for te:nperature variation such as an infect:!. on, inso;nnia 
or indigestion should ba noted on the graph above the reading for that day. 
6. Ovulation in som'! ;;omen is detectab:;.e by a twinge of pain lo;.r on one side 
of the abdomen or by a few drops cf vaf.inal bleeding about mid-cycle. If 
this la noticed indicate lt on the graph. 
7. Please record the number of spells or seizures you have ea:.:h day, i.f ar,y, 
in the space provided on the graph. 
6. If you huve more than one type of 3pell or seiz'~s, please keep a sepa~ate 
record for each type. List the first typa on one line a.Ld the se~ond type 
C"•n the l:l.no bclrM. fl.J'lothcr chnrt is prcvi"ct:'. ':or -orn o;:<:>11'pl.-.t0 f'"?i ,.u..-n ::'"'"''·-r· 
Basal Temperature Record 
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Seizure Record 
Patient's Name Study No. I 
-·- ---
PLEASE RECORD NL'7>ii>ER Or SEIZURES EACH DAY. (Record co.mm.;nts on bnck.) 
Pltt4<.e 1"\..'t rl( Fl~n- DAY c~ mc..I'!S)Y<A<li ~~!.riOt(~ 
HONTil YEAR MONTI! YEAR ~lONTil YEAR 
-- ---
--- ---
1 1 l 
2 2 2 
3 3 3 
4 4 4 
5 5 5 
6 6 6 
7 7 7 
8 8 8 
9 9 9 
10 10 10 
11 11 11 
12 12 12 
13 13 13 
14 14 14 
15 15 15 
-----------
16 16 16 
-----
17 17 17 
---
18 18 18 
---~-... ------
19 19 19 
20 20 20 
21 21 21 
----
22 22 22 
--------
23 23 23 
24 24 24 
---·--~-·-
25 25 25 
26 26 26 
-----------
27 27 27 
----·---·-
28 28 23 
----------
__________ ... _ .. 
29 29 29 
-----------
30 .30 30 
!1 .51 31 
" 
Name. __ 
Date 
Weight. __ _ 
EPILEPSY AND THE MENSTRUAL CYCLE 
CLINIC VISIT 
Study No. 
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l seizures since last visit--------
average # seizures I month 
calendar re:turned yes __ no_ 
Antiepileptic Drug 
Total daily dose (mg/d~ 
hours since last dose ~p} 
serum concentration 
(total JJ9/ml} 
free drug cone. (yg/m1) 
% free 
estrogen cone. pg/ml 
progesterone cone. ng/ml 
date last menstrual period started _{=day 1) 
I days since first day 
phase of cycle (adjusted to cycie length. ____ _ 
Use of adjunct medication since last visit yes _____ no 
Next c 1 in i c vis it----·--·-·-·-------.. -·-
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CHECKLIST FOR MENSTRUAL CYCLE STUDY 
Name Date Session.Number 
·--------· ---
A. 3lood Work 
B. EEG 
1. Three tubes of blood, red-top. Make sure patient is asked 
total dose of anticor.vu1sants that day, and hours since 
last dose. 
2. Blood spun down, seruM labeled, tl-10 tubes frozen. One tube 
to Special Chemistry for anticonvu1sant levels. 
3. Save lab slips that carrie up from Special Chemistry, put on 
yellow sheets in the Men_strual Study patient's charts. 
1. Electroencephalogram performed. 
2. Paoer run labeled with patient name, tape number, Session 
Number, Time given, Reel number on tape~ date. 
3. Tape labelled with patient nume, tape number, Session Number, 
Time given, Reel number on tape., date. 
4. Replace tape and paper run in ,Janet's office. 
__ C. Epilepsy and the Menstrual Cycle Clinic Visit Chart. 
1. Compare returned thermometers \d th patient graphs. 
--2. Nake sure a11 the following information is recorded: 
· a. Name. 
b. Date. 
c. Number of seizures, kind of seizut·es, and the dates they 
occurred, for example: 7/14/78- 2 Petit Male, 1 Grand Mal. 
d. W~ether calendar was returned for checking or not. 
e. Antiepileptic drugs, tota1 daily dose, hours since last dose. 
f. Date last Menstrual period started. 
g. Use of adjunct medication since last visit. 
3. Nake sure diary is up-tO-date (green book or steno notebook). 
__ D. Questionnaires 
l. Henstr·ual Distress Questionnaire, Form T 
2. Weekly Schedule of Recent Experiences (SRE) 
3. POl-IS Profile of Mood States 
4. Self-Evaluation Questionnaire STAI Form X-1 
C~ECI:L !ST FOR ~;EJl_~TRIJ~L CYCLE STUDY 
Page lwo 
Name ___ Date ----Session riumber· 
__ ·:E. Neuropsychological Testing 
1. Grip Strength 
2. Finger Tapping 
3. Pegs 
4. Color Naming 
5. Trunkal Ataxia 
6. Digit. Span 
7. Dig it Symbo 1 
e. Trails B 
9. Visual Search 
249 
JI.PPENDIX C 
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CONSENT FOR PARTICIPATION IN A P.J..:SEARC}! PROJr~CT 
You are ir.vltcd to pe.rticip.<J.te in a study to evaluste th'"l rcle.tionohip between 
seizure lnddence and menstrual c:rclf~S. The purpose of the study is to •::>bserve 
whcthqr some •.romen ex:perienc~~ mere seizu:-es durir.e a particular phase of the 
menstrual cycle, Wouen epileptic patlents vjll be selected to partic1pnt in 
this study, F.ach WClD11n shou-ld have a regu1ar menntru.al cycle currently and ·.rill 
report an association with sai~ures und menstrual cycle; so~e women will ha~0 
noticed no pattern of seizure occurrence, 
Participation in the 3 rr.onth study will requir.a no hospitalization. You ;.rill 
be asked to maintain a calendar {to be provided) recording all seizures including 
comments about severity of r,pisodes. Daily body temperature e.nc! mer.st::-ual flo~,; 
will ~lso be recorded. You will be asked to visit ~he Epilepsy Latoratory ~or 
three months for interview and blood tests on the first and second rlay of your 
menstrual flo;~, two veeks later during mid-cycle, and during the third veek of 
your cycle. (A fourth visit several days before your ~enses is expected, may tP. 
requested). During these laboratory visits thre.:l :::mall tubes of blood w~.ll be 
drawn (approximately one ounce), vhich may cause tri3f discom.:'oC"t, EEG recordings 
vill be perfortled. Each visit will te.ke approximately tvo hours. 
If the study documents an increase in seizure frequency during a p!1~.se of the 
menstrual cycle, the patient may benefit by special additional dr•.1g th;;:·o.py 
adJusted to known requirements, The general benefit of the study vill be a 
knovledge that cyclic changes in seizure incidence do occur ax:d may rt:Jquire 
special therapeutic regimens to protect patients wnen sei'<:u:res are ezpected. 
All possible steps will be taken to maintain confir1enti1:l.lity of all ir_formt.ion 
provided by you. In.forma.tton obtained f:rom you vill become a part of your 
medical record. If you de·cide not to participate, or if at any time you wish to 
terminate participation in the study, you may do so and coatinue to recei-;e 
appropriate therapy for your condition. This will havo n::; effAct on your care 
here. You s.re welcome to ask questions at anyti;:r;e. B-:~fore you dgn t.his form, 
please nsk any questions or any aspect of this study that is unclear to y-ou. 
You mey take as much time as necessary to think this over. 
Authoriztt't!on: I h!'.ve read the ab<'ve ar.:d decide that -:---~,-----:----
(name of subject) 
vill participate in the project described above. Its general purposes, the 
particulars of involvement and possible hazards and inconveniences ha·.re been 
explained to my satisfac•ion. My signature also 5.ndicates that I have received 
a copy of this consent form. 
Signature 
RelationshJp (~elf I rarent 1 g:lll.rCian' &tC •) 
Date 
Signature of Principal .Investi;;at.or Telephone 
Siena ture t)f pe:::-son obtaining consent TeJ ephone 
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